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1. Retrosynthetic Applications in Visible Light 
Photoredox Catalysis 
1.1 Introduction 
Visible light mediated chemical reactions received a significant boost in popularity within the past 15-20 
years. Photons which were already predicted to play a vital part in the future of chemistry in the beginning 
of the 20th century, were rediscovered and accepted as traceless and easily accessible reagents by 
organic chemists.[1] The reason for this is not only the availability of selective and intensive light sources 
but also the broad range of newly developed photocatalysts that enable a manifold of formerly unknown 
chemical transformations.[2] With these powerful tools in hand, photocatalysis is not a merely academic 
field of research anymore but slowly find its way into applications in the chemical and pharmaceutical 
industry like e.g. transition metal catalysis in the past.[3]  
However, despite their popularity photochemistry and photo(redox) catalysis rarely constitute a 
significant part of the basic chemical education during bachelor and master studies retarding the overall 
perception and broader application of the field. As a consequence, a chemist who was taught to perform 
retrosynthetic disconnections exclusively with intuitive polar strategies, might be skeptical to integrate 
the less intuitive radical disconnections into his/her lab routine.[4] 
To facilitate the general entry into the field, many reviews try to give an overview of the hardly countable 
number of publications about photochemistry and photocatalysis.[5] For almost all traditional / thermal 
reactions a photocatalytic counterpart was developed and many new disconnections were discovered. 
However, since not all visible light mediated reactions can be discussed in this thesis, the introduction 
focuses on providing a summary of different photochemical and photocatalytic halogenation strategies 
due to their importance in organic synthesis and their thematic connection to this work. Instead of a 
recapitulation of the basic principles of photocatalysis and the individual reaction mechanism, 
retrosynthetic disconnections for each halide are provided as a condensed excerpt of the overall 
published literature (Table 1). These solutions are always displayed in a similar style including the target 
structure, the corresponding retrosynthetic synthon and the required starting materials as published in 
the reference. Next, the functional group tolerance as well as a few selected example structures are 
displayed to illustrate the scope. Additionally, the reaction conditions, additives, photocatalyst and light 
source are provided to give an overview of the required equipment and chemicals. Finally, the scheme 
is discussed concisely in text form (e.g. commercial availability of important reagents/catalysts). If 
multiple procedures for the same/ or very similar disconnection exist, those are listed after the main text 
with short notes about their differences to the method highlighted in the scheme. 
  
__________________________________________________________________________________ 
2 
Table 1-1. Top table: Overview of photocatalytically accessible, retrosynthetic C-C / C-X bond 
disconnections. Bottom Table: Condensed excerpt that will be elucidated in this thesis. 
 
 
 
✓: well exploited, (✓): limited number of examples, X: no / very few, limited examples, n.c. not covered 
in this survey. *: C-sp centered disconnections will not be discussed due to the overall low number of 
examples. 
To summarize the published literature on visible light mediated halogenation reactions it can be stated 
that many different methods including direct C-H activations, the use of prefunctionalized substrates 
(e.g. carboxylic acids) and atom transfer radical addition (ATRA) reactions were reported. Especially the 
fluorination and the bromination of sp3 centered carbon atoms were explored in detail due to the high 
synthetic value of those intermediates. On the other hand, the photocatalytic fluorination of arenes is 
severely underexploited and remains a challenge to be tackled in the future. This leads to the conclusion 
that although chlorination, bromination and iodination reactions are well established text-book 
transformations in organic chemistry, light driven halogenations do not only complement the existing 
methods, but also enable access to new, unknown or challenging C-X bond disconnections. The 
versatility and utility of these new reactions might be the key for a successful transition from academic 
research to application in the chemical or pharmaceutical industry.  
 C-sp3 C-sp2 C-sp* F Cl Br I B N O P S 
C-sp3 ✓ ✓ n.c. ✓ (✓) ✓ (✓) (✓) ✓ ✓ ✓ ✓ 
C-sp2 ✓ ✓ (✓) X (✓) (✓) (✓) ✓ ✓ ✓ ✓ ✓ 
 F Cl Br I 
C-sp3 ✓ (✓) ✓ (✓) 
C-sp2 X (✓) (✓) (✓) 
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1.2 C-F bond: 
Fluorinated organic molecules play an important role in bioactive compounds e.g. pharmaceuticals and 
pesticides.[6] Currently, more than 25% of all candidates in the pharmaceutical pipeline contain at least 
a single fluorine atom due to its influence on drug metabolism and protein stabilizing effects. [6a] Further 
applications of fluorine containing molecules include medicinal diagnostics with 18F labeled PET tracers 
and polyfluorination of organic compounds.[7] Many methods for the introduction of fluorine atoms into 
small molecules on both lab and industrial scale have been developed, relying mainly on the use of 
extremely reactive elemental F2, highly toxic HF or unreactive fluoride salts.[7] Therefore, there is still a 
demand for new, selective and mild procedures facilitating especially late-stage modifications of 
bioactive compounds.[8] In this respect, photocatalysis adds a significant amount of retrosynthetic 
synthons to the toolbox of the organic chemist by supplying both new methods for direct C-H 
fluorinations and for directed decarboxylative fluorinations. 
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1.2.1 Generation of aliphatic C-F bonds 
Strategy 1 – C-H fluorination 
 
Scheme 1-1. Direct fluorination of sec. and tert. aliphatic C-H bonds.[9] 
The selective fluorination of aliphatic C-H bonds is a big challenge of modern organic chemistry and it 
is still desirable to find new and simple methods for this kind of disconnection. One solution was provided 
by the group of Britton who developed a strategy for the fluorination of simple molecules (Scheme  
1-1).[9] The photocatalyst, tetrabutylammonium decatungstate (TBADT), and the fluorination reagent N-
fluorobenzenesulfonimide (NFSI) are commercially available and the reaction mixture was irradiated 
with 365 nm LEDs for 16 h. Although the isolated yields were generally moderate (40-60%) and the 
functional group tolerance was rather low, since mostly only ketones, esters, lactones and protonated 
amino acid esters worked, this work was adopted by Merck & Co for the remote fluorination of leucine 
methyl ester which was a precursor for the (now ceased) anti-cancer agent odanacatib.[10] After transfer 
of the reaction into flow and another optimization cycle, the yield could be increased to 90% in a 45 g 
scale reaction which illustrated the utility of this method for the selective fluorination of tertiary C-H 
bonds. Alternative strategies for this disconnection employed either tetracyanobenzene[11] or 
anthraquinone[12] as photosensitizers and provided a similar substrate scope. Further alternative 
methods used ketones as directing groups recommending these strategies particularly for the 
fluorination of steroids.[13] Hamashima and coworkers demonstrated that not only ketones but also 
phthalimides could act as directing group for selective C-H bond fluorinations.[14] Finally, even an 
uranium and visible light mediated method was described by Sorensen and coworkers.[15]  
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Strategy 2 – C-H fluorination of benzylic C-H bonds 
 
Scheme 1-2. Direct mono or double fluorination of benzylic C-H bonds.[16] 
Since the benzylic position is typically a weak spot in metabolism of biomolecules, Chen and coworkers 
developed a specialized method for mono or double fluorination of benzylic C-H bonds depending on 
the catalyst and fluorination reagent used (Scheme 1-2).[16] Both catalysts, 9-fluorenone and xanthone 
are cheap and commercially available, as are the fluorination reagents Selectfluor® I and II. The reaction 
mixture was irradiated for 6 h to 96 h with a simple 11 W fluorescent light bulb. The yields ranged 
typically from 60% to 80% and the functional group tolerance of the method was moderate including 
aromatic halides (F, Cl, Br), ketones, esters, aromatic carboxylic acids and protected amino groups. 
Alternative strategies for the monofluorination of benzylic C-H bonds were reported by Lectka and 
coworkers who employed tetracyanobenzene as photocatalyst and by Wu and coworkers who used 
Fukuzumi’s catalyst.[17] 
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Strategy 3 – Decarboxylative fluorination 
 
Scheme 1-3. Decarboxylative fluorination of aliphatic carboxylic acids.[18] 
Carboxylic acids are among the most abundant functional groups in both natural products and fine 
chemicals. Therefore, the MacMillan group developed a viable, photoredox-catalytic strategy for the 
decarboxylative fluorination of aliphatic carboxylic acids (Scheme 1-3).[18] The method employed 
commercially available [Ir{dF(CF3)ppy}2(dtbpy)]PF6 as the photocatalyst, Selectfluor® as the fluorine 
source and Na2HPO4 as base. The reaction mixture was irradiated with blue LEDs for 1 h to 15 h leading 
to the fluorinated products in generally very good yields (70-90%). The shown functional group tolerance 
was moderate including alcohols, ethers, ketones, esters and protected amines. Many alternative 
decarboxylative fluorination procedures were published complementing the substrate scope of 
MacMillan’s method e.g. by Paquin and coworkers who used α-oxo carboxylic acids as starting materials 
and the cheaper Ru(bpy)3Cl2 as photosensitizer or by Ye and coworkers who used an organic dye 
instead of transition metals.[19] Another recent, but regarding the scope more limited alternative was 
published by Hammond using a heterogeneous photosensitizer.[20] Moreover, a new strategy for the 
decarboxylative fluorination of heteroarenes was realized by Tang and coworkers.[21] However, the 
method is limited to electron-rich heteroarenes and suffers from dimerization of the heteroaryl radical 
intermediate which lowered the overall yield. Finally, Jamison and coworkers developed a SF6 and 
visible light mediated strategy for aliphatic fluorination starting from allylic alcohols rather than carboxylic 
acids.[22] 
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1.3 C-Cl/Br/I bond: 
Aliphatic and aromatic halides (Cl, Br, I) are valuable synthetic intermediates in organic synthesis which 
are accessible by many standard text book reactions.[23] However, the field for the development of novel 
halogenation strategies is still active. The main goal is to find milder and more selective conditions, to 
enable stereoselective halogenation or to perform late-stage functional group interconversions turning 
bioactive molecules into complex building blocks.[24] The contributions of visible light mediated methods 
to this field are numerous offering both radical and polar reactivity as well as ATRA reactions leading to 
diverse substrate scopes. The versatility of these protocols recommends photocatalysis as a powerful 
tool for aliphatic and aromatic halogenation reactions. 
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1.3.1 Generation of aliphatic C-Cl bonds 
Strategy 1 – Decarboxylative chlorination 
 
Scheme 1-4. Decarboxylative chlorination of aliphatic carboxylic acids.[25] 
For example, Glorius and coworkers published a silver-free procedure for a Hunsdiecker-type 
decarboxylative halogenation of the readily available feedstock of aliphatic carboxylic acids (Scheme  
1-4).[25] The method employed [Ir{dF(CF3)ppy}2(dtbpy)]PF6 as photocatalyst and the common lab 
chemicals N-chloro succinimide (NCS) as chlorine source and cesium carbonate as base. The reaction 
mixture was irradiated with blue LEDs (455 nm) for 14 h providing the corresponding chlorinated 
products in generally very good yields (70-90%). However, the reported functional group tolerance was 
limited to bromides, ethers, esters, protected amines and amides. Noteworthily, the method could not 
only be applied for decarboxylative chlorinations but also for brominations and iodinations if either diethyl 
bromomalonate or N-iodo succinimide (NIS), were used as halide sources. A direct, photocatalytic 
chlorination of aliphatic C-H bonds was developed by Chen and coworkers who employed benzo- or 
acetophenone as photocatalysts and NCS as chlorine source providing a broader functional group 
tolerance but limited to benzylic C-H bonds or low selectivity if molecules without benzylic C-H bonds 
were used.[26] 
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Strategy 2 – ATRA reactions generating chlorinated products 
 
Scheme 1-5. ATRA reaction of fluorinated sulfonyl chlorides with Michael acceptors.[27] 
The group of Dolbier developed a strategy for an atom transfer radical addition (ATRA) of fluorinated 
sulfonyl chlorides to Michael acceptors (Scheme 1-5).[27] The method employed Cu(dap)2Cl as 
photocatalyst, the fluorinated sulfonyl chloride as ATRA precursor and K2HPO4 as base. The reaction 
mixture was irradiated with a 26 W fluorescent light bulb for 12-24 h giving the ATRA products in 
generally excellent yields (70-90%). The functional group tolerance was broad including many different 
electron withdrawing groups (EWG) as well as many different fluorinated sulfonyl chlorides. An 
alternative ATRA chlorotrifluoromethylation was developed by Han and coworkers using Ru(phen)3Cl2 
as photocatalyst providing similar yields and functional group tolerance.[28] Reiser and coworkers 
reported an ATRA chlorination with sulfonyl chlorides and managed to preserve the SO2 in the product 
leading to chlorinated sulfones.[29] Noteworthily, this method is not limited to Michael acceptors but both 
electron rich and poor double as well as triple bonds are tolerated. Finally, the Magnier group managed 
to perform this ATRA reaction with N-chlorinated sulfoximines adding both the sulfoximine and Cl to the 
double bond.[30] 
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Strategy 3 – Generation of β-chloro ketones 
 
Scheme 1-6. Oxochlorination of aryl cyclopropanes.[31] 
Very recently, our group developed a visible light mediated oxychlorination of aryl cyclopropanes 
(Scheme 1-6).[31] No photocatalyst but only diluted HCl and HNO3 as well as irradiation with a high power 
395 nm LED for 2 h were required to promote the reaction giving the corresponding β-chloro ketones in 
generally good yields (50-70%). The functional group tolerance was broad including many common 
functionalities (e.g. halides (F, Cl, Br), alcohols, ethers, aldehydes, esters, amides, CN, CF3 and boronic 
acids) although electron rich starting materials generally gave better yields than electron deficient ones. 
Noteworthily, if sodium anthraquinone-2-sulfonate (SAS) was used as a photosensitizer, other 
nucleophiles than chloride could be used (e.g. bromide, H2O or MeOH) expanding the utility of the 
method. 
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1.3.2 Generation of aromatic C-Cl bonds 
 
Scheme 1-7. Direct chlorination of aromatic C-H bonds of electron rich arenes.[32] 
An electrophilic aromatic substitution relying on simple NaCl rather than Cl2/AlCl3 as the chlorine source 
for a Cl+ synthon was realized. This strategy was reported by Hu and coworkers in 2017 as a method 
for the photocatalytic chlorination of electron rich arenes (Scheme 1-7).[32] Utilization of NaCl and sodium 
persulfate as well as ruthenium trisbipyridine (Ru(bpy)3Cl2) as commercially available photosensitizer 
and irradiation with blue LEDs for 24 h led to the corresponding chlorinated arenes in excellent yields 
(60-90%) albeit only moderate ortho/para regio-selectivity, which was to be expected from the Cl+ 
reactivity. Many functional groups were tolerated including halides (Cl, Br), alcohols, esters, amides, 
CN, CF3 and NO2 groups but the method failed to chlorinate very electron deficient arenes e.g. 
nitrobenzene or trifluoromethoxybenzene. Alternatively, a transition metal free, photocatalytic 
chlorination method was developed by our group giving similar yields and showing the same functional 
group tolerance.[33] 
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1.3.3 Generation of aliphatic C-Br bonds 
Strategy 1 – C-H bromination 
 
Scheme 1-8. Direct bromination of sec. or tert. aliphatic C-H bonds.[34] 
In addition to the chlorination, several photocatalytic strategies for bromination of aliphatic C-H bonds 
were published. Tan and coworkers employed the commercially available disodium salt of Eosin Y as 
photocatalyst and CBr4 as bromine source, as well as morpholine as sacrificial electron donor (Scheme 
1-8).[34] The reaction mixture was irradiated with a simple 11 W household lamp for 24 h providing the 
corresponding brominated products in generally good yields (50-70%). The reported functional group 
tolerance was low including only alkyl halides (Cl, Br), ethers, ketones and esters. An alternative 
procedure with a similar substrate scope was published by Lu and coworkers using KBr and NaNO2 as 
bromination system.[35] Another strategy was published by Franzén and coworkers employing NBS as 
the bromine source.[36] The authors proposed that a trityl-cation as Lewis acid together with simple hood 
light promoted an efficient bromination of the benzylic position of electron rich arenes. 
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Strategy 2 – Deoxygenative bromination 
 
Scheme 1-9. Deoxygenative bromination of aliphatic alcohols.[37] 
Another text book bromination is the Appel reaction which turns aliphatic alcohols into the corresponding 
halides.[38] However, its significant disadvantage is the generation of stochiometric amounts of 
triphenylphosphinoxide as side product which is often hard to separate.[37] Therefore, Stephenson and 
coworkers developed an elegant method for a photocatalytic Appel reaction which completely avoids 
the generation of triphenylphosphinoxide (Scheme 1-9).[39] The strategy required Ru(bpy)3Cl2 as 
photocatalyst, a mixture of CBr4 and NaBr as bromine sources as well as DMF as the solvent. The 
reaction mixture was illuminated with blue LEDs for 5-15 h giving the corresponding deoxobrominated 
products in generally very good yields (70-90%). The reported functional group tolerance was moderate 
including double and triples bonds, ethers, esters and protected amines. Noteworthily, also iodinations 
could be performed if iodoform and NaI instead of CBr4 and NaBr were used.  
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Strategy 3 – Remote oxidative bromination 
 
Scheme 1-10. Remote oxidative bromination of cyclic, aliphatic alcohols.[40] 
Zhu and coworkers developed a photocatalytic, oxidative ring opening bromination of unstrained, cyclic, 
benzylic, tertiary alcohols (Scheme 1-10).[40] The procedure used [Ir(ppy)2(dtbbpy)]PF6 as photocatalyst, 
NBS as bromine source and phenyliodine(III) diacetate (PIDA) as hypervalent iodine species. The 
reaction mixture was irradiated with blue LEDs giving the corresponding remotely brominated ketones 
in generally good yields (50-70%). The functional group tolerance was moderate including aromatic 
halides (F, Cl, Br), ethers, esters, CN and CF3 groups. Noteworthily, the reaction times were very long 
ranging from 12 h to 100 h. 
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Strategy 3 – ATRA reactions generating brominated products 
 
Scheme 1-11. ATRA reaction between diethyl bromomalonate and alkenes.[41] 
Stephenson and coworkers published a visible light mediated ATRA reaction of diethyl bromomalonate 
with alkenes (Scheme 1-11).[41] The method employed Ru(bpy)3Cl2 as photocatalyst, diethyl 
bromomalonate as ATRA precursor and LiBr. The reaction mixture was irradiated with a fluorescent light 
bulb for 24 h giving the ATRA reaction products in generally excellent yields (70-90%). The functional 
group tolerance was moderate including alcohols, ethers, esters, amides and carbamates. However, 
the authors demonstrated that also many other ATRA precursors instead of just diethyl bromomalonate 
could be used e.g. CF2BrCO2Et or CCl3Br providing the corresponding products also in excellent yields. 
Many alternative methods for this transformation were published e.g. by Pericàs using Bi2O3 as 
heterogeneous photocatalyst[42] or by Reiser using Cu(dap)2Cl instead of Ru(bpy)3Cl2.[43] 
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1.3.4 Generation of aromatic C-Br bonds 
 
Scheme 1-12. Direct bromination of aromatic C-H bonds of electron rich arenes.[44] 
Our group published a method for the direct bromination of electron rich arenes and heteroarenes using 
sodium anthraquinone-2-sulfonate (SAS) as an inexpensive and commercially available photocatalyst 
as well as NaBr and TFA as common lab reagents (Scheme 1-12).[44] The reaction mixture was irradiated 
with a 400 nm LED for 4 h giving the brominated products in generally very good yields (60-80%). The 
functional group tolerance was broad including double and triple bonds, halides, alcohols, acids, esters 
and free amines but the procedure failed to brominate electron deficient arenes e.g. chlorobenzene. An 
alternative method published by Lamar uses NBS as bromine source extending the substrate scope by 
phenols and free amine groups.[45] The groups of Fukuzumi and Zhang also published visible light 
mediated methods for the oxidative bromination of arenes however with more limited substrate 
scopes.[46]  
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1.3.5 Generation of aliphatic C-I bonds 
Strategy 1 – C-H iodination 
 
Scheme 1-13. Direct iodination of sec. or benzylic aliphatic C-H bonds.[47] 
The direct, visible light mediated iodination of benzylic and secondary C-H bonds was realized by 
Gandelmann and coworkers (Scheme 1-13).[47] The method did not require a photocatalyst and used  
1-iodo-3,5,5-trimethylhydantoin (1-ITMH) which was activated by white light (400-800 nm) and high 
temperatures (100 °C). The yields of the iodinated produces were moderate (40-60%) and the reaction 
was unselective towards alkyl chains. The functional group tolerance was low (only chloride and fluoride 
were shown) but the reaction time was short (0.5-2 h). Additional methods for the generation of aliphatic 
iodides were developed by Glorius and coworkers focusing on the decarboxylative iodination of aliphatic 
carboxylic acids[25] (see 1.3.1, Strategy 1 for details) and by Stephenson and coworkers enabling the 
deoxygenative iodination of aliphatic alcohols (see 1.3.3, Strategy 2 for details).[39] 
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Strategy 2 – ATRA reactions generating iodinated products 
 
Scheme 1-14. ATRA reaction between perfluoroalkyl iodides and alkenes/alkynes.[48] 
Reiser and coworkers developed a visible light mediated ATRA reaction between perfluoroalkyl iodides 
and alkenes or alkynes (Scheme 1-14).[48] The method employed Cu(dap)2Cl as photocatalyst as well 
as perfluorinated octyl iodide as ATRA reagent and did not require any other additives. The reaction 
mixture was irradiated with green LEDs for 12-42 h giving the ATRA products in generally very good 
yields (60-80%). The functional group tolerance was good including halides, alcohols, ethers, esters, 
acids, carbamates and silanes. Alternative methods focusing on other fluorinated alkyl iodides were 
published by Stephenson[41] (e.g. CF3I) and Guo[49] (CF3CH2I) providing similar yields and functional 
group tolerance.   
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1.3.6 Generation of aromatic C-I bonds 
 
Scheme 1-15. Decarboxylative iodination of aromatic carboxylic acids.[50] 
Fu and coworkers published a procedure for the decarboxylative aromatic iodination (Scheme 1-15).[50] 
They used [Ir{dF(CF3)ppy}2(dtbpy)]PF6 as commercially available photocatalyst, N-iodosuccinimide 
(NIS) in combination with I2 as iodine source and cesium carbonate as base. The reaction mixture was 
illuminated with blue LEDs for 24-36 h giving the products in generally good yields (60-80%). The 
functional group tolerance was broad including both electron donating and electron withdrawing 
substituents (halides, ethers, CN and NO2 group) as well as pyridine and thiophene as heterocycles. 
Another method which did not require a photocatalyst, was published by Li and coworkers and started 
from aryl triflates instead of carboxylic acids providing similar yields and functional group tolerance.[51] 
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2. Photocatalytic Oxidative Bromination of Electron-
Rich Arenes and Heteroarenes by Anthraquinone 
 
 
 
 
 
 
 
 
 
 
 
 
 
The estimated excited oxidation potential of sodium anthraquinone-2-sulfonate (SAS) increases from 
1.8 V to about 2.3 V vs SCE by protonation with Brønsted acids. This increased photooxidation power 
of protonated anthraquinone was used for the regio-selective oxidative bromination of electron rich 
(hetero)arenes and drugs in good yield. The mild reaction conditions are compatible with many 
functional groups, such as double and triple bonds, ketones, amides and amines, hydroxyl groups, 
carboxylic acids and carbamates. Mechanistic investigations indicate the photooxidation of the arene 
followed by nucleophilic bromide addition as the likely pathway. 
 
 
This chapter has been published in: 
D. Petzold, B. König Adv. Syn. Catal. 2018, 360, 626–630. (Communication) – Reproduced with 
permission from John Wiley and Sons. 
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mechanistic investigations and wrote the manuscript. BK supervised the project and is the 
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2.1 Introduction 
The development of novel, photocatalytic transformations received tremendous attention in the past 
decade due to the versatile reactivity of radical intermediates.[1] To form radicals, a single electron 
transfer step is necessary.[1] However, direct single electron oxidation or reduction of many substrates 
is thermodynamically not feasible by the currently available photocatalysts. Proton coupled electron 
transfer (PCET) extends the accessible range, as the interaction with acids or bases alters the oxidation 
or reduction potential of carbonyl compounds, amides and other substances up to 500 mV.[2] 
However, PCET activation of aromatic C-H bonds is difficult to realize, because they cannot be polarized 
by simple bases. Thus, the direct photocatalytic activation of aromatic C-H bonds is still challenging and 
requires photocatalysts with a high oxidation potential. Commonly used photocatalysts for these 
processes are [Ir{dF(CF3)ppy}2(dtbpy)]PF6 (EOx ~+1.2-1.7 V) and acridinium based dyes  
(EOx ~+2.0 V).[1] Photocatalysts offering a significantly higher oxidation potential have not been 
developed yet or require multistep syntheses.[3] 
To enable the photo-oxidation of arenes and heteroarenes with easily available photocatalysts, we 
envisioned enhancing the oxidative power of anthraquinones by protonation.[2] The applicability of this 
approach was demonstrated by the photocatalytic bromination of electron-rich arenes.[4] Employing 
sodium anthraquinone sulfonate (SAS) as the photocatalyst, sodium bromide as bromine source and 
oxygen as terminal oxidant allows an efficient and selective bromination of aromatic substrates with 
oxidation potentials up to 2.3 V vs. SCE.[5] The excited state oxidation potential of SAS was estimated 
from electrochemical and spectroscopic data.[6] The interaction of arenes with the SAS excited state was 
confirmed by fluorescence quenching studies.[7] Furthermore, the viability of this method for late-stage 
functionalization of complex, bioactive molecules was demonstrated.[8] 
2.2 Results and Discussion 
2.2.1 Synthesis 
We started our investigations using anisole (1a) as a model substrate, sodium anthraquinone sulfonate 
as the catalyst, two equivalents of acetic acid (pKa = 4.76) to activate the anthraquinone derivative and 
five equivalents of sodium bromide in a mixture of acetonitrile and demineralized water (4:1) under air 
atmosphere. Irradiation at 445 nm by a single LED for 18 h gave 43% conversion to the corresponding 
brominated anisole derivative (2a) (Table 2-1, entry 1). As an increase of the amount of the acid did not 
improve the yield significantly (entry 2), different acids were tested (entries 3-4). The amount of 
converted starting material increased with the strength of the corresponding acid. Employing KHSO4 
(pKa = 2.1) gave 80% conversion and changing to TFA (pKa = 0.2) lead to full conversion. After more 
optimization steps, the best conditions were identified, using 2 equiv. of NaBr, 2 equiv. of TFA and  
5 mol% of catalyst in a mixture of MeCN H2O 1:1 at 400 nm irradiation, giving full conversion of the 
starting material within 4 h (entry 5). Especially the change of the light source from 445 nm to 400 nm 
greatly accelerated the reaction due to the greater extinction coefficient of the catalyst at shorter 
wavelengths (see Chapter 2.4.2 for details). Moreover, control experiments revealed that in absence of 
acid, catalyst, light and/or air no reaction took place (entries 6-8).   
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Table 2-1. Optimization of the reaction conditions. 
 
 
 
 
 
Entry SAS [mol%] Acid [equiv.] NaBr [equiv.] Yield of 2a[a] 
1 20 AcOH [2] 5 43% 
2 20 AcOH [5] 5 50% 
3 20 KHSO4 [2] 5 80% 
4 20 TFA [2] 5 100% 
5[b] 5 TFA [2] 2 100% 
6[b] 5 - 2 n.r. 
7[b] - TFA [2] 2 n.r. 
8[c] 5 TFA [2] 2 n.r. 
9[d] 5 TFA [2] 2 traces 
General conditions: 0.1 mmol of 1a, indicated amount of SAS, acid and NaBr in 1 mL of MeCN H2O 4:1, 
18 h irradiation at 445 nm. [a] Yield determined by GC-FID using naphthalene as internal standard. [b] 
MeCN H2O 1:1 and 400 nm irradiation was used. [c] MeCN H2O 1:1 but no light. [d] MeCN H2O 1:1,  
400 nm irradiation under nitrogen atmosphere. n.r. no reaction. 
In the next step, the synthetic scope of the photocatalytic oxidative bromination was explored (Fig. 2-1). 
All tested methoxy arenes showed full conversion and good isolated yields (2a-2i). Moreover, despite 
the acidic environment, Boc-protected amine 2k was isolated in good yield. On the other hand, the 
electron withdrawing substituent in compound 2l reduces its reactivity in the reaction significantly. 
Interestingly, amide 2m gave only the displayed brominated product despite the presence of two 
electron-donating groups at the second aromatic ring. This indicates that also steric factors influence 
the selectivity of the bromination. Electron-deficient indole derivative 2o gave a moderate yield, as well 
as the electron-rich benzimidazole derivative 2p. Notably, SAS could oxidize pyrazole 2q and its 
derivatives 2r and 2s to give the brominated compounds in excellent yields. This extends recent 
observations, in which pyrazole (EOx = 2.21 V vs SCE)[5] was shown to be inert towards the oxidation by 
acridinium dyes and used as a nucleophile in amination reactions instead. [3, 9] Finally, also bioactive 
compounds were brominated. The painkillers phenazone (2t) and tramadol (2u) gave excellent yields 
of only a single brominated product and the complex alkaloid strychnine (2v) could be selectively 
brominated in moderate yield. The hypolipidemic agent gemfibrozil (2w) and the anesthetic lidocaine 
(2x) gave moderate yields due to a competing oxidation of the benzylic position to the aldehyde.[10] The 
reaction of the benzylic position was exploited for toluene (1ac) (EOx = 2.2 V vs SCE)[4a] if persulfate was 
used as oxidant under inert atmosphere (scheme 2-1). In this case, it was possible to achieve exclusive 
bromination of the benzylic position in good yield. Unfortunately, benzene (1y) and electron-poor 
benzene derivatives 1z-1ab did not give any brominated products due to their high oxidation potentials.[5] 
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Figure 2-1. General conditions: 0.1 mmol of substrate, 5 mol% of SAS, 2 equiv. of TFA and 2 equiv. of 
NaBr were dissolved in 1 mL of MeCN H2O 1:1 and irradiated at 400 nm for 4 h. Given yields are isolated 
yields. a: Yield determined by GC-FID calibration using naphthalene as internal standard. b: An oxygen 
balloon was connected to the vial through the septum. c: Yield determined by 1H-NMR using dimethyl 
sulfone as internal standard. d: mixture of isomers at pyrazole position 4 and 5, ratio C4:C5 6:4.  
e: 4 equiv. of TFA were used. 
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Scheme 2-1. Benzylic bromination of toluene. Conditions: 0.1 mmol of 1ac, 5 mol% of SAS, 2 equiv. of 
TFA, K2S2O8 and NaBr respectively were in dissolved in 1 mL of MeCN H2O 1:1 and irradiated at  
400 nm for 4 h. a: Yield determined by 1H-NMR using dimethyl sulfone as internal standard. 
2.2.2 Mechanistic Investigations 
To get insight into the mechanism, cyclovoltammetric and spectroscopic investigations were performed. 
Cyclovoltammetry revealed a ground state reduction potential of -0.56 V vs. SCE for SAS in MeCN H2O 
1:1 (see Chapter 2.4.2 for details). Addition of TFA to this solution showed a tremendous impact by 
lowering the required potential by 0.55 V to merely -0.01 V vs. SCE. We propose that the reduction is 
facilitated by protonation in the presence of TFA (see Chapter 2.4.2 for details).[11] This shift of the 
ground state reduction potential leads to a significant increase of the excited state oxidation potential by 
approximately the same voltage from 1.76 V to 2.3 V vs SCE (see Chapter 2.4.2 for details) and explains 
why TFA is required to successfully oxidize anisole (EOx = 1.81 V vs. SCE). To support this hypothesis, 
control experiments using substrates with a low oxidation potential were performed. These experiments 
revealed that the photocatalytic bromination was also possible without TFA. 1,3,5-Trimethoxy-benzene 
(EOx = 1.4 V vs. SCE)[4a] and 2-methoxynapthalene (EOx = 1.5 V vs. SCE)[4a] gave the corresponding 
brominated products, but at a much slower rate and in lower yield indicating that the PCET increases 
the driving force of the reaction. To investigate the interaction between the excited photocatalyst and 
the substrate, emission quenching experiments were performed. We found that anisole and the more 
electron rich 1,3-dimethoxybenzene (1,3-DMB) are efficient quenchers, whereas N-methylpyrazole is a 
moderate quencher of the delayed fluorescence of SAS (Fig. 2-2 A).[12] Notably, all three compounds 
showed non-linear quenching, which might indicate a ground state pre-orientation via π-stacking 
between the substrates and SAS. On the other hand, TFA showed no significant quenching at all as 
well as benzene, which has an oxidation potential of 2.48 V vs SCE.[13] This observation is in good 
agreement with the estimated oxidation potential of SAS and the experimental findings, because 
benzene did not react under our bromination conditions. Moreover, sodium bromide showed similar 
quenching compared to anisole and 1,3-DMB at low quencher concentrations (Fig. 2-2 A). However, the 
formation of elemental bromine was not observed during the reaction or without substrate present (vide 
infra). This indicates that bromide is not oxidized by SAS and only engages in intermolecular heavy 
atom fluorescence quenching.[14] Next, we investigated the ground state interaction between the catalyst 
and the other reaction components by UV-VIS spectroscopy. No significant change of the spectrum was 
observed by addition of NaBr or TFA (not shown). However, a small, concentration dependent change 
of the SAS spectrum could be observed after addition of 1,3-DMB to the catalyst (Fig. 2-2 B).[15] The 
reason for the shift might be π-stacking of the non-polar anthraquinone core and 1,3-DMB in the polar 
solvent mixture rather than the formation of a charge transfer complex. This potential pre-orientation of 
substrate and catalyst might also play a role in the selectivity of the reaction.[16]  
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Figure 2-2. A: Stern-Volmer quenching plot of different substrates and additives. The oxidation 
potentials of TFA and benzene are too high to quench the catalyst whereas 1,3-DMB, anisole and  
N-methylpyrazole are good/moderate quenchers. Sodium bromide also shows moderate quenching of 
the catalyst, which can be attributed to the intermolecular heavy atom quenching effect. [14] B: UV-VIS 
absorption spectra of pure SAS and after addition of different amounts of 1,3-DMB.[15] 
Thus, the oxidation of the arene is proposed as the key step of the mechanism (Fig. 2-3). To demonstrate 
that this step is exergonic, the ΔG value for the oxidation of pyrazole, which had the highest investigated 
oxidation potential, was estimated to be -2.1 kcal. Therefore, the catalytic cycle commences by 
protonation of SAS by TFA to give the SAS-H+ cation, which is excited by 400 nm and transitions into 
the long-lived triplet state SAS-H+*. This intermediate oxidizes the arene and the resulting radical cation 
is subsequently attacked by a bromide anion. Hydrogen abstraction by a hydroperoxyl radical yields the 
product and hydrogen peroxide.[17] The formation of hydrogen peroxide enables a second mechanistic 
pathway via electrophilic bromination by hypobromous acid.[18] However, control experiments indicated 
that this process is much slower than the photocatalytic pathway under the investigated conditions. The 
reason for this is the slow reaction rate of the bromide anion with H2O2.[19] Moreover, compounds 7 and 
9 showed neither addition of bromine to the triple bond nor α-bromination of the ketone indicating that 
electrophilic bromine species do not contribute significantly to the conversion of the substrates. To clarify 
the role of H2O2, a competition experiment between anisole and trans-stilbene was performed, because 
in situ formed HOBr or Br2 should react several orders of magnitude faster with trans-stilbene than with 
anisole (Scheme 2-2). However, no brominated stilbene was observed supporting the subordinate role 
of electrophilic bromine species in the reaction mixture. 
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Scheme 2-2. Competition experiment between aromatic and olefinic bromination to elucidate the role 
of H2O2 in the reaction mixture. 
  
Figure 2-3. Proposed mechanism for the photocatalytic bromination of arenes and heteroarenes 
yielding exclusively mono-brominated compounds. 
2.3 Conclusion 
In summary, we have developed a new, photocatalytic bromination method using protonated 
anthraquinone as a strongly oxidizing photocatalyst. The procedure extends previously reported 
methods and shows good regio-selectivity and functional group tolerance including double and triple 
bonds, ketones, amides and amines, hydroxyl groups, carboxylic acids and carbamates. The proton 
activation of anthraquinone was shown using cyclovoltammetry. An interaction between the aromatic 
substrates and SAS in the ground as well as in the excited state was confirmed by UV-VIS spectrometry 
and emission quenching experiments. The readily available photocatalyst, very simple reaction 
conditions and a good substrate scope recommend the procedure for the mild oxidative bromination of 
arenes and heteroarenes. 
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2.4 Experimental Part 
2.4.1 General Information 
Starting materials and reagents were purchased from commercial suppliers (Sigma Aldrich, Alfa Aesar, 
Acros, Fluka or abcr) and were used without further purification. Solvents were used as p.a. grade. 
Industrial grade of solvents was used for automated flash column chromatography. Dry nitrogen was 
used as inert gas atmosphere. Liquids were added via syringe, needle and septum technique unless 
stated differently.  
Nuclear magnetic resonance spectroscopy  
All NMR spectra were measured at room temperature using a Bruker Avance 300 (300 MHz for 1H,  
75 MHz for 13C) or a Bruker Avance 400 (400 MHz for 1H, 101 MHz for 13C) NMR spectrometer. All 
chemical shifts are reported in δ-scale as parts per million [ppm] (multiplicity, coupling constant J, 
number of protons) relative to the solvent residual peaks as the internal standard.[20]The spectra were 
analyzed by first order and coupling constants J are given in Hertz [Hz]. Abbreviations used for signal 
multiplicity: 1H-NMR: br = broad, s = singlet, d = doublet, t = triplet, q = quartet, dd = doublet of doublets, 
ddd = doublet of doublet of doublet, dt = doublet of triplets and m = multiplet. 
Gas chromatography and gas chromatography coupled with mass spectrometry 
GC measurements were performed on a GC 7890 from Agilent Technologies. Data acquisition and 
evaluation was done with Agilent ChemStation Rev.C.01.04.  
GC-MS measurements were performed on a 7890A GC system from Agilent Technologies with an 
Agilent 5975 MSD Detector. Data acquisition and evaluation was done with MSD ChemStation 
E.02.02.1431.  
A capillary column HP-5MS/30 m x 0.25 mm/0.25 μM film and helium as carrier gas (flow rate of  
1 mL/min) were used. The injector temperature (split injection: 40:1 split) was 300 °C and the detection 
temperature was 300 °C for the flame ionization detector (FID). GC measurements were performed and 
investigated via integration of the signals obtained. The GC oven temperature program was adjusted as 
follows: initial temperature 40 °C was kept for 3 min, the temperature was increased at a rate of  
25 °C/min over a period of 10.4 min until 300 °C was reached and kept for 5 min.  
Mass spectrometry  
The mass spectrometric measurements were performed at the Central Analytical Laboratory of the 
University of Regensburg. All mass spectra were recorded on a Finnigan MAT 95, ThermoQuest 
Finnigan TSQ 7000, Finnigan MAT SSQ 710 A or an Agilent Q-TOF 6540 UHD instrument. 
Thin layer chromatography  
Analytical TLC was performed on silica gel coated alumina plates (MN TLC sheets ALUGRAM® Xtra 
SIL G/UV254). Visualization was done by UV light (254 or 366 nm). If necessary, potassium 
permanganate was used for chemical staining.   
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Automated flash column chromatography  
Purification by column chromatography was performed with silica gel 60 M (40–63 μm, 230–440 mesh, 
Merck) on a Biotage® IsoleraTM Spektra One device.  
UV-VIS / fluorescence spectroscopy 
Absorption spectra were measured on an Agilent Cary 100 UV/VIS spectrometer in a quartz cuvette at 
25.0 °C. Fluorescence spectra were measured on a Horiba Scientific Fluoromax-4 spectrometer at room 
temperature in a quartz cuvette. 
Cyclic voltammetry measurements  
CV measurements were performed with the three-electrode potentiostat galvanostat PGSTAT302N 
from Metrohm Autolab using a glassy carbon working electrode, a platinum wire counter electrode, a 
silver wire as a reference electrode and tetrabutylammonium tetrafluoroborate (TBATFB) 0.1 M as 
supporting electrolyte. The potentials are given relative to the Fc/Fc+ redox couple with ferrocene as 
internal standard. The control of the measurement instrument, the acquisition and processing of the 
cyclic voltammetric data were performed with the software Metrohm Autolab NOVA 1.10.4. The 
measurements were carried out as follows: a 0.1 M solution of TBATFB in acetonitrile was added to the 
measuring cell and the solution was degassed by argon purge for 5 min. After recording the baseline, 
the electroactive compound was added (0.01 M) and the solution was again degassed by a stream of 
argon for 5 min. The cyclic voltammogram was recorded with one to three scans. Afterwards ferrocene 
(2.20 mg, 12.0 μmol) was added to the solution which was again degassed by argon purge for 5 min 
and the final measurement was performed with three scans. 
General Procedure for the photocatalytic bromination 
Sodium anthraquinone sulfonate (1.6 mg, 0.005 mmol, 0.05 equiv.), NaBr (20.6 mg, 0.2 mmol, 2 equiv.) 
and the substrate (0.1 mmol) were weight into a 5 mL crimp cap vial. A stirring bar and 1 mL of a mixture 
of MeCN and H2O 1:1 were added and the vial was sealed with a crimp cap with septum under air 
atmosphere. Trifluoroacetic acid (15.4 µL, 0.2 mmol, 2 equiv.) was added via syringe through the septum 
and the vial was shaken briefly. The vial was placed approximately 2 cm above a 455 nm or 400 nm 
LED and stirred under irradiation for 4 h. After completion of the reaction, the reaction mixture was 
poured into a 50 mL round bottom flask and diluted with DCM. Silica was added, the solvent was 
evaporated from the suspension and the residue was used as dry load for column chromatography on 
a Biotage® IsoleraTM Spektra One using a petrol ether and ethyl acetate (and/or methanol) mixture as 
the mobile phase. For compounds containing a free amine or a carboxylic acid functional group 1% v/v 
triethylamine or trifluoroacetic acid were added to the ethyl acetate. A 10 g column was employed with 
silica gel of type 60 M (40-63 µm, 230-440 mesh) by Merck as stationary phase. 
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2.4.2 Mechanistic Investigations 
Catalyst absorption and LED Emission Spectra 
 
A: Absorption spectra of different concentrations of SAS in MeCN H2O 1:1 detected at 25.0 °C in a  
10x0.1 mm quartz cuvette.  
 
B: Normalized absorption and emission spectrum of SAS in MeCN H2O 1:1 detected at 25.0 °C in a 
10x10 mm quartz cuvette. 
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C: Absorption spectrum of SAS in MeCN H2O 1:1 before and after addition of different amounts of TFA 
detected at 25.0 °C in a 10x0.1 mm quartz cuvette. Addition of TFA leads to a minor increase of the 
absorption at ~400 nm and 300 nm however the absorption maximum at 350 nm decreases. The change 
of the absorption spectrum might indicate a ground state interaction between SAS and TFA. 
 
D: Emission spectra of the employed LEDs recorded by an OceanOptics HR4000CG-UV-NIR 
spectrometer. In combination, the spectra explain, why the initial reaction of anisole proceeded slowly 
at 445 nm irradiation considering the broad emission peak of the LED. The type of the 400 nm LED was 
“Ultraviolet Edixeon” by “Edison Opto Corporation” with an irradiation intensity of about 20 mW/cm2 and 
the type of the 445 nm LED was “OSLON SLL LD CQ7P” by “Osram Opto Semiconductors” with an 
irradiation intensity of about 80 mW/cm2. 
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Cyclovoltammetry of SAS 
Pure SAS 
 
  Index Peak position 
  1 -0.750 V 
  2 -0.612 V 
 
SAS with 40 equiv. TFA 
 
  Index Peak position 
  1 -0.287 V 
  2 -0.075 V 
Comparison of the potentials of SAS with and without TFA indicates a significant difference of 0.5 V. 
Explaining the increased excited state oxidation potential. Values were determined against ferrocene 
(not shown) and then calculated against SCE.[21] 
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Fluorescence quenching of SAS with anisole 
Stern-Volmer quenching was performed with 1.6 mg (5 µmol) sodium anthraquinone sulfonate (SAS) in 
3 mL MeCN H2O 1:1 at 25 °C in a 10x10 mm quartz cuvette. The indicated amounts of anisole were 
added stepwise via syringe. The fluorescence count at 527 nm was used for the creation of the Stern-
Volmer Plot because it showed the highest intensity after addition of the first µL of anisole. The energy 
of this wavelength (2.35 eV) was used to estimate the excited state oxidation potential of the catalyst 
according to the Rehm-Weller equation.[6]  
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2.5 Product Characterizations 
1-Bromo-4-methoxybenzene[22] 
  2a 
GC-Yield: 100%. 
LR-MS (EI): (M)+∙: calc.: 185.9680, found: 185.9672. MF: C7H7BrO. MW: 187.04 g/mol. 
 
2-Bromo-1,3,5-trimethoxybenzene[23] 
 2b 
Yield: 20.0 mg, 0.081 mmol, 81%, colorless liquid. 
1H NMR (400 MHz, DMSO-d6); δ 6.33 (s, 2H); 3.81 (s, 6H); 3.79 (s, 3H). 13C NMR (101 MHz; DMSO-
d6); δ 160.3; 156.9; 92.0; 90.6; 56.3; 55.5. LR-MS (EI): (M)+∙: calc.: 245.9892, found: 245.9909. MF: 
C8H11BrO3. MW: 247.09 g/mol. 
 
1-Bromo-2,4-dimethoxybenzene[24] 
 2c 
Yield: 18.5 mg, 0.085 mmol, 85%, colorless oil. 
1H NMR (400 MHz, DMSO-d6); δ 7.46-7.40 (d, J = 8.7 Hz, 1H); 6.68-6.64 (d, J = 2.9 Hz, 1H); 6.53-6.46 
(dd, J = 11.4 Hz, 2.7 Hz, 1H); 3.82 (s, 3H); 3.76 (s, 3H). 13C NMR (101 MHz; DMSO-d6); δ 160.1; 156.1; 
132.8; 106.7; 101.2; 100.0; 56.1; 55.5. LR-MS (EI): (M)+∙: calc.: 215.9786, found: 216.080. MF: 
C8H9BrO2. MW: 217.06 g/mol. 
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1,5-Dibromo-2,4-dimethoxybenzene[25] 
 2d 
Yield: 25.4 mg, 0.086 mmol, 86%, white solid. 
1H NMR (400 MHz, CDCl3); δ 7.65 (s, 1H); 6.48 (s, 1H); 3.90 (s, 3H) 13C NMR (101 MHz; CDCl3); δ 
156.3; 136.0; 102.5; 97.5; 56.7. LR-MS (EI): (M)+∙: calc.: 295.8871, found: 295.8951. MF: C8H8Br2O2. 
MW: 217.06 g/mol. 
Reaction conditions: An O2 balloon was used in addition to the air in the vial. 
 
1,3-Dibromo-2,4-dimethoxybenzene[26] 
 2e 
Yield: 20.7 mg, 0.07 mmol, 70%, white solid. 
1H NMR (300 MHz, CDCl3); δ 7.48-7.40 (d, J = 9.3 Hz, 2H); 6.63-6.57 (d, J = 9.3 Hz, 2H); 3.88 (s, 3H). 
13C NMR (75 MHz; CDCl3); δ 156.9; 155.2; 131.8; 108.9; 108.8; 108.5; 60.7; 56.8. LR-MS (EI): (M)+∙: 
calc.: 295.8871, found: 295.8891. MF: C8H8Br2O2. MW: 295.96 g/mol. 
 
1-Bromo-2,4-bis(prop-2-yn-1-yloxy)benzene 
 2f 
Yield: 14.8 mg, 0.056 mmol, 56%, yellowish oil. 
1H NMR (400 MHz, CDCl3); δ 7.47-7.42 (d, J = 8.8 Hz, 1H); 6.76-6.72 (d, J = 2.7 Hz, 1H); 6.56-6.51 (dd, 
J = 11.5, 2.9 Hz, 1H); 4.76-4.74 (d, J = 2.5 Hz, 2H); 4.69-4.67 (d, J = 2.5 Hz, 2H); 2.58-2.52 (m, 2H). 
13C NMR (101 MHz; CDCl3); δ 158.0; 154.8; 133.5; 108.4; 104.2; 102.9; 78.2; 77.9; 76.5; 76.1; 57.0; 
56.3. HR-MS (EI): (M+H)+∙: calc.: 264.9859, found: 264.9860. MF: C12H9BrO2. MW: 265.11 g/mol. 
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N-(2-Bromo-3,5-dimethoxybenzyl)acetamide 
 2g 
Yield: 25.7 mg, 0.089 mmol, 89%, yellowish solid. 
1H NMR (400 MHz, CDCl3); δ 6.58-6.54 (d, J = 2.8 Hz 1H); 6.42-6.39 (d, J = 2.8 Hz 1H); 6.07 (brs, 1H); 
4.49-4.44 (d, J = 6.1 Hz 2H); 3.85 (s, 3H); 3.78 (s, 3H); 2.00 (s, 3H). 13C NMR (101 MHz; CDCl3); δ 
170.1; 160.0; 156.9; 139.3; 106.8; 104.1; 99.1; 56.5; 55.7; 44.4; 23.4. LR-MS (ESI): (M+H)+∙: calc.: 
288.0230, found: 288.0219. MF: C11H14BrNO3. MW: 288.14 g/mol. 
 
1-Bromo-2-methoxynaphthalene[27] 
 2h 
 
Yield: 16.8 mg, 0.071 mmol, 71%, white solid. 
1H NMR (400 MHz, DMSO-d6); δ 8.11-8.05 (d, J = 8.4 Hz 1H); 8.04-7.98 (d, J = 9.1 Hz 1H); 7.97-7.91 
(d, J = 8.4 Hz 1H); 7.66-7.59 (m, 1H); 7.56-7.51 (d, J = 9.1 Hz, 1H); 7.48-7.42 (m, 1H); 3.99 (s, 3H). 13C 
NMR (101 MHz; DMSO-d6); δ 153.6; 132.2; 129.4; 129.3; 128.3; 128.1; 125.1; 124.3; 114.3; 106.9; 
56.9. LR-MS (EI): (M)+∙: calc.: 235.9837, found: 236.0177. MF: C11H9BrO. MW: 237.10 g/mol. 
 
1-(4-Bromophenoxy)propan-2-one 
 2i 
Yield: 17.4 mg, 0.076 mmol, 76%, white solid. 
1H NMR (400 MHz, CDCl3); δ 7.42-7.37 (m, 2H); 6.80-6.74 (m, 2H); 4.51 (s, 2H); 2.27 (s, 3H). 13C NMR 
(101 MHz; CDCl3); δ 205.1; 156.9; 132.7; 116.5; 114.2; 73.2; 26.7. LR-MS (EI): (M)+∙: calc.: 227.9786, 
found: 227.9781. MF: C9H9BrO2. MW: 229.07 g/mol. 
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N-(4-Bromophenyl)acetamide[28] 
2j 
Yield: 19.4 mg, 0.091 mmol, 91%, white solid. 
1H NMR (400 MHz, CDCl3); δ 7.41 (brs, 4H); 2.13 (s, 3H). 13C NMR (101 MHz; CDCl3); δ 168.5; 137.1; 
132.1; 121.5; 117.0; 24.7. LR-MS (EI): (M)+∙: calc.: 212.9789, found: 212.9773. 
MF: C8H8BrNO. MW: 214.06 g/mol. 
 
tert-Butyl (4-bromophenyl)carbamate[29] 
 2k 
Yield: 19.8 mg, 0.073 mmol, 73%, white solid. 
1H NMR (400 MHz, CDCl3); δ 7.41-7.33 (m, 2H); 7.31-7.22 (m, 2H); 6.51 (brs, 1H); 1.51 (s, 9H). 13C 
NMR (101 MHz; CDCl3); δ 152.6; 137.6; 132.0; 120.2; 115.5; 81.0; 28.4. LR-MS (ESI): (M+Na)+∙: calc.: 
294.0100, found: 294.0102. MF: C11H14BrNO2. MW: 272.14 g/mol. 
 
2-Acetamide-5-bromobenzamide[30] 
 2l 
Yield: 6.5 mg, 0.007 mmol, 25%, yellowish solid. 
1H NMR (400 MHz, CDCl3); δ 11.21 (s, 1H); 8.53-8.44 (d, J = 8.9 Hz, 1H); 7.86-7.81 (d, J = 2.6 Hz, 1H) 
(s, 4H); 7.63-7.57 (dd, J = 11.2 Hz, 2.4 Hz, 1H); 6.98 (brs, 1H); 6.30 (brs, 1H); 2.09 (s, 3H). 13C NMR 
(101 MHz; CDCl3); δ 170.8; 169.8; 140.4; 136.1; 131.9; 123.2; 121.9; 111.0; 25.4. LR-MS (ESI): (M+H)+∙: 
calc.: 256.9920, found: 256.9920. MF: C9H9BrN2O2. MW: 257.09 g/mol. 
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3-Acetamido-N-(4-bromophenyl)-4-methoxybenzamide 
 2m 
Yield: 31.6 mg, 0.087 mmol, 87%, yellowish solid. 
1H NMR (400 MHz, CDCl3); δ 10.22 (s, 1H); 9.31 (s, 1H); 8.50 (s, 1H); 7.78-7.72 (m, 3H); 7.55-7.49 (m, 
2H); 7.18-7.13 (d, J = 9.1 Hz, 1H); 3.91 (s, 3H); 2.11 (s, 3H). 13C NMR (101 MHz; CDCl3); δ 168.7; 165.2; 
152.5; 138.8; 131.4; 127.1; 126.5; 124.3; 122.2; 120.3; 115.1; 110.5; 56.0; 23.8. HR-MS (ESI): (M+H)+∙: 
calc.: 363.0339, found: 363.0340. MF: C16H15BrN2O3. MW: 363.21 g/mol. 
 
1-(4-Bromophenyl)urea[31] 
 2n 
Yield: 20.0 mg, 0.093 mmol, 93%, white solid. 
1H NMR (400 MHz, DMSO-d6); δ 8.67 (s, 1H); 7.37 (s, 4H); 5.91 (s, 2H). 13C NMR (101 MHz; DMSO-
d6); δ 155.8; 140.0; 131.3; 119.6; 112.3. LR-MS (ESI): (M+H)+∙: calc.: 214.9815, found: 214.9813. MF: 
C7H7BrN2O. MW: 215.05 g/mol. 
 
Methyl-3-bromo-1H-indole-6-carboxylate 
 2o 
Yield: 16.1 mg, 0.063 mmol, 63%, yellowish oil. 
1H NMR (400 MHz, CDCl3); δ 11.88 (brs, 1H); 8.09 (s, 1H); 7.84-7.80 (d, J = 2.7 Hz, 1H); 7.74-7.70 (m, 
1H); 7.53-7.49 (d, J = 8.3 Hz, 1H); 3.86 (s, 3H). 13C NMR (101 MHz; CDCl3); δ 166.9; 134.6; 129.5; 
128.8; 123.3; 120.4; 118.0; 114.1; 89.0; 52.0. HR-MS (EI): (M)+∙: calc.: 252.9738, found: 252.9737. MF: 
C10H8BrNO2. MW: 254.08 g/mol. 
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6-Bromo-5-methoxy-1H-benzo[d]imidazole 
 2p 
Yield: 11.1 mg, 0.049 mmol, 49%, yellowish solid. 
1H NMR (400 MHz, DMSO-d6); δ 9.15 (brs, 1H); 8.36 (s, 1H); 7.60-7.54 (d, J = 8.8 Hz, 1H); 7.13-7.08 
(d, J = 8.8 Hz, 1H); 3.88 (s, 3H). 13C NMR (101 MHz; DMSO-d6); δ 151.3; 143.4; 142.3; 138.2; 118.5; 
110.8; 109.6; 57.3. HR-MS (EI): (M)+∙: calc.: 225.9742, found: 225.9740. MF: C8H7BrN2O. MW: 227.06 
g/mol. 
Reaction conditions: An O2 balloon was used in addition to the air in the vial. 
 
4-Bromo-1H-pyrazole[32] 
 2q 
NMR-Yield: 83%. 
1H NMR (400 MHz, CD3CN); δ 7.65 (s, 2H). HR-MS (ESI): (M+H)+∙: calc.: 146.9552, found: 146.9553. 
MF: C3H3BrN2. MW: 146.98 g/mol. 
Reaction conditions: The sample was prepared and reacted according to the general procedure but a 
mixture of CD3CN D2O 1:1 was used as a solvent. After 4 h of irradiation the vial was opened and 9.5 
mg dimethyl sulfone as internal standard for H-NMR were added. The mixture was then transferred into 
an NMR tube and quantitated with respect to the H-atom integrals. 
 
4-Bromo-1-methyl-1H-pyrazole[33] 
 2r 
NMR-Yield: 88%. 
1H NMR (400 MHz, CD3CN); δ 7.57 (s, 1H); 7.39 (s, 1H); 3.76 (s, 3H). HR-MS (ESI): (M+H)+∙: calc.: 
160.9709, found: 160.9708. MF: C4H5BrN2. MW: 161.00 g/mol. 
Reaction conditions: The sample was prepared and reacted according to the general procedure but a 
mixture of CD3CN D2O 1:1 was used as a solvent. After 4 h of irradiation the vial was opened and 10.0 
mg dimethyl sulfone as internal standard for H-NMR were added. The mixture was then transferred into 
an NMR tube and quantitated with respect to the H-atom integrals.  
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4-Bromo-3-phenyl-1H-pyrazole / 5-bromo-3-phenyl-1H-pyrazole[34] 
2s 
Yield: 21.6 mg, 0.097 mmol, 97%, yellowish solid. 
1H NMR (400 MHz, DMSO-d6); δ 13.58 (s, 0.4H); 13.36 (s, 0.6H); 8.09 (s, 0.6H); 7.87-7.66 (m, 2.4H); 
7.56-7.35 (m, 3H). 13C NMR (101 MHz; DMSO-d6); δ 147.0; 141.0; 132.3; 131.2; 128.9; 127.9; 127.1; 
90.4. LR-MS (EI): (M)+∙: calc.: 221.9793, found: 221.9958. MF: C9H7BrN2. MW: 223.07 g/mol. 
 
4-Bromo-1,5-dimethyl-2-phyenyl-1,2-dihydro-3H-pyrazol-3-one[35] 
 2t 
Yield: 19.4 mg, 0.041 mmol, 41%, yellowish solid. 
1H NMR (400 MHz, CD3CN); δ 7.53-7.47 (m, 2H); 7.39-7.32 (m, 3H); 3.09 (s, 3H); 2.28 (s, 3H). 13C NMR 
(101 MHz; CD3CN); δ 163.1; 155.7; 136.2; 130.1; 128.1; 126.6; 88.8; 36.7; 12.7. HR-MS (EI): (M)+∙: 
calc.: 266.0055, found: 266.0054. MF: C8H7BrN2O. MW: 267.13 g/mol. 
Reaction conditions: An O2 balloon was used in addition to the air in the vial. 
 
(1R, 2R)-1-(4-Bromo-3-methoxyphenyl)-2-((dimethylamino)methyl)cyclohexan-1-ol 
2u 
Yield: 25.2 mg, 0.074 mmol, 74% yellowish oil. 
1H NMR (400 MHz, DMSO-d6); δ 7.48-7.41 (d, J = 8.4 Hz, 1H); 7.22-7.16 (m, 1H); 7.01-6.95 (m, 1H); 
5.04 (brs, 1H); 3.83 (s, 3H); 2.14-2.07 (m, 1H); 1.95-1.87 (m, 6H); 1.86-1.21 (m, 10H). 13C NMR (101 
MHz; DMSO-d6); δ 156.5; 153.0; 133.3; 119.6; 110.6; 109.0; 77.3; 62.1; 56.8; 47.5; 44.8; 42.1; 28.3; 
27.1; 23.0. HR-MS (ESI): (M+H)+∙: calc.: 342.1063, found: 342.1062. MF: C16H24BrNO2. MW: 342.28 
g/mol.  
Reaction conditions: An O2 balloon was used in addition to the air in the vial. 4 equiv. of TFA were 
used to keep the tertiary amine protonated to prevent it from transferring an electron to the excited 
photocatalyst. 
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(4aR,4a1R,5aS,8aR,8a1S,15aS)-10-Bromo-2,4a,4a1,5,5a,7,8,8a1,15,15a-decahydro-14H-4,6-
methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinolin-14-one 
 2v 
Yield: 13.5 mg, 0.035 mmol, 35% yellowish solid. 
1H NMR (400 MHz, CDCl3); δ 8.00-7.93 (d, J = 8.7 Hz, 1H); 7.38-7.32 (dd, J = 6.6 Hz, 2.1 Hz, 1H); 7.25-
7.23 (m, 1H); 5.96-5.87 (m, 1H); 4.31-4.25 (dt, J = 3.2 Hz, J = 8.5 Hz, 1H); 4.19-4.00 (m, 2H) 3.93-3.83 
(m, 2H); 3.75-3.66 (m, 1H); 3.28-3.19 (m, 1H); 3.18-3.07 (m, 2H); 2.93-2.82 (m, 1H); 2.77-2.70 (d, J = 
15.0 Hz, 1H); 2.69-2.60 (dd, J = 3.2 Hz; 14.2 Hz; 1H); 2.41-2.32 (dt, J = 4.4 Hz; 14.4 Hz, 1H); 1.94-1.84 
(m, 2H); 1.50-1.42 (d, J = 14.6 Hz, 1H); 1.29-1.25 (m, 1H). 13C NMR (101 MHz; CDCl3); δ 169.5; 141.4; 
140.0; 135.1; 131.7; 128.0; 125.7; 117.8; 116.7; 77.6; 64.7; 60.5; 60.4; 52.7; 52.0; 50.4; 48.2; 42.8; 42.5; 
31.6; 26.9. HR-MS (ESI): (M+H)+∙: calc.: 413.0859, found: 413.0863. 
MF: C21H21BrN2O2. MW: 413.32 g/mol. 
Reaction conditions 4 equiv. of TFA were used to keep the tertiary amine protonated to prevent it from 
transferring an electron to the excited photocatalyst. 
 
5-(4-Bromo-2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid 
2w 
Yield: 10.1 mg, 0.031 mmol, 31%, yellowish solid. 
1H NMR (400 MHz, DMSO-d6); δ 12.13 (brs, 1H); 7.30 (s, 1H); 6.90 (s, 1H); 3.96-3.86 (m, 2H); 2.28 (s, 
3H); 2.09 (s, 3H); 1.70-1.56 (m, 4H); 1.11 (s, 6H). 13C NMR (101 MHz; DMSO-d6); δ 178.7; 156.0; 135.2; 
133.0; 125.8 114.1; 113.7; 68.0; 41.0; 36.5; 25.0; 24.7; 22.4; 15.1. HR-MS (-ESI): (M-H)-∙: calc.: 
327.0601, found: 327.0603. MF: C15H21BrO3. MW: 329.23 g/mol. 
 
N-(4-Bromo-2,6-dimethylphenyl)-2-(diethylamino)acetamide 
 2x 
 
Yield: 11.3 mg, 0.036 mmol, 36%, yellowish oil. 
1H NMR (300 MHz, DMSO-d6); δ 9.25 (brs, 1H); 7.29 (s, 2H); 3.22-3.15 (m, 2H); 2.69-2.58 (m, 4H); 
2.13 (s, 6H); 1.11-1.03 (m, 6H). 13C NMR (75 MHz; DMSO-d6); δ 169.5; 138.0; 134.8; 130.0; 118.9; 
56.6; 48.1; 17.9; 12.0. HR-MS (ESI): (M+H)+: calc.: 313.0910, found: 313.0916. MF: C14H21BrN2O. MW: 
313.24 g/mol. 
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Reaction conditions 4 equiv. of TFA were used to keep the tertiary amine protonated to prevent it from 
transferring an electron to the excited photocatalyst. 
 
Bromomethyl-benzene[36] 
 2ac 
NMR-Yield: 70%. 
1H NMR (400 MHz, CD3CN); δ 4.50 (s, 2H). LR-MS (EI): (M)+∙: calc.: 169.9731, found: 169.9736. MF: 
C7H7Br. MW: 171.04 g/mol. 
Reaction conditions: The sample was prepared and reacted according to the general procedure but a 
mixture of CD3CN D2O 1:1 was used as a solvent and 54 mg (0.2 mmol, 2 equiv.) K2S2O8 were added. 
Then the reaction mixture was degassed by three consecutive freeze-pump-thaw cycles using dry 
nitrogen as inert gas. After 4 h of irradiation the vial was opened and 9.9 mg dimethyl sulfone as internal 
standard for H-NMR were added. The mixture was then transferred into an NMR tube and quantitated 
with respect to the H-atom integrals.  
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3. Visible Light Mediated Synthesis of β Chloro 
Ketones from Aryl Cyclopropanes 
 
We report the visible light mediated synthesis of β chloro ketones from aryl cyclopropanes, oxygen, 
hydrochloric acid and nitric acid. The operationally simple and catalyst free method uses cheap standard 
lab reagents and displays a broad functional group tolerance. Moreover, scale up of the reaction and 
late stage functionalization of bioactive compounds is possible, providing the opportunity to utilize the 
cyclopropane ring as a masked β chloro ketone in a reaction sequence. We propose a light-driven 
radical chain reaction initiated by the reaction of diluted hydrochloric and nitric acid producing small 
quantities of molecular chlorine. The mechanistic hypothesis is supported by 18O labelling and UV-VIS 
experiments, cyclovoltammetry and several control reactions.  
 
 
This chapter has been published in: 
D. Petzold, P. Singh, F. Almqvist, B. König Angew. Chem. Int. Ed. 2019, 
https://doi.org/10.1002/ange.201902473. (Communication) – Reproduced with permission from John 
Wiley and Sons. 
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3.1 Introduction 
The cyclopropane ring offers many synthetic opportunities in organic and total synthesis, medicinal 
chemistry and crop science due to its versatile reactivity originating from a high ring strain.[1] Moreover, 
different activation modes are possible by thermal or catalytic methods depending on the ring 
substitution pattern.[2] Since the cyclopropane ring reacts also well with radicals, it is especially useful in 
photocatalytic and photochemical reactions which often proceed via radical intermediates.[3] This 
phenomenon was already exploited in the 1970s by the group of Hixson. They found that electron rich 
cyclopropyl arenes could be oxidized by excited 1,4-dicyanobenzene leading to ring opening via an anti 
Markownikow addition of methanol.[4] The aryl cyclopropane radical cation was proposed as key 
intermediate and its formation could be confirmed in several studies.[5] However, despite the intensive 
research on aryl cyclopropanes and their behavior in light driven reactions, the addition of a nucleophile 
and subsequent trapping of the benzylic radical by oxygen has not been reported yet. 
Therefore, we envisioned to develop a visible light mediated method for the synthesis of beta substituted 
ketones from aryl cyclopropanes. We focused on the preparation of β chloro ketones, which are useful 
building blocks for many chemical transformations e.g. the synthesis of heterocycles, cross coupling, 
alkylation reactions or chemical probes in bioassays.[6] Thereby, the aryl cyclopropane could act as 
synthon in a reaction sequence over several steps for the much more reactive β chloro ketone. 
Traditionally, aromatic β chloro ketones are prepared via Friedel-Crafts acylation which suffers from a 
limited substrate scope and regioselectivity issues (Scheme 3-1).[7] Moreover, Zhu and coworkers 
reported a ring-opening chlorination of prefunctionalized cyclopropanes which requires a silver salt as 
catalyst, a strong stochiometric oxidant and NCS as a source for Cl radicals.[8]  
 
Scheme 3-1. Overview of preparation methods for chlorinated ketones. A: Traditional preparation via 
Friedel-Crafts acylation. B: Silver mediated ring-opening chlorination of hydroxy-cyclopropanes.  
C: Catalyst and metal free ring-opening chlorination of unfunctionalized aryl cyclopropanes. 
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3.2 Results and Discussion 
3.2.1 Synthesis 
We intended to avoid super stoichiometric amounts of strong Lewis acids, the use of precious metals 
and pre-functionalized aryl cyclopropanes by employing photoredox catalysis. Therefore, we started our 
investigations using simple cyclopropyl benzene (1a) as model substrate, sodium chloride as chloride 
source, sodium anthraquinone-2-sulfonate (SAS) as strongly oxidizing photosensitizer and 
trifluoroacetic acid (TFA) to activate the photocatalyst.[9] Under these conditions we observed 53% of 
the desired β chloro ketone 2a (Table 3-1, entry 1). The use of sulfuric acid instead of TFA or a 
combination of HCl and HNO3 did not alter the yield significantly (entries 2-3). Surprisingly, the control 
reaction without photocatalyst using HCl and HNO3 gave 2a in 80% 1H-NMR and 77% isolated yield, 
while all other control reactions did not show significant product formation (entries 4-8, see Chapter 
3.4.2 for more control reactions and see the mechanistic section for more details on this observation). 
Table 3-1. Optimization of the reaction conditions[a] 
 
Entry Photocatalyst / λ Chloride source, Acid Yield of 2a[b] 
1 SAS (10%) / 395 nm NaCl (5 equiv.), TFA (2.5 equiv.) 53% 
2 SAS (10%) / 395 nm NaCl (5 equiv.), H2SO4 (2.5 equiv.) 45% 
3 SAS (10%) / 395 nm HCl (5 equiv.), HNO3 (10 mol%) 51% 
4 - / 395 nm HCl (5 equiv.), HNO3 (10 mol%) 80% (77%) 
5[c] - / - HCl (5 equiv.), HNO3 (10 mol%) 0% 
6 - / 395 nm NaCl (5 equiv.), TFA (2.5 equiv.) 0% 
7 - / 395 nm HCl (5 equiv.) 0% 
8[d] - / 455 nm or 400 nm HCl (5 equiv.), HNO3 (10 mol%) <10% 
[a] General conditions: Cyclopropylbenzene (0.1 mmol) and the indicated amount of SAS, chloride 
source and acid were dissolved in 2 mL of MeCN H2O 1:1, set under oxygen atmosphere and irradiated 
with one high intensity 395 nm LED for 2 h. [b] Yield determined by 1H-NMR using benzene as internal 
standard, isolated yield in brackets. [c] Either no light for 24 h at rt or no light for 24 h at 80 °C. [d] Either 
two 455 nm high power or one low intensity 400 nm LED were used (see Chapter 3.4.2 for details about 
the light sources). 
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Figure 3-1. Substrate scope or the reaction. a: Gram scale reaction with 10 mmol of 1a as substrate 
(see Chapter 3.4.1 for details). b: Mixture of product and elimination product, ratio: 1.5:1. c: 4 h reaction 
time. d: Oxygen overpressure (~2 bar) was used. e: Yield determined with 1H-NMR using benzene as 
internal standard. 
With the best conditions in hand, we explored the substrate scope of the reaction (Fig. 3-1). Electron 
donating substituents in 4 or 2 position increased the yield of the corresponding product (2b-2d), while 
electron withdrawing substituents in 2,3 or 4 position gave lower yields or suppressed the reaction 
completely, except in case of 4-chloro substitution (2e-2m). In addition, different alkyl or aryl substituents 
gave moderate to excellent yields (2n-2p, 2r) and even a boronic acid substituent was well tolerated 
under the reaction conditions (2q). In case of 2o the yield might be lower due to the many oxidizable 
benzylic C-H bonds which could have led to side reactions. However, to our delight, also an electron 
deficient thiophene derivative as well as a benzothiophene gave low to moderate yields (2s, 2t). While 
the methyl substituted cyclopropane derivative 1u gave only a single product in moderate yield, also a 
double substituted aromatic ring was well tolerated giving the corresponding product (2v) in moderate 
yield. Finally, we submitted bioactive compounds like derivatives of ciprofibrate, tramadol and 
antibacterially active ring-fused 2-pyridones[10] to our reaction conditions leading to mixed results. The 
free aliphatic carboxylic acid of the ciprofibrate derivative was probably easily decarboxylated under the 
reaction conditions giving 2w only in low yield. On the other hand, the ciprofibrate methyl ester as well 
as the tramadol derivative gave the products in high yields (2x-2y). Since 2-pyridones are known to 
react with oxygen under irradiation, only low yields were obtained in case of ring-fused 2-pyridones 
under optimized conditions (2z-2aa).[11] To illustrate the utility of the method, a gram scale reaction 
(10 mmol scale) was performed giving 2a in 79% isolated yield. In addition, if SAS was used as 
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photosensitizer, it was possible to add other nucleophiles, e.g. bromide, water or methanol, to the 
cyclopropyl arene in moderate to excellent yields (3a-3i). 
Finally, we explored the utility of the β chloro ketones in further synthetic transformations (Fig. 3-2). The 
synthesis of 2-isoxazoline derivative 4a or 2-pyrazoline derivative 4b proceeded in moderate yield. In 
addition, the formation of the phosphonium chloride 4c proceeded smoothly and in high yield generating 
a valuable precursor for a Wittig type reaction.[12] Finally, we believe that β chloro ketones generated 
from bioactive compounds might be interesting precursors for bioconjugation of pharmacophores to 
antibodies and/or biological probes for the exploration of receptor functions (4d).[13]  
 
Figure 3-2. Illustration of different applications for β chloro ketones synthesized from aryl 
cyclopropanes. For “conditions” see Fig. 3-1. 
3.2.2 Mechanistic Investigations 
To investigate the reaction mechanism, we performed 18O labelling experiments, as well as UV-VIS 
measurements, cyclovoltammetric investigations and control reactions. The 18O labelling experiments 
showed that the ketone oxygen atom originates from molecular oxygen and not from a nucleophilic 
attack by water (see Chapter 3.4.2 for details). The UV-VIS measurements of elemental chlorine 
dissolved in an acetonitrile water mixture showed, that it absorbs reasonably well at 395 nm supporting 
the light induced initiation (see Chapter 3.4.2 for details). On the other hand, also the cyclovoltammetric 
measurements of several substrates (1a, 1b, 1h, 1i, 1n) in an acetonitrile water mixture revealed that 
their oxidation by a chlorine radical (EOx(Cl·) in MeCN ~+1.84 V vs. SCE[5a], in H2O ~+2.2 V vs SCE[14]) 
is feasible (see Chapter 3.4.2 for oxidation potentials of the substrates). In combination, UV-VIS and 
cyclovoltammetric experiments provide good evidence for a Cl· initiated reaction. To get further insight 
into the mechanism, several control experiments were performed. To demonstrate that the reaction is 
initiated by the light driven cleavage of Cl2, we performed reactions with super stoichiometric and 
catalytic amounts of chlorine gas (Fig. 3-3 A). Only polychlorinated side products could be observed if 
an excess of chlorine gas and HCl were used to promote the reaction. If catalytic amounts of Cl2 and 
excess of HCl were used, the desired product was obtained in 50% yield and the amount of side products 
was reduced. Since the opening of cyclopropyl rings by chloride radicals is well known to proceed via 
oxidation of the cyclopropyl arene and since other nucleophiles could only be used in the presence of a 
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photosensitizer, we assume the presence of an aryl cyclopropyl radical cation intermediate.[5a] The 
presence of this radical cation could be observed in the reaction of 4-bromocyclopropyl-benzene (1ab), 
because the para-bromo substituent was replaced partially by chloride giving a mixture of p-brominated 
and p-chlorinated product (Fig. 3-3 B).[15] Furthermore, if the substituted starting materials 1ac or 1ad 
were used, only 1ac gave the decarboxylated product 2a, whereas 1ad was completely recovered. This 
indicates that either a positively charged leaving group or an oxidizable/hydrogen atom donor is required 
in the benzylic position (Fig. 3-3 C, see Chapter 3.4.2 for more mechanistic investigations). 
 
Figure 3-3. Overview of control reactions that support the mechanistic proposal. A: Experiments with 
elemental chlorine. B: Evidence for the intermediary of a cyclopropyl arene radical cation. C: Evidence 
that a positively charged or good radical leaving group is required.  For “conditions” see Fig. 3-1. 
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As a summary of the mechanistic investigations, we propose the following mechanism (Fig. 3-4). We 
propose that Cl2 is generated from the reaction between the diluted hydrochloric and nitric acid 
mixture.[16] The generated molecular chlorine is cleaved by light into chlorine radicals, which can oxidize 
the aryl cyclopropane (A) and initiates a radical chain reaction. The so formed cyclopropyl radical cation 
(B) can be opened by Cl– to give a transient benzylic radical (C) which can be trapped by the persistent 
triplet oxygen diradical to give a benzylic peroxylradical (D). This species can react rapidly with a second 
chlorine molecule which releases another Cl· to continue the radical chain.[17] The formed hydroperoxyl 
chloride (E) can undergo a heterolytic fragmentation to give the desired ketone (F).[18] Upon this 
fragmentation, hypochlorous acid is released which can react with HCl to give molecular chlorine which 
continues the chain reaction.[19] 
 
Figure 3-4. Conclusive mechanism for the generation of β chloro ketones from aryl cyclopropanes. 
3.3 Conclusion 
In summary, we developed a light mediated procedure for the oxidative ring opening of aryl 
cyclopropanes yielding β chloro ketones in low to excellent yields. The method uses cheap standard lab 
chemicals and leads to an increased molecular complexity and synthetic utility comparing the product 
and the starting material. The substrate scope exhibits a broad functional group tolerance and a scale 
up of the reaction could be performed. The products are valuable precursors for heterocycles, further 
synthetic transformations and might find application in biochemistry. We assume that HCl and HNO3 
react, despite the dilution, like in aqua regia leading to traces of Cl2 that start an efficient chain reaction 
upon light-induced homolytic cleavage. The mechanistic proposal is supported by several control 
reactions, 18O labelling and UV-VIS experiments as well as cyclovoltammetry. Moreover, other 
nucleophiles than chloride could be used in presence of a simple, anthraquinone based photosensitizer 
recommending the reaction for many applications.  
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3.4 Experimental Part 
3.4.1 General Information 
See Chapter 2.4.1 for General Information.[20] 
General ring opening procedure A  
The aryl cyclopropane (0.1 mmol, 1 equiv.) was weight into a 5 mL crimp cap vial, 1 mL of acetonitrile 
and 1 mL of 0.5M aqueous HCl (0.5 mmol, 5 equiv.), 0.5 µL (0.01 mmol, 0.1 equiv.) fuming HNO3  and 
a stirring bar were added, the vial was closed with a crimp cap with septum, shaken briefly and purged 
with oxygen from a balloon for 1 minute. The reaction mixture was irradiated with one 395 nm LED for 
2 h. Upon completion, three equal reaction mixtures were combined, diluted with 10 mL of DCM and  
10 mL of water and the phases were separated. The aqueous phase was extracted with an additional 
10 mL of DCM and the combined organic phases were dried with MgSO4, concentrated and the residue 
was purified by column chromatography to give the title compound. 
Gram scale reaction 
1.3 mL (10 mmol, 1 equiv.) cyclopropylbenzene was added into a 500 mL round bottom Schlenk flask 
under oxygen atmosphere, 100 mL of acetonitrile and 100 mL of 0.5M aqueous HCl (50 mmol, 5 equiv.), 
48 µL (1.0 mmol, 0.1 equiv.) fuming HNO3 and a stirring bar were added. The reaction mixture was 
irradiated with four 395 nm LEDs for 16 h. Upon completion, the reaction mixture was diluted with  
150 mL of DCM and 100 mL of water and the phases were separated. The aqueous phase was extracted 
with an additional 50 mL of DCM and the combined organic phases were dried with MgSO4, 
concentrated and the residue was purified by column chromatography. 
General ring opening procedure B  
The aryl cyclopropane (0.1 mmol, 1 equiv.), (only for the bromination: 21 mg (0.2 mmol, 2 equiv.) NaBr 
and 3.2 mg (0.01 mmol, 0.1 equiv.) sodium anthraquinone-2-sulfonate were weight into a 5 mL crimp 
cap vial, 1 mL of acetonitrile and 1 mL water (or 1 mL of methanol for the methoxylation) and a stirring 
bar were added, the vial was closed with a crimp cap with septum and purged with oxygen from a balloon 
for 1 minute. Oxygen overpressure was applied by adding an additional 12 mL of oxygen via syringe 
into the vial. The reaction mixture was irradiated with one 395 nm LED for 2 h. Upon completion, three 
equal reaction mixtures were combined, diluted with 10 mL of DCM and 10 mL of water and the phases 
were separated. The aqueous phase was extracted with an additional 10 mL of DCM and the combined 
organic phases were dried with MgSO4, concentrated and the residue was purified by column 
chromatography to give the title compound. 
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3.4.2 Mechanistic Investigations 
UV-VIS spectroscopy 
 
The UV-VIS spectra of diluted solutions of molecular chlorine in MeCN H2O 1:1 show that excitation of 
small chlorine quantities is possible by the employed 395 nm LEDs. 
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Cyclovoltammetry 
 
 
The cyclovoltammetric data show that single electron oxidation of substrates 1a, 1b, 1n and 1i by a 
chlorine radical is possible in an acetonitrile water mixture under acidic conditions (HBF4 was used 
instead of HCl as proton source because it cannot be degraded under the applied electrochemical 
conditions). The required oxidation potential of 1h is too high to be oxidized by Cl·, which is in good 
agreement with the reported literature potentials for Cl· and the experimental observations. 
Control experiments 
 
No reaction to the desired product occurred under N2 atmosphere and if the reaction was performed in 
pure MeCN (no water). 
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18O labeling experiments 
 
The labeling experiments showed that if H218O is used more than 90% 18O is incorporated into the 
product (A), while if 18O2 is used no incorporated 18O could be detected by mass spectrometry (B). 
However, if the labeled compound is stirred for 2.5 h in acidic, unlabeled water, full exchange to the non-
labeled oxygen was detected (C). We assume that the ketone was protonated and exchanged with the 
labeled/unlabeled solvent to bias the results. 
Therefore, we repeated the reaction using unlabeled methanol as solvent (D), which did not give a clean 
reaction but was supposed to exchange less with the ketone. Indeed, we found a significant  
18O incorporation being good evidence that the oxygen in the product originates from O2. 
Exclusion of a singlet oxygen mediated ring opening pathway 
 
If Rose Bengal, a common singlet oxygen sensitizer, was employed as photocatalyst no reaction 
occurred, excluding a singlet oxygen mediated ring opening pathway.  
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3.4.3 Starting Material Synthesis and Characterizations 
General procedure A: Suzuki-Coupling Reaction[21] 
 
Into a 20 mL microwave vial were weight the aryl halide (1.5-3 mmol, 1 equiv.), tricyclohexylphosphine 
(0.1 equiv.), palladium(II) acetate (0.05 equiv.), potassium phosphate (3 equiv.) and cyclopropylboronic 
acid (1.5 equiv.). A magnetic stirring bar, toluene (0.3M) and 0.5 mL of water were added, and the vial 
was closed. The reaction mixture was shaken briefly and set under inert atmosphere by bubbling 
nitrogen gas through the vial for 5 minutes. Afterwards, the vial was placed into an oil bath and stirred 
at 110 °C for 24-72 h. The reaction was monitored by LCMS or GC-FID. Upon completion, the reaction 
mixture was poured into a separatory funnel, diluted with ethyl acetate and washed with 15 mL water 
twice (sat. NaHCO3 in case of pyridines). The organic layer was dried with Na2SO4, concentrated in 
vacuo and purified by column chromatography to give the title compound. 
General procedure B: Simmons-Smith Cyclopropanation[22] 
 
To 15 mL distilled DCM was added 10 mL (10.0 mmol, 2 equiv.) Et2Zn (1.0 M in hexanes) under N2 
atmosphere. The solution was cooled in an ice bath and a solution of trifluoroacetic acid (0.8 mL,  
10.0 mmol, 2 equiv.) in 5 mL DCM was then dripped very slowly into the reaction mixture via syringe. 
Upon stirring for 20 min, a solution of CH2l2 (0.8 mL, 10.0 mmol, 2 equiv.) in 5 mL DCM was added. 
After an additional 20 min of stirring, a solution of the respective styrene derivative (5.0 mmol, 1 equiv.) 
in 5 mL DCM was added, and the ice bath was removed. After an additional 3 h of stirring, the reaction 
mixture was quenched with 1M HCl (10 mL) and the phases were separated. The aqueous layer was 
extracted with DCM. The combined organic layers were washed with saturated NaHCO3, and brine and 
then dried with Na2SO4, filtered and concentrated. The residue was purified by column chromatography 
to give the title compound. 
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Starting Material Characterizations 
 1b 
1-Cyclopropyl-4-methoxybenzene was prepared on 1.5 mmol scale following general procedure A 
using 4-bromoanisole as starting material (reaction time 72 h) and isolated as a colorless oil (178 mg, 
1.2 mmol, 80%). 1H NMR (400 MHz, CDCl3): δ 7.06-7.00 (m, 2H), 6.85-6.80 (m, 2H), 3.79 (s, 3H), 1.91-
1.83 (m, 1H), 0.94-0.88 (m, 2H), 0.66-0.61 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 157.7, 136.0, 127.0, 
113.9, 55.4, 14.7, 8.6. NMR data matches literature reference.[23] HRMS: calcd. for C10H12O∙+, (M)+∙: 
148.0883; found: 148.0878. MF: C10H12O. MW: 148.21. 
  1c 
1-Cyclopropyl-2-methoxybenzene was prepared on 3 mmol scale following general procedure A using 
2-bromoanisole as starting material (reaction time 24 h) and isolated as a colorless oil (164 mg,  
1.1 mmol, 74%). 1H NMR (400 MHz, CDCl3): δ 7.34-7.27 (m, 1H), 7.08-6.96 (m, 3H), 4.00 (s, 3H), 2.45-
2.32 (m, 1H), 1.14-1.06 (m, 2H), 0.88-0.80 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 158.3, 131.9, 126.3, 
124.7, 120.5, 110.1, 55.4, 9.4, 7.8. NMR data matches literature reference.[24] C10H12O∙+, (M)+∙: 
148.0883; found: 148.0879. MF: C10H12O. MW: 148.21. 
  1d 
N-(4-Cyclopropylphenyl)acetamide was prepared on 2 mmol scale following general procedure A 
using 4-bromoacetanilide as starting material (reaction time 24 h) and isolated as a white/yellowish solid 
(250 mg, 1.43 mmol, 71%). 1H NMR (600 MHz, CDCl3): δ 7.36 (d, J = 8.2 Hz, 2H), 7.00 (d, J = 8.2 Hz, 
2H), 2.13 (s, 3H), 1.89-1.83 (m, 1H), 0.95-0.89 (m, 2H), 0.66-0.61 (m, 2H). 13C NMR (151 MHz, CDCl3): 
δ 168.6, 140.2, 135.4, 126.3, 120.3, 24.5, 15.05, 9.1. NMR data matches literature reference.[23] HRMS: 
calcd. for C11H13NO+, (M+H)+: 176.1070; found: 176.1090. MF: C11H13NO. MW: 175.23. 
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  1e 
Tert-butyl (3-cyclopropylphenyl)carbamate was prepared on 2 mmol scale following general 
procedure A using tert-butyl (3-bromophenyl)carbamate as starting material (reaction time 24 h) and 
isolated as a yellowish crystals (392 mg, 1.68 mmol, 84%). 1H NMR (400 MHz, CDCl3) δ 7.19-7.05 (m, 
3H), 6.79-6.68 (m, 1H), 6.44 (s, 1H), 1.93-1.81 (m, 1H), 1.52 (s, 9H), 0.96-0.88 (m, 2H), 0.73-0.65 (m, 
2H). 13C NMR (101 MHz, CDCl3): δ 152.9, 145.2, 138.5, 128.9, 120.5, 116.1, 115.8, 80.5, 28.5, 15.6, 
9.3. HRMS: calcd. for C14H20NO2+, (M+H)+: 234.1489; found: 234.1489. MF: C14H19NO2. MW: 233.31. 
 1fp 
4-Cyclopropylphenol was prepared on 1.5 mmol scale by demethylation of 1b.[25] 229 µL (1.5 mmol, 
1.0 equiv.) 1b were dissolved in 5 mL of dry DCM in a dried 100 mL round bottom flask under inert 
atmosphere and cooled with an ice bath. 1.65 mL (1.65 mmol, 1.1 equiv.) BBr3 (1M in DCM) was added 
dropwise via syringe through the septum and the reaction was stirred at 0 °C for 3 h. The reaction 
mixture was diluted with 5 mL of DCM and 10 mL of 1M aqueous NaOH were added and the phases 
were separated. The organic phase was extracted with another 10 mL of 1M NaOH. The combined 
aqueous phases were acidified with conc. HCl and extracted with DCM twice. The organic phase was 
concentrated, and the residue was purified by column chromatography to give the title compound as 
white crystal (90 mg, 0.67 mmol, 45%). 1H NMR (400 MHz, CDCl3): δ 7.00-6.92 (m, 1H), 6.76-6.69 (m, 
1H), 4.64 (brs, 1H), 1.90-1.77 (m, 1H), 0.99-0.79 (m, 1H), 0.68-0.52 (m, 1H).13C NMR (101 MHz, CDCl3): 
δ 153.4, 136.2, 129.8, 127.2, 115.2, 14.8, 8.7. NMR data matches literature reference.[26] HRMS: calcd. 
for C9H10O∙+, (M)+∙: 134.0726; found: 134.0730. MF: C9H10O. MW: 134.18.  
  1f 
4-cyclopropylphenyl acetate was prepared on 0.3 mmol scale by acetylation of 1fp. 55 mg (0.4 mmol, 
1 equiv.) 1fp, 113 µL (0.8 mmol, 2 equiv.) triethylamine and a few mg of DMAP were dissolved in 5 mL 
of DCM. 37 µL (0.5 mmol, 1.25 equiv.) acetyl chloride were added dropwise via syringe and the reaction 
mixture was stirred for 5 h at room temperature. Upon completion, the reaction mixture was diluted with 
10 mL of DCM, 10 mL of 1M aqueous HCl were added and the phases were separated. The aqueous 
phase was extracted with another 10 mL of DCM and the combined organic phases were dried with 
MgSO4, concentrated and the residue was purified by column chromatography giving the product as 
colorless oil (62 mg, 0.35 mmol, 88%). 1H NMR (300 MHz, CDCl3): δ 7.12-7.05 (m, 2H), 7.00-6.94 (m, 
2H), 2.29 (s, 3H), 196-184 (m, 1H), 1.01-0.91 (m, 2H), 0.72-0.62 (m, 2H).13C NMR (75 MHz, CDCl3): δ 
169.8, 148.5, 141.6, 129.6, 126.7, 121.3, 21.2, 15.0, 9.2. NMR data matches literature reference.[27] 
HRMS: calcd. for C11H12O2∙+, (M)+∙: 176.0832; found: 176.0827. MF: C11H12O2. MW: 176.22. 
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  1g 
4-Cyclopropylbenzonitrile was prepared on 1.5 mmol scale following general procedure A using 4-
bromobenzonitrile as starting material (reaction time 24 h) and isolated as a colorless oil (212 mg, 1.5 
mmol, 99%). 1H NMR (400 MHz, CDCl3): δ 7.51 (d, J = 8.4 Hz, 2H), 7.11 (d, J = 8.3 Hz, 2H), 1.97-1.88 
(m, 1H), 1.11-1.05 (m, 2H), 0.79-0.73 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 150.3, 132.2, 126.2, 119.3, 
108.9, 16.0, 10.7. NMR data matches literature reference.[28] HRMS: calcd. for C10H9N∙+, (M)+∙: 143.0730; 
found: 143.0722. MF: C10H9N. MW: 143.19. 
  1h 
2-Cyclopropylbenzonitrile was prepared on 3 mmol scale following the general procedure A using 2-
iodobenzonitrile as starting material (reaction time 24 h) and isolated as a yellowish oil (400 mg, 2.8 
mmol, 93%). 1H NMR (400 MHz, CDCl3): δ 7.61-7.55 (m, 1H), 7.50-7.42 (m, 1H), 7.25-7.18 (m, 1H), 
6.96-6.90 (m, 1H), 2.33-2.23 (m, 1H), 1.18-1.10 (m, 2H), 0.82-0.76 (m, 2H). 13C NMR (101 MHz, CDCl3): 
δ 148.0, 132.9, 132.7, 125.9, 124.4, 118.5, 113.1, 14.2, 9.7. NMR data matches literature reference.[29] 
HRMS: calcd. for C10H9N∙+, (M)+∙: 143.0730; found: 143.0731. MF: C10H9N. MW: 143.19. 
 1i 
1-Cyclopropyl-4-(trifluoromethyl)benzene was prepared on 2 mmol scale following general 
procedure A using 1-bromo-4-(trifluoromethyl)benzene as starting material (reaction time 24 h) and 
isolated as a colorless oil (225 mg, 1.2 mmol, 60%). 1H NMR (600 MHz, CDCl3): δ 7.49 (d, J = 8.0 Hz, 
2H), 7.15 (d, J = 8.0 Hz, 2H), 1.98-1.90 (m, 1H), 1.07-1.00 (m, 2H), 0.77-0.72 (m, 2H). 13C NMR (151 
MHz, CDCl3): δ 148.5 (s), 127.7 (q, J = 32.3 Hz), 125.9 (s), 125.3 (q, J = 3.8 Hz), 124.55 (q, J = 271.5 
Hz), 15.6 (s), 10.1 (s). 19F NMR (600 MHz, CDCl3): -62.2. NMR data matches literature reference.[30] 
HRMS: calcd. for C10H9F3∙+, (M)+∙: 186.0651; found: 186.0644. MF: C10H9F3. MW: 186.18. 
 1j 
1-Chloro-4-cyclopropylbenzene was prepared on 5 mmol scale following general procedure B using 
4-chlorostyrene as starting material and isolated as a colorless oil (750 mg, 4.91 mmol, 98%). 1H NMR 
(400 MHz, CDCl3): δ 7.24-7.19 (m, 2H), 7.03-6.96 (m, 2H), 1.92-1.81 (m, 1H), 1.00-0.93 (m, 2H), 0.70-
0.63 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 142.6, 131.0, 128.4, 127.2, 15.1, 9.4. NMR data matches 
literature reference.[27] HRMS: calcd. for C9H9Cl∙+, (M)+∙: 152.0387; found: 152.0383. MF: C9H9Cl. MW: 
152.62.  
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  1l 
Methyl 2-cyclopropylbenzoate was prepared on 2 mmol scale following the general procedure A using 
methyl 2-iodobenzoate as starting material (reaction time 24 h) and isolated as a brownish oil (300 mg, 
1.70 mmol, 85%). 1H NMR (400 MHz, CDCl3): δ 7.79 (dd, J = 7.8, 1.5 Hz, 1H), 7.19 (td, J = 7.6, 1.1 Hz, 
2H), 7.01 (d, J = 7.9 Hz, 1H), 3.91 (m, 1H), 2.69-2.60 (m, 1H), 1.03-0.95 (m, 2H),0.72-0.64 (m, 2H). 13C 
NMR (101 MHz, CDCl3): δ 168.8, 144.8, 131.9, 131.3, 130.1, 125.7, 125.3, 52.1, 13.6, 8.9. NMR data 
matches literature reference.[31] HRMS: calcd. for C11H13O2+, (M+H)+: 177.0910; found: 177.0913. MF: 
C11H12O2. MW: 176.22. 
 1n 
1-(Tert-butyl)-4-cyclopropylbenzene was prepared on 2 mmol scale following the general procedure 
A using 1-bromo-4-(tert-butyl)benzene as starting material (reaction time 24 h) and isolated as a 
colorless oil (325 mg, 1.9 mmol, 93%). 1H NMR (400 MHz, CDCl3): δ 7.29 (d, J = 8.4 Hz, 2H), 7.03 (d, 
J = 8.3 Hz, 2H), 1.92-1.82 (m, 1H), 1.31 (s, 9H), 0.96-0.90 (m, 2H), 0.71-0.65 (m, 2H). 13C NMR (101 
MHz, CDCl3): δ 148.4, 141.0, 125.5, 125.3, 34.5, 31.6, 15.0, 9.1. NMR data matches literature 
reference.[32] HRMS: calcd. for C13H18∙+, (M)+∙: 174.1403; found: 174.1402. MF: C13H18. MW: 174.29. 
 1o 
2-Cyclopropyl-1,3,5-trimethylbenzene was prepared on 3 mmol scale following general procedure A 
using 2-bromo-1,3,5-trimethylbenzene as starting material (reaction time 24 h) and isolated as a 
colorless oil (450 mg, 2.81 mmol, 94%). 1H NMR (400 MHz, CDCl3): δ 6.90 (s, 2H), 2.47 (s, 6H), 2.33 
(s, 3H), 1.80-1.67 (m, 1H), 1.10-1.01 (m, 2H), 0.63-0.55 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 139.0, 
136.2, 135.7, 128.7, 20.9, 20.7, 11.9, 8.2. NMR data matches literature reference.[33] HRMS: calcd. for 
C12H16·+, (M)+∙: 160.1252; found: 160.1245. MF: C12H16. MW: 160.26.  
  1p 
4-Cyclopropyl-1,1'-biphenyl was prepared on 3 mmol scale following the general procedure A using 
4-bromo-1,1'-biphenyl as starting material (reaction time 24 h) and isolated as white crystals (550 mg, 
2.83 mmol, 94%). 1H NMR (400 MHz, CDCl3): δ 7.63-7.58 (m, 2H), 7.55-7.50 (m, 2H), 7.48-7.42 (m, 
2H), 7.38-7.32 (m, 1H), 7.21-7.15 (m,2H), 2.01-1.92 (m, 1H), 1.06-0.99 (m, 2H),0.80-0.74 (m, 2H). 13C 
NMR (101 MHz, CDCl3): δ 143.3, 141.2, 138.5, 128.8, 127.1, 127.1, 127.1, 126.2, 15.3, 9.5. NMR data 
matches literature reference.[34] HRMS: calcd. for C15H14∙+, (M)+∙: 194.1096; found: 194.1094. MF: 
C15H14. MW: 194.28.  
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  1r 
1-Cyclopropylnaphthalene was prepared on 1.5 mmol scale following the general procedure A using 
1-bromonapthalene as starting material (reaction time 24 h) and isolated as a colorless oil (226 mg, 1.34 
mmol, 90%). 1H NMR (400 MHz, CDCl3): δ 8.45 (d, J = 8.7 Hz, 1H), 7.89 (d, J =8.1 Hz, 1H), 7.62-7.50 
(m, 2H), 7.51-7.48 (m, 1H), 7.45-7.39 (m,1H), 7.33-7.29 (m, 1H), 2.43-2.34 (m, 1H), 1.14-1.07 (m, 
2H),0.84-0.78 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 139.3, 133.66, 133.65, 128.6, 126.7, 125.8, 125.7, 
125.6, 124.6, 123.9, 13.4, 6.6. NMR data matches literature reference.[34] HRMS: calcd. for C13H12∙+, 
(M)+∙: 168.0934; found: 168.0923. MF: C13H12. MW: 168.24. 
  1s 
4-Cyclopropylthiophene-2-carbaldehyde was prepared on 2 mmol scale following general procedure 
A using 4-iodothiophene-2-carbaldehyde as starting material (reaction time 18 h) and isolated as a 
yellow/brownish oil (220 mg, 1.83 mmol, 92%) 1H NMR (600 MHz, CDCl3): δ 9.84 (s, 1H), 7.49 (s, 1H), 
7.30 (s, 1H), 1.97-1.89 (m, 1H), 0.99-0.93 (m, 2H), 0.69-0.63 (m, 2H). 13C NMR (151 MHz, CDCl3): δ 
183.0, 146.8, 143.7, 135.0, 128.5, 11.2, 8.8. HRMS: calcd. for C8H8OS∙+, (M)+∙: 152.0290; found: 
152.0282. MF: C8H8OS. MW: 152.21. 
  1t 
3-Cyclopropylbenzo[b]thiophene was prepared on 3 mmol scale following general procedure A using 
3-bromobenzo[b]thiophene as starting material (reaction time 18 h) and isolated as a yellow oil (450 mg, 
2.58 mmol, 86%) 1H NMR (400 MHz, CDCl3): δ 7.98 (d, J = 8.1 Hz, 1H), 7.85 (d, J = 7.8 Hz, 1H), 7.46-
7.34 (m, 2H), 6.96 (d, J = 0.9 Hz, 1H), 2.11-2.02 (m, 1H), 1.02-0.95 (m, 2H), 0.74-0.69 (m, 2H). 13C NMR 
(101 MHz, CDCl3): δ 140.6, 140.0, 138.9, 124.5, 124.0, 122.9, 122.2, 119.9, 9.3, 6.3. HRMS: calcd. for 
C11H10S∙+, (M)+∙: 174.0498; found: 174.0497. MF: C11H10S. MW: 174.26.  
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  2u 
2-Methylcyclopropylbenzene was prepared on 5 mmol scale following general procedure B using (E)-
prop-1-en-1-ylbenzene as starting material and isolated as a colorless oil (410 mg, 3.10 mmol, 62%) 1H 
NMR (400 MHz, CDCl3): δ 7.28-7.22 (m, 2H), 7.17-7.11 (m, 1H), 7.07-7.02 (m, 2H), 1.58 (dt, J = 8.9, 
4.7 Hz, 1H), 1.20 (d, J = 5.9 Hz, 3H), 1.12-1.02 (m, 1H), 0.93-0.87 (m, 1H), 0.78-0.72 (m, 1H). 13C NMR 
(101 MHz, CDCl3): δ 144.2, 128.4, 125.6, 125.3, 24.5, 19.2, 18.1, 17.8. NMR data matches literature 
reference.[27] HRMS: calcd. for C10H12∙+, (M)+∙: 132.0934; found: 132.0936. MF: C10H12. MW: 132.21. 
 1vp 
2-Bromo-N,N-diethyl-5-fluorobenzamide was prepared on 2.3 mmol scale by coupling of 2-bromo-4-
fluorobenzoic acid with diethylamine. 500 mg (2.3 mmol, 1 equiv.) 2-bromo-4-fluorobenzoic was 
suspended in 5 mL DCM and stirred at 0°C. 217 µL (2.53 mmol, 1.1 equiv.) oxalylchloride was added 
dropwise over 5 minutes. After 1 h of additional stirring an excess of diethylamine (2 mL, 20 mmol, 8.7 
equiv.) was added slowly at 0°C and stirred for 30 min. The reaction mixture was diluted with 10 mL 
DCM, poured into a separatory funnel, washed with 10 mL 1M HCl and 10 mL sat. NaHCO3, dried with 
Na2SO4 and concentrated in vacuo. The residue was loaded onto silica and purified by column 
chromatography to give the product as a yellowish oily liquid (490 mg, 1.79 mmol, 78%). 1H NMR (400 
MHz, CDCl3): δ 7.56-7.45 (m, 1H), 7.03-6.90 (m, 2H), 3.87-3.74 (m, 1H), 3.39-3.27 (m, 1H), 3.22-3.08 
(m, 2H), 1.26 (t, J = 7.1 Hz, 3H), 1.08 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ 167.1 (d, J = 
1.7 Hz), 161.8 (d, J = 249.4 Hz)., 140.3 (d, J = 6.9 Hz), 134.4 (d, J = 8.0 Hz), 117.3 (d, J = 22.5 Hz), 
114.8 (d, J = 24.0 Hz), 113.5 (d, J = 3.4 Hz), 42.7, 39.0, 13.9, 12.5. 19F NMR (400 MHz, CDCl3): -114.1. 
HRMS: calcd. for C11H14BrFNO+, (M+H)+: 274.0237; found: 274.0273. MF: C11H13BrFNO. MW: 274.13. 
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 1v 
2-Cyclopropyl-N,N-diethyl-5-fluorobenzamide was prepared on 2 mmol scale following general 
procedure A using 2vp as starting material (reaction time 24 h) and isolated as a yellowish oil (154 mg, 
0.65 mmol, 33%) 1H NMR (600 MHz, CDCl3): δ 6.97-6.92 (m, 1H), 6.89-6.84 (m, 2H), 3.87-3.73 (m, 1H), 
3.42-3.31 (m, 1H), 3.16 (q, J = 7.1 Hz, 1H), 1.90-1.81 (m,1H), 1.25 (t, J = 7.1 Hz, 2H), 1.07 (t, J = 7.1 
Hz, 1H), 0.97-0.85 (m, 2H), 0.82-0.73 (m, 1H), 0.58-0.49 (m, 1H). 13C NMR (151 MHz, CDCl3): δ 169.5, 
160.8 (d, J = 245.5 Hz), 139.2 (d, J = 6.6 Hz), 135.2 (d, J = 3.2 Hz), 126.8 (d, J = 8.0 Hz), 115.7 (d, J = 
21.1 Hz), 112.6 (d, J = 22.7 Hz), 42.9, 38.8, 14.1, 12.9, 12.2, 9.0, 8.1. HRMS: calcd. for C14H19FNO+, 
(M+H)+: 236.1445; found: 236.1448. MF: C14H18FNO. MW: 235.30. 
 1w 
2-(4-Cyclopropylphenoxy)-2-methylpropanoic acid was prepared 1.5 mmol scale by dehalogenation 
of Ciprofibrate. 443 mg (1.5 mmol, 1 equiv.) Ciprofibrate was dissolved in 15 mL of ethanol and cooled 
with an ice bath. 700 mg (30 mmol, 20 equiv.) finely cut sodium pieces were added piece by piece and 
the reaction mixture was stirred for 5 h until all solid sodium disappeared. 1M aqueous HCl was added 
dropwise (very slowly) until pH 1. The aqueous phase was extracted 3x with 20 mL ethyl acetate and 
the combined organic phases were dried with MgSO4, concentrated and purified by reversed phase 
column chromatography (H2O (0.5% formic acid) / MeCN) giving the title compound as a white solid 
after freeze-drying. (90 mg, 0.41 mmol, 27%) 1H NMR (400 MHz, CDCl3): δ 10.91 (s, 1H), 7.03-6.94 (m, 
2H), 6.89-6.81 (m, 2H), 1.92-1.79 (m, 1H), 1.59 (s, 6H), 0.99-0.88 (m, 2H), 0.67-0.60 (m, 2H). 13C NMR 
(101 MHz, CDCl3): δ 179.7, 152.4, 138.9, 126.6, 120.8, 79.6, 25.2, 14.9, 9.0. HRMS: calcd. for  
C13H15O3-, (M-H)-: 219.1027; found: 217.1033. MF: C13H16O3. MW: 220.27. 
 1x 
Methyl 2-(4-cyclopropylphenoxy)-2-methylpropanoate was prepared 0.75 mmol scale by 
etherification of methyl α-bromoisobutyrate with 1fp. 101 mg (0.75 mmol, 1 equiv.) 1fp and 311 mg (2.25 
mmol, 3 equiv.) K2CO3 were dissolved in 4 mL of DMF and stirred for 10 min at rt. Then, 96 µL (0.75 
mmol, 1 equiv.) methyl α-bromoisobutyrate was added and the reaction mixture was stirred for 16 h at 
rt. 15 mL of ethyl acetate were added and the organic layer was washed with 10 mL of 1M NaOH, 10 
mL of water and 10 mL of brine subsequently. The organic phase was dried with MgSO4, concentrated 
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and purified by column chromatography giving the title compound as colorless oil. (70 mg, 0.3 mmol, 
40%) 1H NMR (400 MHz, CDCl3): δ 6.98-6.90 (m, 2H), 6.77-6.70 (m, 2H), 3.76 (s, 3H), 1.88-1.78 (m, 
1H), 1.56 (s, 6H), 0.93-0.85 (m, 2H), 0.65-0.57 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 175.0, 153.2, 
137.9, 126.5, 119.6, 79.3, 52.5, 25.4, 14.8, 8.9. HRMS: calcd. for C14H19O3+, (M+H)+: 235.1329; found: 
235.1333. MF: C14H18O3. MW: 234.30.  
 1yp 
(1R,2R)-1-(4-Bromo-3-methoxyphenyl)-2-((dimethylamino)methyl)cyclohexan-1-ol was prepared 
on 0.9 mmol scale by photocatalytic bromination of Tramadol hydrochloride.[44] Into a 5 mL crimp vial 
were weight 45 mg (0.15 mmol, 1 equiv.) Tramadol hydrochloride, 31.5 mg (3 mmol, 2 equiv.) NaBr, 
and 2.4 mg (0.075 mmol, 0.05 equiv.) sodium anthraquinone-2-sulfonate and 1.5 mL of MeCN and 1.5 
mL of water were added. 46 µL (0.6 mmol, 4 equiv.) of trifluoroacetic acid and a stirring bar were added, 
the vial was closed and purged with oxygen for 1 minute. The reaction mixture was irradiated with a 
single 400 nm LED for 6 h. Upon completion, 6 equal reaction mixtures were combined and diluted with 
20 mL of ethyl acetate and 20 mL of saturated, aqueous Na2CO3. The phases were separated and the 
aqueous phase was extracted with another 20 mL of ethyl acetate. The combined organic phases were 
dried with MgSO4 and concentrated. The residue was purified by column chromatography giving the title 
compound as viscous oil. (195 mg, 0.57 mmol, 63%). 1H NMR (400 MHz, CD3CN): δ 7.48-7.41 (d, J = 
8.4 Hz, 1H), 7.22-7.16 (m, 1H), 7.01-6.95 (m, 1H), 5.04 (brs, 1H), 3.83 (s, 3H), 2.14-2.07 (m, 1H), 1.95-
1.87 (m, 6H), 1.86-1.21 (m, 10H). 13C NMR (101 MHz, CDCl3): δ 156.5, 153.0, 133.3, 119.6, 110.6, 
109.0, 77.3, 62.1, 56.8, 47.5, 44.8, 42.1, 28.3, 27.1, 23.0. NMR data matches literature reference.[35] 
HRMS: calc. for C16H25BrNO2+, (M+H)+: 342.1063, found: 342.1062. MF: C16H24BrNO2. MW: 342.28. 
 1y 
(1R,2R)-1-(4-Cyclopropyl-3-methoxyphenyl)-2-((dimethylamino)methyl)cyclohexan-1-ol was 
prepared on 0.57 mmol scale following general procedure A using 1yp as starting material (reaction 
time 18h), purified by reversed phase column chromatography and isolated as a white solid (70 mg, 
0.23 mmol, 42%). 1H NMR (400 MHz, Methanol-d4): δ 7.09 (s, 1H), 6.97 (d, J = 8.0 Hz, 1H), 6.84 (d, J 
= 8.0 Hz, 1H), 3.88 (s, 3H), 2.97 (dd, J = 13.3, 9.3 Hz, 1H), 2.78-2.57 (m, 7H), 2.27-2.19 (m, 1H), 2.16-
2.07 (m, 1H), 2.00-1.46 (m, 9H), 0.93-0.82 (m, 2H), 0.65-0.55 (m, 2H). 13C NMR (101 MHz, Methanol-
d4) δ 159.8, 147.2, 131.8, 125.8, 117.9, 108.4, 75.9, 62.0, 56.1, 46.1, 43.0, 42.7, 41.7, 27.1, 26.1, 22.5, 
10.0, 8.1, 8.0. HRMS: calc. for C19H30NO2+, (M+H)+: 304.2271, found: 304.2275. MF: C19H29NO2. MW: 
303.45.  
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 1z 
Methyl (R)-8-cyclopropyl-5-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyridine-3-carboxylate was 
prepared 27.6 mmol scale following literature known methods and isolated as a dark red, viscous oil 
(2.25 g, 8.95 mmol, 32%).[36] 1H NMR (400 MHz, CDCl3): δ 7.07 (d, J = 9.3 Hz, 1H), 6.23 (d, J = 9.3 Hz, 
1H), 5.61 (dd, J = 8.5, 2.3 Hz, 1H), 3.80 (s, 3H), 3.73-3.66 (m, 1H), 3.54 (dd, J = 11.7, 2.3 Hz, 1H), 1.61-
1.50 (m, 1H), 0.87-0.80 (m, 2H), 0.59-0.53 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 166.7, 161.6, 146.6, 
141.1, 115.3, 114.5, 63.4, 53.4, 31.8, 12.5, 6.3, 6.1. HRMS: calcd. for C12H13NO3S+, (M+H)+: 252.0724; 
found: 252.0724. MF: C12H13NO3S. MW: 251.30. 
 1aa 
Methyl (R)-6-chloro-8-cyclopropyl-5-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyridine-3-carboxylate 
was prepared on 0.6 mmol scale by chlorination of compound 1z. 150 mg (0.6 mmol, 1.0 equiv.) 1z was 
dissolved in 5 mL of DCM and cooled to 0°C. 88 mg (0.66 mmol, 1.1 equiv.) N-Chlorosuccinimide was 
added and the reaction mixture was stirred overnight, diluted with DCM, washed with 10 mL of sat. 
NaHCO3 twice, dried with Na2SO4, concentrated in vacuo and purified by column chromatography. The 
title compound was isolated as a dark brownish viscous oil (116 mg, 0.41 mmol, 77%) 1H NMR (400 
MHz, CDCl3): δ 7.22 (s, 1H), 5.60 (dd, J = 8.5, 2.0 Hz, 1H), 3.77 (s, 3H), 3.77-3.70 (m, 1H), 3.54 (dd, J 
= 11.8, 2.0 Hz, 1H), 1.58-1.49 (m, 1H), 0.87-0.79 (m, 2H), 0.59-0.50 (m, 2H). 13C NMR (101 MHz, 
CDCl3): δ 168.1, 157.5, 145.7, 139.1, 120.4, 114.0, 64.0, 53.5, 32.2, 12.4, 6.5, 6.2. HRMS: calcd. for 
C12H13ClNO3S+, (M+H)+: 286.0299; found: 286.0301. MF: C12H12ClNO3S. MW: 285.74. 
 1ab 
1-Bromo-4-cyclopropylbenzene was prepared on 5 mmol scale following general procedure B using 
4-bromostyrene as starting material and isolated as a colorless oil (800 mg, 4.06 mmol, 81%). 1H NMR 
(400 MHz, CDCl3): δ 7.38-7.33 (m, 2H), 6.97-6.90 (m, 2H), 1.89-1.80 (m, 1H), 1.00-0.92 (m, 2H), 0.69-
0.62 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 143.2, 131.4, 127.6, 118.9, 15.1, 9.5. NMR data matches 
literature reference.[27] HRMS: calcd. for C9H9Br∙+, (M)+∙: 195.9885; found: 195.9882. MF: C9H9Br. MW: 
197.08.  
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(Cyclopropylmethyl)benzene was prepared on 5 mmol scale following general procedure B using allyl 
benzene as starting material and isolated as a colorless oil (422 mg, 3.19 mmol, 64%) 1H NMR (400 
MHz, CDCl3): δ 7.38-7.24 (m, 4H), 7.23-7.17 (m, 1H), 2.57 (d, J = 6,9 Hz, 2H), 1.06-0.95 (m, 1H), 0.60-
0.47 (m, 2H), 024-0.18 (m, 2H).13C NMR (101 MHz, CDCl3): δ 142.3, 128.5, 128.4, 126.0, 40.5, 12.0, 
4.8. NMR data matches literature reference.[27] HRMS: calcd. for C10H12∙+, (M)+∙: 132.0934; found: 
132.0925. MF: C10H12. MW: 132.21. 
 
3-Cyclopropyl-2-methylpyridine was prepared on 1.5 mmol scale following general procedure A using 
3-bromo-2-methylpyridine as starting material (reaction time 24 h) and isolated as a yellowish oil (226 
mg, 1.34 mmol, 90%) 1H NMR (400 MHz, CDCl3): δ 8.28-8.18 (m, 1H), 7.34-7.22 (m, 1H), 6.86 (dd, J = 
7.5, 4.8 Hz, 1H), 2.34 (s, 3H), 2.07-1.96 (m, 1H), 1.07-1.01 (m, 2H), 0.94-0.87 (m, 2H). 13C NMR (101 
MHz, CDCl3): δ 160.4, 146.5, 136.7, 128.6, 130.9, 120.0, 18.8, 13.5, 8.8. HRMS: calcd. for C9H11N∙+, 
(M)+∙: 133.0886; found: 133.0885. MF: C9H11N. MW: 133.19. 
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3.4.4 Product Characterizations 
 2a 
3-Chloro-1-phenylpropan-1-one was prepared following the general ring opening procedure A using 
cyclopropylbenzene as starting material and isolated as yellowish crystals (39 mg, 0.23 mmol, 77%). 1H 
NMR (400 MHz, CDCl3): δ 7.99-7.93 (m, 2H), 7.63-7.56 (m, 1H), 7.52-7.45 (m, 2H), 3.93 (t, J = 6.8 Hz, 
2H), 3.46 (t, J = 6.8 Hz, 2H). 13C NMR (101 MHz, CDCl3): δ 196.8, 136. 5, 133.7, 128.9, 128.2, 41.4, 
38.8. HRMS: calcd. for C9H10ClO+, (M+H)+: 169.0415; found: 169.0425. MF: C9H9ClO. MW: 168.62. 
  2b 
3-Chloro-1-(4-methoxyphenyl)propan-1-one was prepared following the general ring opening 
procedure A using 1b as starting material and isolated as a colorless solid (53 mg, 0.26 mmol, 88%). 1H 
NMR (400 MHz, CDCl3): δ 7.94 (d, J = 8.9 Hz, 2H), 6.95 (d, J = 8.9 Hz, 2H), 3.92 (t, J = 6.9 Hz, 2H), 
3.88 (s, 3H), 3.41 (t, J = 6.9 Hz, 2H). 13C NMR (101 MHz, CDCl3): δ 195.4, 164.0, 130.5, 129.7, 114.0, 
55.7, 41.1, 39.1. NMR data matches literature reference.[37] HRMS: calcd. for C10H12ClO2+, (M+H)+: 
199.0520; found: 199.0536. MF: C10H11ClO2. MW: 198.65. 
 2c 
3-Chloro-1-(2-methoxyphenyl)propan-1-one was prepared following the general ring opening 
procedure A using 1c as starting material and isolated as a yellow oil (59 mg, 0.3 mmol, 99%). 1H NMR 
(300 MHz, CDCl3): δ 7.76 (dd, J = 7.7, 1.8 Hz, 1H), 7.48 (ddd, J = 8.4, 7.3, 1.8 Hz, 1H), 7.06–6.93 (m, 
3H), 3.92 (s, 3H), 3.87 (t, J = 6.8 Hz, 2H), 3.48 (t, J = 6.8 Hz, 2H). 13C NMR (75 MHz, CDCl3): δ 198.5, 
159.0, 134.3, 130.7, 127.2, 120.9, 111.7, 55.6, 46.7, 39.3. HRMS: calcd. for C10H12ClO2+, (M+H)+: 
199.0520; found: 199.0524. MF: C10H11ClO2. MW: 198.65. 
 2d 
N-(4-(3-Chloropropanoyl)phenyl)acetamide was prepared following the general ring opening 
procedure A using 1d as starting material and isolated as a white solid (47 mg, 0.21 mmol, 70%). 1H 
NMR (400 MHz, DMSO-d6) δ 10.29 (s, 1H), 7.94 (d, J = 8.8 Hz, 2H), 7.72 (d, J = 8.8 Hz, 2H), 3.91 (t, J 
= 6.3 Hz, 2H), 3.48 (t, J = 6.3 Hz, 2H), 2.09 (s, 3H). 13C NMR (101 MHz, DMSO-d6): δ 195.8, 169.4, 
144.4, 131.3, 129.8, 118.7, 40.8, 40.1, 24.7. HRMS: calcd. for C11H13ClNO2+, (M+H)+: 226.0629; found: 
226.0630. MF: C11H12ClNO2. MW: 225.67. 
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  2e 
Tert-butyl (3-(3-chloropropanoyl)phenyl)carbamate was prepared following the general ring opening 
procedure A using 1e as starting material and isolated as a beige solid (21 mg, 0.07 mmol, 25%). 1H 
NMR (400 MHz, CDCl3) δ 8.00-7.91 (m, 1H), 7.70-7.57 (m, 2H), 7.40 (t, J = 7.9 Hz, 1H), 6.68 (s, 1H), 
3.91 (t, J = 6.8 Hz, 2H), 3.45 (t, J = 6.8 Hz, 2H), 1.53 (s, 9H). 13C NMR (101 MHz, CDCl3): δ 196.6 152.7, 
139.2, 137.2, 129.6, 123.5, 122.7, 117.9, 81.2, 41.5, 38.8, 28.5. HRMS: calcd. for (C14H22ClN2O3, 
(M+NH4)+: 301.1313; found: 301.1319. MF: C14H18ClNO3. MW: 283.75.  
 2f 
4-(3-Chloropropanoyl)phenyl acetate was prepared following the general ring opening procedure A 
using 1f as starting material and isolated as a yellow solid (21 mg, 0.09 mmol, 31%). 1H NMR (400 MHz, 
CDCl3) δ 8.04-7.96 (m, 2H), 7.25-7.19 (m, 2H), 3.92 (t, J = 6.8 Hz, 2H), 3.44 (t, J = 6.8 Hz, 2H), 2.33 (s, 
3H). 13C NMR (101 MHz, CDCl3): δ 195.6, 168.9, 154.8, 134.1, 129.8, 122.1, 41.4, 38.7, 21.3. HRMS: 
calcd. for C11H12ClO3+, (M+H)+: 227.0496; found: 227.0494. MF: C11H11ClO3. MW: 226.66. 
 2g 
4-(3-Chloropropanoyl)benzonitrile was prepared following the general ring opening procedure A 
using 1g as starting material and isolated as yellowish oil (28,5 mg, 0.15 mmol, 49%). 1H NMR (400 
MHz, CDCl3) δ 8.09-8.03 (m, 2H), 7.82-7.77 (m, 2H), 3.92 (t, J = 6.6 Hz, 2H), 3.47 (t, J = 6.6 Hz, 2H). 
13C NMR (101 MHz, CDCl3): δ 195.5, 139.3, 132.8, 131.9, 128.6, 117.0, 41.6, 38.2. HRMS: calcd. for 
C10H8ClNO+, (M+H)+: 193.0289; found: 193.0286. MF: C10H8ClNO. MW: 193.63. 
 2h 
3-Chloro-1-(4-(trifluoromethyl)phenyl)propan-1-one was prepared following the general ring opening 
procedure A using 1i as starting material and isolated as yellowish solid (40 mg, 0.17 mmol, 56%). 1H 
NMR (400 MHz, CDCl3) δ 8.07 (d, J = 8.2 Hz, 2H), 7.76 (d, J = 8.2 Hz, 2H), 3.93 (t, J = 6.7 Hz, 2H), 3.49 
(t, J = 6.7 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ 195.9, 139.1, 135.0 (q, J = 32.8 Hz), 128.6, 126.0 (q, 
J = 3.7 Hz), 123.63 (q, J = 272.8 Hz), 41.7, 38.4. 19F NMR (400 MHz, CDCl3): -63.7. HRMS: calcd. for 
C10H8ClF3O∙+, (M)+∙: 236.0216; found: 236.0214. MF: C10H8ClF3O. MW: 236.62.  
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  2j 
3-Chloro-1-(4-chlorophenyl)propan-1-one was prepared following the general ring opening procedure 
A using 1j as starting material and isolated as yellowish oil (54 mg, 0.27 mmol, 89%). 1H NMR (400 
MHz, CDCl3) 1H NMR δ 7.83-7.74 (m, 2H), 7.39-7.31 (m, 2H), 3.81 (t, J = 6.8 Hz, 3H), 3.32 (t, J = 6.8 
Hz, 2H). 13C NMR (101 MHz, CDCl3) δ 195.6, 140.2, 134.8, 129.6, 129.2, 41.3, 38.6. HRMS: calcd. for 
C9H9Cl2O∙+, (M)+∙: 203.0025, found: 203.0019. MF: C9H8Cl2O. MW: 203.06. 
  2k 
1-(3-Bromophenyl)-3-chloropropan-1-one was prepared following the general ring opening procedure 
A using 3-bromocyclopropylbenzene as starting material and isolated as colorless solid (42 mg, 0.17 
mmol, 57%). 1H NMR (300 MHz, CDCl3) 1H NMR δ 8.08 (t, J = 1.7 Hz, 1H), 7.88 (ddd, J = 7.8, 1.6, 1.1 
Hz, 1H), 7.72 (ddd, J = 8.0, 2.0, 1.0 Hz, 1H), 7.37 (t, J = 7.9 Hz, 1H), 3.91 (t, J = 6.7 Hz, 2H), 3.43 (t, J 
= 6.7 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 13C NMR (75 MHz, CDCl3) δ 195.5, 138.2, 136.6, 131.3, 
130.5, 126.7, 123.3, 41.5, 38.5. HRMS: calcd. for C9H8BrClO∙+, (M)+∙: 245.9442, found: 245.9436. MF: 
C9H8BrClO. MW: 247.52.  
 2l 
Methyl 2-(3-chloropropanoyl)benzoate was prepared following the general ring opening procedure A 
using 1l as starting material and isolated as yellowish oil (34 mg, 0.15 mmol, 50%). 1H NMR (400 MHz, 
CDCl3): δ 7.93 (dd, J = 7.8, 0.9 Hz, 1H), 7.59 (td, J = 7.5, 1.3 Hz, 1H), 7.51 (td, J = 7.6, 1.3 Hz, 1H), 
7.36 (dd, J = 7.5, 0.9 Hz, 1H), 3.91 (t, J = 6.9 Hz, 2H), 3.90 (s, 3H), 3.28 (t, J = 6.9 Hz, 2H). 13C NMR 
(101 MHz, CDCl3): δ 202.6, 167.0, 142.8, 132.6, 130.2, 130.2, 128.3, 126.3, 52.8, 45.6, 38.7. HRMS: 
calcd. for C11H12ClO3+, (M+H)+: 227.0469; found: 227.0490. MF: C11H11ClO3. MW: 226.66.  
 2m 
4-(3-Chloropropanoyl)benzoic acid was prepared following the general ring opening procedure A 
using 4-cyclopropyl benzoic acid as starting material and isolated as white solid (34 mg, 0.16 mmol, 
53%). 1H NMR (1H NMR (400 MHz, DMSO-d6) δ 13.31 (brs, 1H), 8.07 (s, 4H), 3.93 (t, J = 6.3 Hz, 2H), 
3.60 (t, J = 6.3 Hz, 2H). 13C NMR (101 MHz, DMSO-d6) δ 196.8, 166.6, 139.3, 134.8, 129.6, 128.2, 
41.1, 39.5. HRMS: calcd. for C10H8ClO3-, (M-H)-: 211.0167; found: 211.0172. MF: C10H9ClO3. MW: 
212.63.   
__________________________________________________________________________________ 
72 
 2n 
1-(4-(Tert-butyl)phenyl)-3-chloropropan-1-one was prepared following the general ring opening 
procedure A using 1n as starting material and isolated as colorless oil (46 mg, 0.21 mmol, 68%). 1H 
NMR (300 MHz, CDCl3): δ 7.90 (d, J = 8.7 Hz, 2H), 7.49 (d, J = 8.7 Hz, 2H), 3.92 (t, J = 6.9 Hz, 2H), 
3.44 (t, J = 6.9 Hz, 2H), 1.34 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 196.5, 157.5, 133.9, 128.2, 125.8, 
41.3, 39.0, 35.3, 31.2. HRMS: calcd. for C13H18ClO+, (M+H)+: 225.1041; found: 225.1090. MF: 
C13H17ClO. MW: 224.73. 
  2o 
3-Chloro-1-mesitylpropan-1-one was prepared following the general ring opening procedure A using 
1o as starting material and isolated as colorless oil (22 mg, 0.10 mmol, 35%). 1H NMR (300 MHz, 
CDCl3): δ 7.90 (d, J = 8.7 Hz, 2H), 7.49 (d, J = 8.7 Hz, 2H), 3.92 (t, J = 6.9 Hz, 2H), 3.44 (t, J = 6.9 Hz, 
2H), 1.34 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 206.9, 139.0, 138.6, 132.9, 128.8, 47.2, 37.9, 21.2, 19.3. 
HRMS: calcd. for C12H16ClO+, (M+H)+: 211.0884; found: 211.0887. MF: C12H15ClO. MW: 210.70.  
 2p 
1-([1,1'-Biphenyl]-4-yl)-3-chloropropan-1-one was prepared following the general ring opening 
procedure A using 1p as starting material and isolated as white crystals (64 mg, 0.26 mmol, 87%). 1H 
NMR (400 MHz, CDCl3): δ 8.06-8.01 (m, 2H), 7.73-7.68 (m, 2H), 7.66-7.61 (m, 2H), 7.51-7.45 (m, 2H), 
7.44-7.39 (m, 1H), 3.95 (t, J = 6.8 Hz, 2H), 3.49 (t, J = 6.8 Hz, 2H). 13C NMR (101 MHz, CDCl3): δ 196.4, 
146.3, 139.8, 135.2, 129.1, 128.8, 128.5, 127.5, 127.4, 41.4, 38.9. HRMS: calcd. for C15H13ClO∙+, (M)+∙: 
244.0655; found: 244.0649. MF: C15H13ClO. MW: 244.72. 
 2q 
(4-(3-Chloropropanoyl)phenyl)boronic acid was prepared following the general ring opening 
procedure A using 4-cyclopropylbenzene boronic acid as starting material. The yield was determined 
using 1H-NMR with benzene as internal standard (65%). 1H NMR (300 MHz, D2O) δ 8.29-8.14 (m, 4H), 
4.21 (t, J = 6.2 Hz, 2H), 3.82 (t, J = 6.2 Hz, 2H). 13C NMR (101 MHz, Acetone-d6) δ 197.4, 138.8, 135.1, 
127.6, 41.9, 39.8. HRMS: calcd. for C9H9BClO3-, (M-H)-: 211.0339; found: 211.0339. MF: C9H10BClO3. 
MW: 212.44.  
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 2r 
3-Chloro-1-(naphthalen-1-yl)propan-1-one was prepared following the general ring opening 
procedure A using 1r as starting material and isolated as yellowish oil (33 mg, 0.15 mmol, 50%). 1H 
NMR (400 MHz, CDCl3): δ 8.67 (d, J = 9.0 Hz, 1H), 8.02 (d, J = 8.2 Hz, 1H), 7.92-7.87 (m, 2H), 7.64-
7.50 (m, 3H), 3.99 (t, J = 6.6 Hz, 2H), 3.54 (t, J = 6.6 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ 200.6, 
135.1, 134.1, 133.4, 130.2, 128.6, 128.4, 128.1, 126.8, 125.9, 124.5, 44.4, 39.3. HRMS: calcd. for 
C13H11ClO∙+, (M)+∙: 218.0493; found: 218.0487. MF: C13H11ClO. MW: 218.68.  
 2s 
4-(3-Chloropropanoyl)thiophene-2-carbaldehyde was prepared following the general ring opening 
procedure A using 1s as starting material and isolated as yellow crystalline solid (19 mg, 0.09 mmol, 
31%). 1H NMR (400 MHz, CDCl3): δ 9.96 (s, 1H), 8.41 (s, 1H), 8.19 (s, 1H), 3.91 (t, J = 6.6 Hz, 2H), 3.38 
(t, J = 6.6 Hz, 2H). 13C NMR (101 MHz, CDCl3): δ 190.4, 182.9, 144.9, 142.4, 139.7, 135.0, 42.4, 38.2, 
29.8. HRMS: calcd. for C8H8ClO2S+, (M+H)+: 202.9928; found: 202.9931. MF: C8H7ClO2S. MW: 202.65. 
  2t 
41-(Benzo[b]thiophen-3-yl)-3-chloropropan-1-one was prepared following the general ring opening 
procedure A using 1t as starting material and isolated as colorless oil (31 mg, 0.14 mmol, 46%). 1H NMR 
(400 MHz, CDCl3): δ 8.77 (d, J = 8.5 Hz, 1H), 8.31 (s, 1H), 7.87 (d, J = 8.1 Hz, 1H), 7.54-7.48 (m, 1H), 
7.47-7.41 (m, 1H), 3.96 (t, J = 6.7 Hz, 2H), 3.47 (t, J = 6.7 Hz, 2H). 13C NMR (101 MHz, CDCl3): δ 191.7, 
139.9, 137.49, 136.51, 135.0, 126.2, 125.8, 125.8, 122.4, 42.7, 38.9. NMR data matches literature 
reference.[38] HRMS: calcd. for C11H9ClOS∙+, (M)+∙: 224.0057; found: 224.0052. MF: C11H9ClOS. MW: 
224.70.  
 2u 
3-Chloro-1-phenylbutan-1-one was prepared following the general ring opening procedure A using 1u 
as starting material and isolated as colorless solid (26 mg, 0.14 mmol, 47%). 1H NMR (400 MHz, CDCl3): 
δ 7.98-7.93 (m, 2H); 7.62-7.56 (m, 1H), 7.52-7.45 (m, 2H), 4.67 (h, J = 6.6 Hz, 1H), 3.59 (dd, J = 17.1, 
6.8 Hz, 1H), 3.26 (dd, J = 17.1, 6.5 Hz, 1H), 1.64 (d, J = 6.6 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ 
196.8, 136.7, 133.6, 128.9, 128.3, 52.9, 48.8, 25.5. NMR matches literature reference.[39] HRMS: calcd. 
for C10H11ClO∙+, (M)+∙: 182.0493; found: 182.0488. MF: C10H11ClO. MW: 182.65.  
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 2v 
2-(3-Chloropropanoyl)-N,N-diethyl-5-fluorobenzamide was prepared following the general ring 
opening procedure A using 1v as starting material and isolated as colorless oil (35 mg, 0.12 mmol, 41%). 
1H NMR (400 MHz, CDCl3): δ 7.84 (dd, J = 8.7, 5.2 Hz, 1H), 7.14 (td, J = 8.3, 2.6 Hz, 1H), 6.98 (dd, J = 
8.4, 2.6 Hz, 1H), 3.85 (t, J = 6.8 Hz, 2H), 3.55 (q, J = 7.2 Hz, 2H), 3.37 (t, J = 6.8 Hz, 2H), 3.09 (q, J = 
7.1 Hz, 2H), 1.29 (t, J = 7.1 Hz, 3H), 1.05 (t, J = 7.2 Hz, 3H). 13C NMR (101 MHz, CDCl3): 196.0 , 169.1 
(d, J = 1.6 Hz), 164.9 (d, J = 257.2 Hz), 141.3 (d, J = 7.7 Hz), 131.8 (d, J = 9.3 Hz), 131.0 (d, J = 3.3 
Hz), 115.7 (d, J = 21.7 Hz), 115.0 (d, J = 23.1 Hz), 42.9, 42.5, 39.0, 38.6, 13.6, 12.3. 19F NMR (400 
MHz, CDCl3): -104.9. HRMS: calcd. for C14H18ClFNO2+, (M+H)+: 286.1005; found: 286.1025. MF: 
C14H17ClFNO2. MW: 285.74.  
 2w 
2-(4-(3-Chloropropanoyl)phenoxy)-2-methylpropanoic acid was prepared following the general ring 
opening procedure A using 1w as starting material and isolated as colorless solid (6 mg, 0.02 mmol, 
7%). 1H NMR (400 MHz, CDCl3): δ 7.95-7.89 (m, 2H), 6.96-6.91 (m, 2H), 3.91 (t, J = 6.8 Hz, 2H), 3.40 
(t, J = 6.8 Hz, 2H), 1.70 (s, 6H). HRMS: calcd. for C13H14ClO4-, (M-H)-: 269.0586; found: 269.0593. MF: 
C13H15ClO4. MW: 270.71. 
 2x 
Methyl 2-(4-(3-chloropropanoyl)phenoxy)-2-methylpropanoate was prepared following the general 
ring opening procedure A using 1x as starting material and isolated as colorless oil (59 mg, 0.20 mmol, 
65%). 1H NMR (400 MHz, CDCl3): δ 7.92-7.83 (m, 2H), 6.87-6.79 (m, 2H), 3.90 (t, J = 6.9 Hz, 2H), 3.76 
(s, 3H), 3.39 (t, J = 6.9 Hz, 2H), 1.66 (s, 6H). 13C NMR (101 MHz, CDCl3): δ 195.3, 174.3, 160.2, 130.2, 
117.6, 79.5, 52.9, 41.1, 39.0, 25.5. HRMS: calcd. for C13H14ClO4+, (M+H)+: 285.0888; found: 285.0891. 
MF: C14H17ClO4. MW: 284.74.  
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 2y 
3-Chloro-1-(4-((1R,2R)-2-((dimethylamino)methyl)-1-hydroxycyclohexyl)-2-
methoxyphenyl)propan-1-one was prepared following the general ring opening procedure A (but only 
on 0.15 mmol scale) using 1y as starting material and isolated as white solid (TFA salt) after reverse 
phase column chromatography and lyophilization (51 mg, 0.11 mmol, 73%). 1H NMR (400 MHz, DMSO-
d6) δ 9.34 (s, 1H), 7.64 (d, J = 8.1 Hz, 1H), 7.30 (s, 1H), 7.20 (d, J = 8.1 Hz, 1H), 3.93 (s, 3H), 3.89 (t, 
J = 6.3 Hz, 2H), 3.44 (t, J = 6.3 Hz, 2H), 2.89 (t, J = 11.7 Hz, 1H), 2.66 (d, J = 4.3 Hz, 3H), 2.53 (d, J = 
4.5 Hz, 3H), 2.43-2.29 (m, 2H), 1.93-1.34 (m, 9H). 13C NMR (101 MHz, DMSO-d6) δ 197.1, 158.8, 155.4, 
129.8, 124.9, 117.3, 109.4, 74.2, 59.3, 55.9, 45.8, 44.9, 40.8, 40.1, 39.9, 39.6, 25.3, 24.2, 21.0. HRMS: 
calcd. for C19H29ClNO3+, (M+H)+: 354.1830; found: 354.1845. MF: C21H29ClF3NO5. MW: 467.91.  
 2z 
Methyl (R)-8-(3-chloropropanoyl)-5-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyridine-3-carboxylate 
was prepared following the general ring opening procedure A using 1z as starting material and isolated 
as yellowish solid (9 mg, 0.03 mmol, 10%). 1H NMR (400 MHz, CDCl3) δ 7.78 (d, J = 9.6 Hz, 1H), 6.32 
(d, J = 9.6 Hz, 1H), 5.61 (dd, J = 9.6, 2.6 Hz, 1H), 3.89 (t, J = 6.9 Hz, 2H), 3.81 (s, 3H), 3.64 (dd, J = 
12.1, 9.6 Hz, 1H), 3.49 (dd, J = 12.1, 2.6 Hz, 1H), 3.26 (t, J = 6.7 Hz, 2H). HRMS: calcd. for 
C12H13ClNO4S+, (M+H)+: 302.0248; found: 302.0250. MF: C12H12ClNO4S. MW: 301.74. 
 2aa 
Methyl (R)-6-chloro-8-(3-chloropropanoyl)-5-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyridine-3-
carboxylate was prepared following the general ring opening procedure A using 1aa as starting material 
and isolated as yellowish solid (11 mg, 0.03 mmol, 11%). 1H NMR (400 MHz, CDCl3) δ 7.95 (s, 1H), 
5.64 (dd, J = 9.6, 2.4 Hz, 1H), 3.89 (t, J = 6.7 Hz, 1H), 3.81 (s, 3H), 3.68 (dd, J = 12.2, 9.6 Hz, 1H), 3.52 
(dd, J = 12.2, 2.5 Hz, 1H), 3.26 (t, J = 6.6 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 191.1, 167.8, 157.6, 
156.7, 136.7, 120.1, 111.4, 62.8, 53.8, 40.8, 38.3, 31.9. HRMS: calcd. for C12H12Cl2NO4S+, (M+H)+: 
335.9859; found: 335.9864. MF: C12H11Cl2NO4S. MW: 336.18.  
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  2ad    2j 
1-(4-Bromophenyl)-3-chloropropan-1-one was prepared following the general ring opening procedure 
A using 1ad as starting material and isolated as yellow solid as a 1:1 mixture with 2j (27 mg, 0.11 mmol, 
36% + 22 mg, 0.11 mmol 2j). 1H NMR (300 MHz, CDCl3) δ 7.84-7.79 (m, 2H), 7.65-7.60 (m, 2H), 3.91 
(t, J = 6.7 Hz, 2H), 3.43 (t, J = 6.8 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ 195.9, 135.2, 132.2, 129.7, 
128.7, 41.3, 38.6. NMR data matches literature reference.[40] HRMS: calcd. for C9H8BrClO∙+, (M)+∙: 
245.9442; found: 245.9440. MF: C9H8BrClO. MW: 247.52. 
 3a 
3-Bromo-1-phenylpropan-1-one was prepared following general ring opening procedure B using 1a 
as starting material and isolated as white crystals (23 mg, 0.15 mmol, 51%). 1H NMR (400 MHz, CDCl3) 
δ 7.99-7.92 (m, 2H), 7.62-7.57 (m, 1H), 7.52-7.45 (m, 2H), 3.75 (t, J = 7.1 Hz, 2H), 3.58 (t, J = 7.0 Hz, 
2H). 13C NMR (101 MHz, CDCl3) δ 197.1, 136.4, 133.7, 128.9, 128.2, 41.7, 25.9. NMR data matches 
literature reference.[41] HRMS: calcd. for C9H10BrO+, (M+H)+: 212.9910; found: 212.9912. MF: C9H9BrO. 
MW: 213.07. 
 3b 
3-Hydroxy-1-phenylpropan-1-one was prepared following general ring opening procedure B using 1a 
as starting material and isolated as yellow oil (25 mg, 0.17 mmol, 56%). 1H NMR (400 MHz, CDCl3): δ 
7.99-7.93 (m, 2H), 7.63-7.55 (m, 1H), 7.52-7.44 (m, 2H), 4.04 (t, J = 5.3 Hz, 2H), 3.23 (t, J = 5.3 Hz, 
2H), 2.80 (brs, 1H).13C NMR (101 MHz, CDCl3) δ 200.6, 136.8, 133.7, 128.8, 128.2, 58.2, 40.5. NMR 
matches literature reference.[42] HRMS: calcd. for C9H11O2+, (M+H)+: 151.0754; found: 151.0763. MF: 
C9H10O2. MW: 150.18.  
 3c 
3-Methoxy-1-phenylpropan-1-one was prepared following general ring opening procedure B using 1a 
as starting material and isolated as colorless oil (32 mg, 0.19 mmol, 65%). 1H NMR (400 MHz, CDCl3): 
δ 7.99-7.93 (m, 2H), 7.59-7.53 (m, 1H), 7.49-7.43 (m, 2H), 3.83 (t, J = 6.5 Hz, 2H), 3.38 (s, 3H), 3.25 (t, 
J = 6.5 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ 198.5, 137.1, 133.3, 128.7, 128.3, 68.0, 59.1, 38.8. NMR 
matches literature reference.[43] HRMS: calcd. for C10H13O2+, (M+H)+: 165.0910; found: 165.0927. MF: 
C10H12O2. MW: 164.20.  
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  3d 
3-Bromo-1-(4-chlorophenyl)propan-1-one was prepared following general ring opening procedure B 
using 1j as starting material and isolated as colorless oil (24 mg, 0.10 mmol, 32%). 1H NMR (400 MHz, 
CDCl3) δ 7.93-7.84 (m, 2H), 7.50-7.41 (m, 2H), 3.73 (t, J = 6.8 Hz, 2H), 3.54 (t, J = 6.8 Hz, 2H). 13C 
NMR (101 MHz, CDCl3) δ 195.9, 140.2, 134.7, 129.6, 129.2, 41.6, 25.6. NMR data matches literature 
reference.[41] HRMS: calcd. for C9H9BrClO+, (M+H)+: 246.9520; found: 246.9522. MF: C9H8BrClO. MW: 
247.52.  
 3e 
1-(4-Chlorophenyl)-3-hydroxypropan-1-one was prepared following general ring opening procedure 
B using 1j as starting material and isolated as colorless oil (29 mg, 0.16 mmol, 52%). 1H NMR (400 
MHz, CDCl3): δ 7.95-7.85 (m, 2H), 7.49-7.39 (m, 2H), 4.03 (t, J = 5.3 Hz, 2H), 3.20 (t, J = 5.3 Hz, 2H), 
2.29 (brs, 1H). 13C NMR (101 MHz, CDCl3) δ 199.3, 140.2, 135.1, 129.6, 129.2, 58.1, 40.5. NMR data 
matches literature reference.[42] HRMS: calcd. for C9H10ClO2+, (M+H)+: 185.0364; found: 185.0364. MF: 
C9H9ClO2. MW: 184.62. 
 3f 
1-(4-Chlorophenyl)-3-methoxypropan-1-one was prepared following general ring opening procedure 
B using 1j as starting material and isolated as colorless oil (32 mg, 0.19 mmol, 65%). 1H NMR (400 
MHz, CDCl3): δ 7.93-7.86 (m, 2H), 7.46-7.40 (m, 2H), 3.81 (t, J = 6.4 Hz, 2H), 3.37 (s, 3H), 3.20 (t, J = 
6.4 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ 197.3, 139.8, 135.5, 129.7, 129.1, 67.9, 59.1, 38.8. NMR 
matches literature reference.[43] HRMS: calcd. for C10H12ClO2+, (M+H)+: 199.0520; found: 199.0521. MF: 
C10H11ClO2. MW: 198.65. 
 3g 
1-([1,1'-Biphenyl]-4-yl)-3-bromopropan-1-one was prepared following general ring opening 
procedure B using 1p as starting material and isolated as white crystals (57 mg, 0.20 mmol, 66%). 1H 
NMR (400 MHz, CDCl3): δ 8.07-7.99 (m, 2H), 7.74-7.68 (m, 2H), 7.66-7.61 (m, 2H), 7.52- 7.45 (m, 2H), 
7.44-7.39 (m, 1H), 3.77 (t, J = 7.0 Hz, 2H), 3.61 (t, J = 6.8 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ 196.7, 
146.4, 139.8, 135.1, 129.1, 128.8, 128.5, 127.5, 127.4, 41.7, 26.0. HRMS: calcd. for C15H14BrO∙+, (M)+∙: 
289.0223; found: 289.0221. MF: C15H13BrO. MW: 289.17.  
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 3h 
1-([1,1'-Biphenyl]-4-yl)-3-hydroxypropan-1-one was prepared following general ring opening 
procedure B using 1p as starting material and isolated as white crystals (40 mg, 0.18 mmol, 59%). 1H 
NMR (400 MHz, CDCl3): δ 8.00-7.92 (m, 2H), 7.63-7.55 (m, 1H), 7.52-7.43 (m, 2H), 4.48 (brs, 1H), 4.06 
(t, J = 5.3 Hz, 2H), 3.25 (t, J = 5.3 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ 200.8, 136.6, 133.8, 128.9, 
128.2, 58.3, 40.3. HRMS: calcd. for C15H15O2+, (M+H)+: 227.1067; found: 227.1067. MF: C15H14O2. MW: 
226.28. 
 3i 
1-([1,1'-Biphenyl]-4-yl)-3-methoxypropan-1-one was prepared following general ring opening 
procedure B using 1p as starting material and isolated as colorless/yellowish crystals (64 mg, 0.27 
mmol, 89%). 1H NMR (400 MHz, CDCl3): δ 8.08-8.02 (m, 2H), 7.72-7.66 (m, 2H), 7.65-7.60 (m, 2H), 
7.50-7.43 (m, 2H), 7.43-7.36 (m, 1H), 3.86 (t, J = 6.5 Hz, 2H), 3.40 (s, 3H), 3.28 (t, J = 6.5 Hz, 2H). 13C 
NMR (101 MHz, CDCl3) δ 198.0, 145.9, 139.9, 135.8, 129.1, 128.9, 128.3, 127.4, 127.4, 68.1, 59.1, 
38.8. NMR matches literature reference.[43] HRMS: calcd. for C16H17O2+, (M+H)+: 241.1223; found: 
241.1219. MF: C16H16O2. MW: 240.30. 
  4a 
3-Phenyl-4,5-dihydroisoxazole was prepared on 0.3 mmol scale using 2a as starting material. 2a from 
step 1 was dissolved in pyridine (1 mL) and hydroxylamine hydrochloride (192 mg, 1.8 mmol, 6 equiv.) 
was added. Additional pyridine (5 mL) was added, and the reaction was stirred for 24 hours at room 
temperature before heating the reaction to 120 °C. After two hours at 120 °C, the reaction was 
concentrated via rotary evaporation, then purified by column chromatography yielding a white solid (22 
mg, 0.15 mmol, 50% over 2 steps). 1H NMR (400 MHz, CDCl3): δ 7.75-7.64 (m, 1H), 7.46-7.37 (m, 1H), 
4.48 (t, J = 10.1 Hz, 1H), 3.34 (t, J = 10.1 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 156.9, 130.2, 129.6, 
128.8, 126.9, 69.3, 35.4. NMR matches literature reference.[44] HRMS: calcd. for C9H9NO∙+, (M)+∙: 
147.0679; found: 147.0685. MF: C9H9NO. MW: 147.18. 
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 4b 
3-Phenyl-1-(p-tolyl)-4,5-dihydro-1H-pyrazole was prepared on 0.3 mmol scale using 2a as starting 
material. 2a from step 1 was dissolved in ethanol (3 mL) and tolylhydrazine hydrochloride (95 mg, 0.6 
mmol, 2 equiv.) was added. The reaction was stirred for 24 hours at room temperature and afterwards 
concentrated via rotary evaporation, then purified by column chromatography yielding a white solid (34 
mg, 0.14 mmol, 48% over 2 steps). 1H NMR (300 MHz, CDCl3): δ 7.79-7.71 (m, 2H), 7.44-7.29 (m, 3H), 
7.17-7.04 (m, 4H), 3.86 (t, J = 10.5 Hz, 2H), 3.23 (t, J = 10.5 Hz, 2H), 2.36-2.27 (m, 6H). 13C NMR (75 
MHz, CDCl3): δ 148.7, 144.0, 133.2, 129.7, 128.6, 128.5, 128.5, 125.7, 113.2, 48.8, 32.1, 20.7. NMR 
matches literature reference.[45] HRMS: calcd. for C16H17N2+, (M+H)+: 237.1386; found: 237.1391. MF: 
C16H16N2. MW: 236.32. 
  4c 
(3-Oxo-3-phenylpropyl)triphenylphosphonium chloride was prepared on 0.3 mmol scale using 2a 
as starting material. 2a from step 1 was dissolved in benzene (3 mL) and triphenylphosphine (81,1 mg, 
0.3 mmol, 1 equiv.) was added. The reaction was refluxed for 3 hours and the formed, white precipitate 
was filtered, washed with 5 mL benzene twice and dried to give a white solid (88 mg, 0.2 mmol, 69% 
over 2 steps). 1H NMR (400 MHz, DMSO-d6) δ 7.96-7.84 (m, 11H), 7.82-7.73 (m, 6H), 7.68-7.61 (m, 
1H), 7.50 (t, J = 7.7 Hz, 2H), 3.97-3.85 (m, 2H), 3.54-3.43 (m, 2H). 13C NMR (101 MHz, DMSO-d6) δ 
195.7 (d, J = 14.2 Hz), 135.5 (d, J = 1 Hz), 134.9 (d, J = 2.8 Hz), 133.8 (d, J = 10.3 Hz), 130.2 (d, J = 
12.5 Hz), 128.7, 128.1, 118.4 (d, J = 86.4 Hz), 31.1 (d, J = 1.4 Hz), 16.0 (d, J = 55.0 Hz). 31P NMR (162 
MHz, DMSO-d6) δ 26.53 HRMS: calcd. for C24H27NOP+, (M+H)+: 395.1559; found: 395.1605. MF: 
C24H27ClNOP. MW: 430.91. 
  
__________________________________________________________________________________ 
80 
3.5 References 
[1] a) H. N. C. Wong, M. Y. Hon, C. W. Tse, Y. C. Yip, J. Tanko, T. Hudlicky, Chem. Rev. 1989, 89, 
165-198; b) C. Ebner, E. M. Carreira, Chem. Rev. 2017, 117, 11651-11679; c) J. Salaun, Chem. 
Rev. 1989, 89, 1247-1270; d) O. G. Kulinkovich, Chem. Rev. 2003, 103, 2597-2632. 
[2] a) H.-U. Reissig, R. Zimmer, Chem. Rev. 2003, 103, 1151-1196; b) L. K. Sydnes, Chem. Rev. 
2003, 103, 1133-1150. 
[3] a) K. L. Skubi, T. R. Blum, T. P. Yoon, Chem. Rev. 2016, 116, 10035-10074; b) L. Marzo, S. K. 
Pagire, O. Reiser, B. König, Angew. Chem. 2018, 130, 10188-10228. 
[4] a) V. R. Rao, S. S. Hixson, J. Am. Chem. Soc. 1979, 101, 6458-6459; b) S. S. Hixson, D. W. 
Garrett, J. Am. Chem. Soc. 1974, 96, 4872-4879. 
[5] a) A. V. Trukhin, E. V. Eliseenkov, A. S. Dneprovskii, J. Phys. Org. Chem. 2003, 16, 189-193; b) 
J. P. Dinnocenzo, T. R. Simpson, H. Zuilhof, W. P. Todd, T. Heinrich, J. Am. Chem. Soc 1997, 
119, 987-993; c) J. P. Dinnocenzo, H. Zuilhof, D. R. Lieberman, T. R. Simpson, M. W. McKechney, 
J. Am. Chem. Soc 1997, 119, 994-1004. 
[6] a) K. Kaur, V. Kumar, A. K. Sharma, G. K. Gupta, Eur. J. Med. Chem. 2014, 77, 121-133; b) B. 
Varghese, S. N. Al-Busafi, F. O. Suliman, S. M. Z. Al-Kindy, RSC Ad. 2017, 7, 46999-47016; c) 
Z.-L. Shen, K. K. K. Goh, C. H. A. Wong, Y.-S. Yang, Y.-C. Lai, H.-L. Cheong, T.-P. Loh, Chem. 
Commun. 2011, 47, 4778-4780; d) Y. Zhu, K. Lin, D. Ye, W. Zhou, Tetrahedron Lett. 2015, 56, 
5039-5042; e) D. Weichert, P. Gmeiner, ACS Chem. Biol. 2015, 10, 1376-1386. 
[7] W. J. Close, J. Am. Chem. Soc. 1957, 79, 1455-1458. 
[8] X. Fan, H. Zhao, J. Yu, X. Bao, C. Zhu, Org. Chem. Front. 2016, 3, 227-232. 
[9] D. Petzold, B. König, Adv. Syn. Catal. 2018, 360, 626-630. 
[10] a) J. A. D. Good, M. Kulén, J. Silver, K. S. Krishnan, W. Bahnan, C. Núñez-Otero, I. Nilsson, E. 
Wede, E. de Groot, Å. Gylfe, S. Bergström, F. Almqvist, J. Med. Chem. 2017, 60, 9393-9399; b) 
M. Kulén, M. Lindgren, S. Hansen, A. G. Cairns, C. Grundström, A. Begum, I. van der Lingen, K. 
Brännström, M. Hall, U. H. Sauer, J. Johansson, A. E. Sauer-Eriksson, F. Almqvist, J. Med. Chem. 
2018, 61, 4165-4175; c) J. S. Pinkner; H. Remaut; F. Buelens; E. Miller; V. Åberg; N. Pemberton; 
M. Hedenström; A. Larsson; P. Seed; G. Waksman; S. J. Hultgren; F. Almqvist Proc. Natl. Acad. 
Sci. USA 2006, 103, 17897-17902; d) L. Cegelski; J. S. Pinkner; N. D. Hammer; C. K. Cusumano; 
C. S. Hung; E. Chorell; V. Åberg; J. N. Walker; P. C. Seed; F. Almqvist; M. R. Chapman; S. J. 
Hultgren Nat. Chem. Biol. 2009, 5, 913-919. 
[11] S. Callaghan, M. A. Filatov, E. Sitte, H. Savoie, R. W. Boyle, K. J. Flanagan, M. O. Senge, 
Photochem. Photobiol. Sci. 2017, 16, 1371-1374. 
[12] a) B. E. Maryanoff, A. B. Reitz, Chem. Rev. 1989, 89, 863-927; b) P. A. Byrne, D. G. Gilheany, 
Chem. Soc. Rev. 2013, 42, 6670-6696. 
[13] a) A. Beck, L. Goetsch, C. Dumontet, N. Corvaïa, Nat. Rev. Drug Discov. 2017, 16, 315; b) K. 
Tsuchikama, Z. An, Protein Cell 2018, 9, 33-46; c) M. L. J. Doornbos, X. Wang, S. C. Vermond, 
L. Peeters, L. Pérez-Benito, A. A. Trabanco, H. Lavreysen, J. M. Cid, L. H. Heitman, G. Tresadern, 
A. P. Ijzerman, J. Med. Chem 2018 (DOI: 10.1021/acs.jmedchem.8b00051); d) P. M. Kulkarni, A. 
R. Kulkarni, A. Korde, R. B. Tichkule, R. B. Laprairie, E. M. Denovan-Wright, H. Zhou, D. R. 
__________________________________________________________________________________ 
81 
Janero, N. Zvonok, A. Makriyannis, M. G. Cascio, R. G. Pertwee, G. A. Thakur, J. Med. Chem. 
2016, 59, 44-60. 
[14] D. A. Armstrong, R. E. Huie, S. Lymar, W. H. Koppenol, G. Merényi, P. Neta, D. M. Stanbury, S. 
Steenken, P. Wardman, BioInorg. React. Mech., 9, 2013, 59-61. 
[15] a) Y. Wang, L. Li, H. Ji, W. Ma, C. Chen, J. Zhao, Chem. Commun. 2014, 50, 2344-2346; b) C. 
Walling, B. Miller, J. Am. Chem. Soc. 1957, 79, 4181-4187. 
[16] W. C. Moore, J. Am. Chem. Soc. 1911, 33, 1091-1099. 
[17] B. H. J. Bielski, D. E. Cabelli, R. L. Arudi, A. B. Ross, J. Phys. Chem. Rev. Data 1985, 14, 1041-
1100. 
[18] a) T. J. Fisher, P. H. Dussault, Tetrahedron Lett. 2010, 51, 5615-5617; b) H. Hock, H. Kropf, 
Angew. Chem. 1957, 69, 313-321. 
[19] F. A. Cotton, G. Wilkinson in Advanced Inorganic Chemistry (4th ed.), Wiley-Interscience, New 
York, 1980 pp. 556-558. 
[20] a) G. R. Fulmer, A. J. M. Miller, N. H. Sherden, H. E. Gottlieb, A. Nudelman, B. M. Stoltz, J. E. 
Bercaw, K. I. Goldberg, Organometallics 2010, 29, 2176-2179; b) H. E. Gottlieb, V. Kotlyar, A. 
Nudelman, J. Org. Chem. 1997, 62, 7512-7515. 
[21] D. J. Wallace, C.-Y. Chen, Tetrahedron Lett. 2002, 43, 6987-6990. 
[22] J. C. Lorenz, J. Long, Z. Yang, S. Xue, Y. Xie, Y. Shi, J. Org. Chem. 2004, 69, 327-334. 
[23] Y.-Y. Zhou, C. Uyeda, Angew. Chem. Int. Ed. 2016, 55, 3171-3175. 
[24] B. Morandi, E. M. Carreira, Science 2012, 335, 1471-1474. 
[25] Y. Zhang, M. D. Tortorella, Y. Wang, J. Liu, Z. Tu, X. Liu, Y. Bai, D. Wen, X. Lu, Y. Lu, J. J. Talley, 
ACS Med. Chem. Lett. 2014, 5, 1162-1166. 
[26] G. Capocasa, G. Olivo, A. Barbieri, O. Lanzalunga, S. Di Stefano, Catal. Sci. Technol. 2017, 7, 
5677-5686. 
[27] M. H. Gieuw, Z. Ke, Y.-Y. Yeung, Angew. Chem. Int. Ed. 2018, 57, 3782-3786. 
[28] G. A. Molander, P. E. Gormisky, J. Org. Chem. 2008, 73, 7481–7485. 
[29] M. Zhang, X. Cui, X. Chen, L. Wang, J. Li, Y. Wu, L. Hou, Y. Wu, Tetrahedron 2012, 68, 900-905. 
[30] M. H. Gieuw, Z. Ke, Y. Y. Yeung, Angew. Chem. Int. Ed. 2018, 57, 3782-3786. 
[31] M. Arndt, G. Hilt, A. F. Khlebnikov, S. I. Kozhushkov, A. de Meijere, Eur. J. Org. Chem. 2012, 
3112-3121. 
[32] M. Lemhadri, H. Doucet, M. Santelli, Synth. Commun. 2006, 36, 121-128. 
[33] C. Li, G. Xiao, Q. Zhao, H. Liu, T. Wang, W. Tang, Org. Chem. Front. 2014, 1, 225-229. 
[34] G. A. Molander, F. Beaumard, T. K. Niethamer, J. Org. Chem. 2011, 76, 8126-8130. 
[35] D. Petzold, B. König, Adv. Syn. Catal. 2018, 360, 626-630. 
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4. Visible Light Mediated Liberation and in situ 
Conversion of Fluorophosgene 
 
Fluorophosgene was liberated by the photocatalytic reduction of a simple aryltrifluoromethoxyether. This 
highly reactive species was used for the synthesis of cyclic carbonates, carbamates and urea 
derivatives. The reaction mechanism was investigated by an in-depth NMR study as well as 
cyclovoltammetry and transient spectroscopy which suggests a charge-transfer complex dimer as the 
catalytic active species. 
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4.1 Introduction 
Carbonates, carbamates and urea derivatives are privileged structures in organic synthesis and 
common motifs in pharmaceuticals, pesticides and plastics (Fig. 4-1 A).[1] Many methods for the 
synthesis of these compounds have been described.[2] The direct and most hazardous way is the use 
of gaseous phosgene or its less reactive derivatives diphosgene and triphosgene. [3] However, handling 
of those compounds in the lab or in industry plants requires special safety precautions due to their 
severe toxicity.[4] Alternative procedures utilize activated or non-activated carbonates or ureas, which 
are either prepared by reaction with phosgene or less efficiently from CO2 (Fig. 4-1 B).[2, 5] Some of these 
procedures require harsh reaction conditions or suffer from low reactivity and poor atom economy. [2] 
Therefore, there is still a significant demand for a less hazardous, practical and easily controllable 
generation of reactive C1 building blocks. 
Photoredox catalysis with organic photosensitizers has received tremendous attention in the past 
years.[6] Many useful transformations without the need of metal catalysts were discovered, exploiting the 
versatile reduction and oxidation potentials of organic photocatalysts.[7] The common requirement for a 
typical photocatalytic reaction is the generation of a radical species which can either react with another 
radical, a sp2/sp center, a nucleophile or a metal complex.[8] However, the photocatalytic generation of 
intermediates with pure ionic reactivity remains elusive because energy and single electron transfer are 
the predominant reaction paths of all common photocatalysts.[9] But especially under photo-reductive 
conditions most leaving groups are ionic species, e.g. halides, pseudo halides or cyanide, which are 
neglected in the course of the reaction because they possess only limited reactivity and/or were already 
exploited in thermal and photochemical reactions (Fig. 4-1 C).[10] On the other hand, the C-OCF3 bond 
could only be activated electrochemically or under harsh reaction conditions so far.[11] However, the 
photocatalytic N-OCF3 cleavage of complex starting materials was reported very recently.[12] To address 
the need of a hazard- and metal-free access to highly reactive C1 building blocks, we envisioned to 
cleave the C-OCF3 bond of a simple, commercially available aryl trifluoromethoxy ether by photoredox 
catalysis. We identified 4-(trifluoromethoxy)-benzonitrile as a suitable starting material, which can be 
cleaved quantitatively into benzonitrile and fluorophosgene by an organic photosensitizer (Fig. 4-1 D). 
Furthermore, we investigated the reaction mechanism by NMR kinetic and structural analyses and 
propose a photo-reductive mechanism based on the results of radical trapping experiments and excited 
state quenching experiments monitored by transient spectroscopy. 
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Figure 4-1. A: Structures of prominent carbamate or urea containing molecules used in synthesis, 
pharmacy, agriculture and daily life. B: Structures of phosgene and commonly employed alternatives. 
C: Typical leaving groups and their reactivity profile in photoredox catalysis. D: Overview of the 
photocatalytic fluorophosgene generation; Tf = trifluoromethanesulfonate, R = benzonitrile.  
4.2 Results and Discussion 
4.2.1 Synthesis 
We began our investigation using 2-benzylaminoethanol (1a) as a model substrate, Rhodamine 6G (P1) 
as a strongly reducing photosensitizer, diisopropylethylamine (DIPEA) as electron donor and 
trifluoromethoxybenzene (2a) as fluorophosgene precursor in neat acetonitrile.[7b, c] However, no 
conversion of 2a was observed (Table 4-1 entry 1). Switching to commonly employed Ir(ppy)3 (P2) or to 
the recently reported, phenoxazine based photosensitizer P3 did also not lead to fragmentation of 2a 
(entries 2-3).[13] Therefore, trifluoromethoxybenzene derivative 2b bearing an electron withdrawing nitrile 
group was employed. Hence, the redox potential of 2b was much more accessible (Ered(2a) = -3.0 V vs. 
SCE compared with Ered(2b) = -2.1 V vs. SCE, see Chapter 4.4 for details) and 2b showed slow 
conversion in the presence of photosensitizer P2 (entry 4). The reaction was significantly improved by 
switching to P3 giving full conversion of 2b and 1 (entry 5). Further optimization of the reaction lead to 
conditions giving 3a in an excellent isolated yield (entry 6). Control experiments revealed that without 
catalyst, light or DIPEA no or only trace amounts of product could be obtained (entries 7-9). Finally, we 
observed that the cleavage of 2b was independent of the presence of 1 (entry 10).   
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Table 4-1. Optimization of the reaction conditions 
 
 
 
 
 
 
 
 
 
Entry PC (mol%) / λ Conversion of 2a/2b[a] Conversion of 1a[a] 
1 P1 (10) / 455 nm 2a 0% 0% 
2 P2 (2) / 455 nm 2a 0% 0% 
3 P3 (5) / 400 nm 2a 0% 0% 
4 P2 (2) / 455 nm 2b 51% 40% 
5 P3 (5) / 400 nm 2b 100% 100% 
6[b] P3 (2) / 400 nm 2b 100% 100% [96%] 
7[b] 400 nm 2b 0% 0% 
8[b, c] P3 (2) 2b 0% 0% 
9[b, d] P3 (2) / 400 nm 2b traces traces 
10[b, e] P3 (2) / 400 nm 2b 100% 0% 
General conditions: A mixture of 0.1 mmol of 1a, 2 equiv. of 2b, the indicated amount of PC, 4 equiv. of 
DIPEA in neat MeCN (0.1 M) under N2 atmosphere were irradiated for 24 h with 400 nm light (or 455 
nm for P1 and P2). [a] Conversion determined by GC-FID, isolated yield of 3a in brackets. [b] A mixture 
of 0.1 mmol of 1a, 1.05 equiv. of 2b, 2 mol% P3, 3 equiv. of DIPEA in dry MeCN (0.1 M) under N2 
atmosphere were irradiated for 24 h at 400 nm. [c] no light, 48 h. [d] no DIPEA. [e] no 1a. Bz = benzyl.  
In the next step, the synthetic scope of the method was investigated. N-substituted, five membered 
cyclic carbamates and ureas were prepared in good to excellent yield (Scheme 4-1 3b-3d). 
Unsubstituted, five and six membered cyclic carbamates, carbonates and ureas also showed good to 
excellent conversion (3e-3j). More complex carbamate 3k was isolated in good yield with a 
diastereomeric ratio of 1:1. 1,2-Cis-configured carbamate 3l and carbonate 3m were prepared in 
moderate to good yield without racemization. Subsequently, amino acids and amino alcohols were 
investigated. The ethyl and benzyl ester of serine (3n and 3o), as well as the methyl ester of threonine 
(3p) gave good to excellent yields. Noteworthily, 3p was obtained diastereomerically pure indicating that 
no racemization of the reactive α-position took place. The methyl ester of cysteine (3q) gave a moderate 
yield, but demonstrated that also thiocarbamates can be obtained by this method. The corresponding 
carbamates of the amino alcohols prolinol, valinol and tyrosinol were isolated in moderate yields (3r-3t), 
whereas tryptophanol and methioninol showed good to excellent conversion to 3u and 3v, respectively. 
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Finally, some bioactive compounds were subjected to this method. Uridine and ribothymidine as well as 
the antiviral drug ribavirin were converted to 3w, 3x and 3y with low to moderate yields. Finally, the 
beta-blocker propranolol, the neurotransmitter adrenalin and the sympathomimetic ephedrine gave good 
yields of the cyclized products (3z-3ab). To demonstrate the synthetic utility of the reaction, a gram scale 
reaction, using 1a as substrate, was performed. The corresponding product 3a was isolated with 70% 
yield after a prolonged reaction time of 48 h. 
 
Scheme 4-1. General conditions: a mixture of 0.1 mmol of substrate, 1.05 equiv. of 2b, 2 mol% P3, 3 
equiv. of DIPEA in neat MeCN (0.1 M) under N2 atmosphere were irradiated for 24 h with 400 nm light. 
a: 70% isolated yield on a 7 mmol (gram)scale. b: 4 equiv. of DIPEA were used because the starting 
material was a hydrochloride salt. c: DMF (0.1 M) was used as the solvent. Bz = benzyl, Me = methyl, 
n-Bu = n-butyl, Et = ethyl.  
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4.2.2 Mechanistic Investigations 
To investigate the mechanism, transient spectroscopy, cyclovoltammetry as well as radical trapping 
experiments and in-situ and ex-situ NMR analyses were performed. To get insight into the photocatalytic 
mechanism, the quenching of the excited state of P3 was investigated by transient spectroscopy. The 
measurements revealed that both, addition of DIPEA (Eox = +0.8 V vs. SCE) and 2b (Ered = -2.1 V vs. 
SCE) had no influence on the triplet lifetime of P3 (Eox = +0.4 V; Ered = -1.7 V, see Chapter 4.4.2 for 
details).[14] However, during measurements at catalyst concentrations of 30 μM and above (compared 
to 2 mM under the reaction conditions), we observed a charge-transfer band originating from the radical 
cation part in the catalyst CT-complex dimer.[15] The lifetime of this band decreases significantly by 
addition of DIPEA (Fig. 4-2 A). This indicates, that the charge recombination might be slowed down by 
interaction of the radical cation part of the CT-complex with DIPEA. As a consequence, the radical anion 
part can reduce 2b to restore its uncharged ground state. This assumption is supported by 
cyclovoltammetry of P3 revealing a ground state reduction potential of the P3 radical anion of about -
2.5 V vs. SCE in MeCN (see Chapter 4.4.2 for more data about the mechanistic investigation).  
To find evidence for the presence of a benzonitrile radical originating from a photo-reductive mechanism, 
we performed radical trapping experiments in presence of 1a. We observed 48% conversion of 2b to 
the corresponding N-methylpyrrole adduct 5a (Fig. 4-2 B). Moreover, the aryl radical could be trapped 
with the isolated double bond of allylbenzene giving adduct 5b in 45% yield. The different radical 
trapping conditions did not influence the conversion of 1a significantly, as 3a was isolated in high yields. 
The formation of 5a and 5b is a good indication for the intermediacy of an aryl and the operation of a 
photo-reductive mechanism.[16] In-situ 1H and 19F NMR profiles further corroborate this mechanistic step 
monitoring a clean transformation of 2b into 4 upon illumination of P3 in the presence of DIPEA (see 
Chapter 4.4.2 for details). Next, an ex situ NMR profile of the whole reaction with substrate 1a was 
recorded (Fig. 4-2 C). Upon illumination, 2b (black) and 1a (violet) start to decrease, while the two main 
products 3a (green) and 4 (red) can be readily detected. Furthermore, two more reaction intermediates 
could be identified (F-I, magenta and OC-I, cyan). Instead of the highly reactive free fluorophosgene 
itself, the formation of its next downstream more stable reaction intermediate (F-I) with 1a was observed. 
Using advanced 1D and 2D NMR techniques for the 1H, 19F and 13C assignment the intermediate was 
identified as a carbonyl fluoride adduct (F-I) of 1a. The immediate formation of F-I combined with the 
lag-phase of 3a in the illuminated in situ NMR profile (Fig. 4-2 D) suggested F-I as direct precursor of 
3a. This is further solidified by the fact that once the light is turned off, a distinct conversion of F-I into 
3a can be observed (for spectra see Chapter 4.4.2). 
In addition, a second, off-cycle intermediate (OC-I, Fig. 4-2 C) could be assigned. The emergence of 
OC-I is the reason for the evidently faster decrease of 1a with respect to 2b (Fig. 4-2 C), as it stems 
from a side reaction of 1a with acetaldehyde, which in turn is liberated after downstream reactions from 
DIPEA (see Chapter 4.4.2 for details). From the three hour mark on in Fig. 4-2 C, it is evident, that 1a 
and F-I are already gone, whilst OC-I is slowly decreasing and 1a is still slowly increasing. This suggests 
that OC- I and 1a are in a slow off-cycle equilibrium. It could also be shown that this equilibrium is heavily 
water dependent (see Chapter 4.4.2 for details). This results in 3a still being generated even after 1a is 
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fully consumed as long as fluorophosgene is still liberated. Furthermore, addition of water can effectively 
reduce the formation of OC-I and increase the reaction rates significantly (see Chapter 4.4.2 for details). 
Therefore, we propose the following mechanism for the liberation of fluorophosgene from 2b (Fig. 4-3). 
P3 is excited by the light of 400 nm LEDs. The two excited photocatalyst molecules P3* form a  
CT-complex dimer which disproportionates to the corresponding P3∙+ and P3∙-. The P3∙- reduces 2b 
leading to its fragmentation into the aryl radical and trifluoromethanolate. Trifluoromethanolate 
decomposes into F- and fluorophosgene, which readily reacts with amine- or alcohol- based 
nucleophiles resulting in a carbonylfluoride intermediate (see F-I).[17] Subsequent cyclization leads to 
the desired product. To regenerate P3, the P3∙+ oxidizes DIPEA and the aryl radical abstracts a hydrogen 
atom from DIPEA∙+ or the solvent to give benzonitrile. Next to the main pathway, a second off-cycle 
pathway is in progress. Downstream reactions of DIPEA lead to the liberation of acetaldehyde, which 
can readily react with 1a to yield the off-cycle intermediate OC-I. The resulting equilibrium of OC-I and 
1 is heavily dependent on the water concentration. As long as fluorophosgene is provided, OC-I is slowly 
converted into 3a through 1a. Addition of extra water can virtually suppress the off-cycle equilibrium, 
which in turn accelerates the reaction. 
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Figure 4-2. A: Stern-Volmer plot of quenching of the P3 radical cation with DIPEA; inset: comparison of 
P3 radical cation spectrum obtained via transient spectroscopy and spectro-electro chemistry (see 
Chapter 4.4.2 for details). B: Radical trapping experiments with N-methylpyrrole and allylbenzene.  
C: Ex situ reaction profile of 1a (100 mM), 2b (105 mM), P3 (2 mM) and DIPEA (300 mM) in CD3CN. 
Next to the major products 3a (green) and 4 (red), two intermediates can be detected; F-I (magenta), 
which is the next downstream intermediate of fluorophosgene and the direct precursor of 3a and OC-I 
(cyan). OC-I presents an off-cycle intermediate being in an ongoing water dependent equilibrium with 
1a. As long as fluorophosgene is generated, OC-I is slowly converted into 3a through 1a. D: Excerpt of 
the in situ reaction profile of 1a (100 mM), 2b (110 mM), P3 (2 mM) and DIPEA (300 mM) in CD3CN 
showing the initial trend of 3a (green) and F-I (magenta). The formation of 3a is preceded by an initial 
lag-phase whilst the intermediate F-I is generated immediately after the light is turned on as the direct 
precursor of 3a. 
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Figure 4-3. Proposed catalytic cycle for the photocatalytic liberation of fluorophosgene for substrate 1a, 
based on the conducted mechanistic studies. The mechanism can be differentiated into two segments: 
a: The main reaction, which comprises the photocatalytic liberation of fluorophosgene by reducing 2b 
and the subsequent reaction of fluorophosgene with 1a over F-I to yield 3a. b: The off-cycle equilibrium 
(gray background), which describes the water dependent equilibrium between 1a and OC-I through 
addition and cleavage of acetaldehyde (secondary product of DIPEA). Detected products and 
intermediates are highlighted. 
4.3 Conclusion 
In summary, we have developed the first, visible light mediated procedure for the cleavage of an aryl 
trifluoromethoxy ether and the controlled liberation and in-situ conversion of fluorophosgene for the 
synthesis of carbamates, carbonates and urea derivatives. The method shows regio-selectivity for 
aliphatic amines and/or alcohols in presence of aromatic ones. No racemization of amino acid 
stereocenters was observed. Transient spectroscopy suggests the formation of a catalyst CT-complex 
dimer as the catalytic active species. NMR measurements identified key intermediates consolidating a 
stepwise fragmentation into fluorophosgene as the most likely mechanistic pathway; while also 
uncovering a water dependent off-cycle equilibrium, which can be effectively modulated to accelerate 
the reaction. Notably, this method expands the toolbox of photoredox catalysis by the generation of an 
extremely reactive species which is not based on radical reactivity under mild reaction conditions. 
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4.4 Experimental Part 
4.4.1 General Information 
See Chapter 2.4.1 for General Information.[18] 
Preparation of photocatalyst P3 
P3 was prepared according to a reported literature procedure.[19] All photoreactions and NMR 
investigations were performed with self-made catalyst. CV, online UV-VIS, spectro-electro chemistry 
and transient spectroscopic measurements were performed with a commercial catalyst (Sigma-Aldrich). 
General Procedure for the preparation of carbonates, carbamates and urea derivatives 
The photocatalyst (1.2 mg, 0.002 mmol, 0.02 equiv.) and the substrate (0.1 mmol) were weight into a  
5 mL crimp cap vial. A stirring bar, 1 mL of dry MeCN, 15.6 µL (0.105 mmol, 1.05 equiv.)  
4-(trifluoromethoxy)benzonitrile and 51.0 µL (0.3 mmol, 3 equiv.) DIPEA were added into the vial via 
syringe. The vial was sealed with a crimp cap with septum and set under nitrogen atmosphere by three 
consecutive freeze-pump-thaw cycles. The vial was placed approximately 1 cm above a 400 nm LED 
and stirred under continuous irradiation for 24 h. After completion, two equal reaction mixtures were 
combined and quenched by addition of 0.5 mL of H2O. Silica was added, the solvent was evaporated 
from the suspension and the residue was used as dry load for column chromatography on a Biotage® 
IsoleraTM Spektra One using a petrol ether and ethyl acetate or a dichloromethane/methanol mixture as 
the mobile phase. A 10 g column was employed with silica gel of type 60 M (40-63 µm, 230-440 mesh) 
by Merck as stationary phase. 
For the gram scale reaction, the photocatalyst (86 mg, 0.14 mmol, 0.02 equiv.) and 1a (1.1 g, 7.0 mmol, 
1.0 mL) were weight into a 250 mL Schlenk flask. A stirring bar, 70 mL of dry MeCN, 1.1 mL (7.4 mmol, 
1.05 equiv.) 4-(trifluoromethoxy)benzonitrile and 3.6 mL (21 mmol, 3 equiv.) DIPEA were added into the 
flask via syringe. The flask was set under nitrogen atmosphere by three consecutive freeze-pump-thaw 
cycles. The vial was placed approximately 1 cm above two 400 nm LEDs and stirred under continuous 
irradiation for 48 h. The reaction was quenched by addition of 5 mL water and concentrated in vacuo. 
Purfication was done as described above but a 25 g column was used instead of a 10 g column. 
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4.4.2 Mechanistic Investigations 
Cyclovoltammetric data of 2a and 2b (in MeCN) 
 
Index Peak position 
1  -2.709 V         2a 
2   0.675 V    Ferrocene 
3   0.599 V    Ferrocene 
 
Index Peak position 
1  -1.873 V         2b 
2   0.670 V    Ferrocene 
3   0.594 V    Ferrocene 
 
 
2b 
2a 
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Cyclovoltammetric data of P3 (in MeCN) 
  
 Index Peak position 
 1  -2.261 V           P3 
 2   0.665 V      Ferrocene 
 3   0.584 V      Ferrocene 
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Transient Spectroscopy and further mechanistic discussion 
2D Transient Absorption Setup: 
The measurements were performed with a Pump-Probe Setup. The Pump source is the third Harmonic 
of a Nd:YAG laser (Surelite II, Continuum). The wavelength of 355 nm, with a pulse width of about  
5 nm. The typical pulse duration is 8 ns. The repetition rate is 10 Hz and pulses are selected by a shutter 
(LS055, nmLaser). The white probe light is generated by a pulsed xenon flash lamp (MSP-05, Müller 
Elektronik-Optik) and passes the sample orthogonal to the Pump beam. Toroidal mirrors (aluminum-
coated blanks of eyeglass lenses, Rodenstock) are used to focus and guide the probe light without 
chromatic aberrations. A shutter (LS6ZM, Uniblitz) is used to block the continuous light of the xenon 
lamp. A spectrograph (Bruker 200is) disperses the probe light after it passed the sample. The probe 
light is then passed on to a streak camera (C7799, Hamamatsu Photonics), a spectral and temporal 
resolved picture is projected on a phosphor screen and recorded by a CCD camera (ORCA-CR, 
Hamamatsu Photonics). The temporal window of the streak camera can be set between 0.5 ns and  
10 ms. The time resolution in each window is about 0.5% of the temporal window width. All components 
are controlled by a home-built delay controller (DC). 
A 2D transient absorption data matrix (ΔA) is generated from 4 separate images (I) recorded by the 
CCD camera. 
ΔA = −
(𝐼𝐿,𝑃 − 𝐼𝐿)
(𝐼𝑃 − 𝐼𝐷)
 
𝐼𝐿,𝑃 is an image where both the pump (L) and probe (P) light is used. 
𝐼𝐿 records only the emission and scattered light caused by a laser pulse. 
𝐼𝑃 records the probe light passing through the sample without a pump pulse. 
𝐼𝐷 is a dark picture and records only the sensor noise without any pump or probe light. 
Data analysis 
Data were analyzed with homemade software to obtain decay associated difference spectra (DADS). 
This analysis corresponds to the least-squares fit: 
 |∆𝑂𝐷(𝑡, λ) − ∑ 𝑓𝑘(𝑡)𝐷𝐴𝐷𝑆𝑘(λ)
𝑁
𝑘
|
2
= 𝑚𝑖𝑛,  
where ΔOD(t, λ) is the measured data matrix and the fk(t) are exponential (or more complex) decay 
functions convoluted with a Gaussian function as the apparatus response function. 
For each manifold {fk the DADS display the spectral changes associated with particular decay times. 
The DADS are in turn linear combinations of the species spectra where increasing species have 
negative coefficients and decreasing species have positive coefficients. 
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Quenching of the P3 triplet state with 2b in a 30 μM solution of P3 in MeCN. Inset: Transient spectrum 
of the triplet state of a 30 μM solution of P3 in MeCN. 
The lifetime of the triplet state remains unchanged upon addition of 2b indicating that the reduction of 
2b does not proceed via direct SET the triplet state. 
Verification of the radical cation and radical anion spectra via spectro-electro chemistry 
 
 
 
 
 
 
 
 
Left: Absorption spectra of P3 at various positive potentials in MeCN. Right: Absorption spectra of P3 
at various negative potentials in MeCN. 
At positive potentials a strong absorption at 475 nm occurs, while the absorption peak at 380 nm fades, 
indicating the formation of the P3 radical cation. The same band was observed during the transient 
spectroscopic measurements of P3 at concentrations around 30 µM (compared to 2 mM in the reaction 
mixture) which lead to the assumption of the formation of a charge-transfer complex dimer as catalytic 
active species. However, the direct observation and/or quenching of the P3 radical anion could not be 
observed due to the very minuscule shift of the absorption peak at 280 nm compared to the ground state 
absorption spectrum. 
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Investigation of the catalytic active species via online irradiation 
Online irradiation setup: 
A traditional photometric setup was modified by adding a single high-power LED in 3 cm distance to the 
cuvette holder. The LED was mounted in a 90° angle with respect to the photometer lamp irradiation. 
The photometer sample was continuously irradiated by the LED while being stirred magnetically. Every 
10 seconds a photometric scan of the absorption of the sample was performed. 
 
 
 
 
 
 
 
 
 
Left: Absorption spectrum of P3 in MeCN under argon atmosphere before (black) and after (blue)  
30 min. irradiation with 400 nm light. Right: Absorption spectra of the diluted reaction mixture (P3, 2b 
and DIPEA) in MeCN under argon atmosphere taken every 10 sec. for a total of 30 min. irradiation with 
400 nm light. 
If only P3 is irradiated, it degrades rapidly into an unknown species indicated by a strong change of the 
absorption spectrum. However, in the reaction mixture the catalyst is much more stable resembled by 
the insignificant change of the catalyst absorption peak at 380 nm. As we assume the formation of a 
charge transfer complex between two catalyst molecules and subsequent disproportionation into P3∙+ 
and P3∙-, further irradiation of these species might lead to catalyst degradation. Whereas, if these 
transient species can react with DIPEA and 2b to restore the stable ground state, the catalyst can survive 
several turnovers. 
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NMR spectroscopic investigations 
Materials: 
The solvent CD3CN was purchased from Deutero GmbH. The solvent was dried over 4 Å molecular 
sieves and deoxygenated by Freeze-Pump-Thaw cycling prior to use. Starting materials  
(2-benzylaminoethanol (1a) and 4-(trifluoromethyl)benzonitril (2b)) and reagents (DIPEA) were 
purchased from commercial suppliers (Sigma Aldrich, Alfa Aesar, Acros or Fluka) and were used without 
further purification. 
Sample preparation: In situ measurements 
For the measurements in CD3CN 450 µL solutions of 100 mM starting material 1a, 110 mM 2b, 2 mM 
photocatalyst P3 and 300 mM DIPEA were directly prepared in amberized NMR tubes to minimize the 
influence of ambient light in the reaction solution. The solvent was deoxygenated either by Freeze-
Pump-Thaw cycling and then transferred to the NMR tube under argon atmosphere or purged with argon 
(10 min) directly inside the NMR tube. Then a transparent glass insert containing the glass fiber, was 
inserted and everything was sealed airtight. 
Sample preparation: Ex situ measurements 
1 mL or 2 mL reaction solutions in CD3CN were prepared in a 5 mL crimp cap vial with a stirring bar. 
Under standard conditions these solutions contained 2 mM of the photocatalyst P3, 100 mM of substrate 
1a, 105 mM of 2b and 300 mM DIPEA. Deviating conditions are directly mentioned in the text. The vial 
was sealed with a crimp cap with septum and deoxygenated by three consecutive Freeze-Pump-Thaw 
cycles or bubbled with argon for 10 minutes. The vial was placed approximately 1 cm above a 400 nm 
LED inside a cooling block and stirred under irradiation. An aliquot (50 uL or 100 uL) was taken from the 
solution and diluted with 350 uL DMSO-d6 or 300 uL CD3CN to give a total volume of 400 uL for the 
NMR measurements 
NMR Measurements: 
All measurements were conducted on a Bruker Avance III HD 600 (600.13 MHz for 1H; 564.59 MHz for 
19F) spectrometer with a fluorine selective TBIF probe or on a Bruker Avance 500 (500.13 MHz) 
spectrometer with a 5 mm QXI probe. Temperature control was ensured by a Bruker BVTE 3000 unit 
(298 K). The spectra were processed, evaluated and plotted with Bruker TopSpin 3.2. The in situ 
samples were illuminated by a NCSU279AT high power LED (Nichia, 405 nm; 950 mW).  
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In situ measurements 
For the in situ reaction profiles an in situ illumination device previously reported by our working group 
was employed.[20] The reaction profiles were generated by either alternately recording non-illuminated 
and illuminated 1H NMR spectra (and/or 19F NMR spectra) or continuous illumination throughout the 
measurement. In some cases, the 1H NMR spectra were recorded with a T2 spin echo filter (300 μs 
echo time, looped 128 times) to suppress broad, shifting signals like the water signal, which can 
significantly distort the integrals of other signals. After the first spectra without illumination a row of 1H 
and/or 1H and 19F spectra were collected either illuminating continuously or alternating between 
illuminated and non-illuminated spectra.  
Ex situ measurements 
The ex situ reaction profiles were recorded in a straightforward manner by putting the sample into the 
NMR spectrometer. The down time from taking an aliquot from the batch reaction to the NMR 
measurement was approximately 5 minutes. In some cases, the 1H NMR spectra were recorded with a 
T2 spin echo (300 μs echo time, looped 64-128 times) filter to suppress broad, shifting signals like the 
water signal, which can significantly distort the integrals of other signals 
Processing and Evaluation 
The NMR kinetics are derived from signal C3-H for 2b and 4, C3-H for 1a, 3a and the two conformations 
of the fluorointermediate (F-I1 and F-I2) and C2-H for OC-I in the 1H proton spectra and C6-F3 for 2b in 
the 19F spectra and referenced to the respective signal in the first spectrum without illumination  
(Fig. S-4-1). Inversion recovery experiments (for 1H and 19F) were performed prior to illumination to 
ensure full relaxation of the reaction components of interest for correct quantification. Assignments were 
made by evaluation of full sets of 1D and 2D NMR spectra (Fig. S-4-2). For 1H NMR spectra chemical 
shifts were referenced to the solvent signals of CD3CN. For 19F NMR spectra trifluoro acetic acid  
(-76.55 δ (ppm) vs CFCl3 = 0.00 ppm) was added after the reaction was finished/ illumination was 
stopped.  
Pulse sequences and important parameters (O, transmitter frequency offset [ppm]; TD, size of FID; SW, 
spectral width [ppm]; D1, recycling delay [s]; NS, number of scans; DS; number of dummy scans) for 
the 1H19F-HMBCs and the 19F13C-edHSQC are listed below the corresponding spectrum. 
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Figure S-4-1. Numeration of starting materials and relevant reaction products as used for the 
assignments und further characterization. 
Assignments:  
Assignments were made by sets of 1D NMR spectra consisting of 1H, 13C, 19F, and 2D NMR spectra 
consisting of 1H1H-COSY, 1H1H-TOCSY, 1H1H-NOESY, 1H13C-HSQC, 1H13C-HMBC, and in specific 
cases selective 1D 1H1H-TOCSY, selective 1D 1H,1H-NOESY, 1H19F-HMBC and 19F13C-HSQC spectra 
were recorded. 
The 13C chemical shifts of 1a weren’t assigned because all 1D 13C and 2D spectra were usually recorded 
after illumination when 2-benzylaminoethanol (1a) was already fully consumed. It was forgone to assign 
the 13C chemical shifts in an additional measurement, as 1a is commercially available and literature 
known. The chemical shift of the hydroxyl functionality of 1a is heavily dependent on the water content 
of the reaction and is in some instances not detectable at all due to exchange. If detectable, it can be 
witnessed as either a triplet or broad singlet, again dependent on the water content. After illumination 
starts, it rapidly broadens and usually vanishes after a couple of minutes due to further 
interactions/exchange. Hence, its chemical shift was put in parentheses in Figure S-4-2. 
The 1H and 13C chemical shifts of position 6 and 7 for the off-cycle intermediate (OC-I) and the two 
conformations of the fluorointermediate (F-I1 and F-I2) couldn’t be assigned unambiguously, owing to 
heavy overlap with other signals from the starting material 1a and the main product 3a. Hence, only a 
chemical shift region is given for OC-I, F-I1 and F-I2 for signals 6 and 7 in Figure S-4-2. 
Fluoride can be detected as a broad singlet at ~-125 ppm as the reaction progresses. Its chemical shift 
is heavily dependent on the initial water content and progress of the reaction and shifts from high to low 
field during the reaction. Only small amounts of fluoride are detectable since most of the fluoride 
precipitates as insoluble salts.  
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The off-cycle intermediate OC-I is cyclized for substrate 1a, but for other substrates it can also appear 
in its open form, which can also have at least two conformations probably similar the fluorointermediate 
conformations (F-I1 and F-I2) detected for 1a (data not shown).  
 
Figure S-4-2. Assignment of starting materials and relevant reaction products in CD3CN at 298 K.  
1H chemical shifts are highlighted blue and 13C chemical shifts are highlighted black and referenced to 
CD3CN (1.94 ppm 1H; 1.32 ppm 13C). 19F chemical shifts are highlighted red and are referenced to 
trifluoro acetic acid (-76.55 ppm). 
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Relevant spectra for the assignments of the two conformations of the central fluorointermediate  
(F-I1 and F-I2) 
The fluorointermediate F-I was completely assigned during the reaction, mostly under continuous 
illumination. In the case of substrate 1a, F-I can be detected as two stable conformers (F-I1 and F-I2) in 
solution. Figures S-4-3 to S-4-9 show excerpts of relevant spectra and important correlations, which 
were used to deduce the structure of F-I and its role as an intermediate.  
 
Figure S-4-3. Excerpt of the 19F proton spectrum after 50 minutes of continuous illumination. The two 
conformations of the fluorointermediate F-I (F-I1 and FI-2) both yield one singlet in the 19F spectrum. 
 
 
Figure S-4-4. Excerpt of the 1H proton spectrum after 1.5 hours of continuous illumination (black) and 
the reaction mixture in the dark after 20 minutes (red). F-I1 and FI-2 convert into the desired product 3a 
by a dark reaction. The position C3-H of F-I1 and F-I2 usually overlap, hence it appears as one singlet 
in the NMR spectrum. All other signal sets in the NMR spectrum stay constant within the observed time 
frame. 
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Figure S-4-5. 1D 1H1H-NOESY spectrum with selective excitation of the C3-H position at 4.54 ppm of 
F-I1 and F-I2 (red). The selective NOESY yields three distinctive NOE sets (blue) to the signals C1-H, 
C2-H and C5-H of both conformations F-I1 and F-I2, due to spectral overlap at the C3-H position.  
tm = 600 ms. 
 
 
Figure S-4-6. 1H13C HMBC highlighting the relevant cross correlations (orange) for both conformations 
of the fluorointermediate (F-I1 and F-I2). 
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Figure S-4-7. 1H19F-HMBC highlighting the relevant cross correlations (red) for both conformations of 
the fluorointermediate (F-I1 and F-I2). Parameters: PP = hmbcgpndqf; NS = 64; DS = 16; TD-F1 = 16; 
TD-F2 = 2048; D1 = 1; SW-F1 = 5; SW-F2 = 12; O-F1 = -23; O-F2 = 5; evolution long range  
coupling = 71.4 ms. 
 
 
Figure S-4-8. Edited 19F13C-HSQC highlighting the relevant cross correlations (purple) for both 
conformations of the fluorointermediate (F-I1 and F-I2). The cross signals in the HSQC are high field 
shifted in F2 with respect to the 1D 19F projection because of the strong isotope effect of 19F (12C-F in 
regular 1D 19F vs 13C-F in the HSQC).  Parameters: PP = hsqcedhpph; NS = 1024; DS = 16;  
TD-F1 = 16; TD-F2 = 512; D1 = 1; SW-F1 = 50; SW-F2 = 10; O-F1 = 140; O-F2 = -23; adjusted 
 for 1JCF = 283 Hz.   
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Figure S-4-9. Summary of important cross correlations for the assignment of both conformations of the 
fluorointermediate (F-I1 and F-I2) consisting of 1H1H-NOESY (blue), 1H13C-HMBC (orange),  
1H19F-HMBC (red) and 19F13C-HSQC (purple). 
Conformations of F-I1 and F-I2 
Figure S-4-10 depicts two conceivable options for the conformational nature of F-I1 and F-I2. Option 1 
shows the (s-cis)- and (s-trans)-conformers of F-I. These could be possible due a hindered rotation 
around the NC(O) amide bond. But an inversion around the amide bond would also lead to an inversion 
of coupling constants e.g. the 4JHF couplings from position 8 to 3 and 8 to 2. The 1H19F-HMBC spectrum 
in Figure S-4-7 clearly shows that both conformations have clear cross signals to position 2 (and 1), but 
signals to position 3 have never been observed greatly diminishing the likelihood of option 1. Option 2 
suggests an intramolecular hydrogen bond leading to a seven membered ring within the molecule. This 
option splits into two more possibilities as there could be either a slow equilibrium between the open 
form and the seven membered ring or the seven membered ring structure itself can engage two 
conformations. This would also be in line with the 1H19F-HMBC spectrum in Figure S-4-7 as the fluorine 
has cross signals to position 2 and 1 for both conformations, albeit slightly different in intensity. Option 
2 is further supported when investigating other substrates (e.g. N-benzylethylenediamine leading to 
product 3d) where only one conformation could be detected (data not shown). In summary, option 2 
seems the more likely option, although it could never be proven unambiguously  
 
Figure S-4-10. Conceivable options for the two detectable conformers of F-I. Option 1, F-I1 and F-I2 
are the (s-cis)- and (s-trans)-conformers of F-I due to a hindered rotation around the NC(O) amide bond. 
Option 2, F-I can form a stable intramolecular hydrogen bond between the hydroxyl group and the NC(O) 
carbonyl group leading two a seven membered structure. Exchange between the open form and the 
seven membered structure can lead to two conformers. The seven membered structure could also have 
two stable conformations of the seven membered ring. Option 2 is the more likely option as option 1 
doesn’t fit the experimental NMR data (1H19F-HMBC) and is hence, highlighted. (for details see text 
above)  
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Illuminated NMR reaction profiles 
In situ NMR reaction profiles 
Figure S-4-11 illustrates the full in situ 1H NMR reaction profile of the photoreaction of 1a (100 mM), 2b 
(110 mM), DIPEA (300 mM) and P3 (2 mM) in CD3CN at 298 K with illumination at 405 nm. Immediately 
after turning on the light, both starting materials (1a violet and 2b black) start to decrease. Next to the 
starting materials the formation of two main products can be observed. First the fragmentation product 
of 2b, benzonitrile 4 (red) can be assigned, whose formation is directly correlated with the decrease of 
2b (see also Fig. S-4-13). Secondly the desired product 3a (green) can be designated, whose formation 
is also strongly correlated with the decrease of 2b and the increase of 4. Furthermore, a third major 
species could be assigned as the chiral off-cycle intermediate OC-I (cyan), resulting from a side reaction 
of 1a with acetaldehyde, which in turn is a fragmentation product of DIPEA (see also Chapter 4.2.2  
Fig. 4-2). Next to those three products one other significant intermediate species (F-I, magenta) could 
be readily assigned. This intermediate is a result from the reaction of the starting material 1a with in situ 
generated fluorophosgene (COF2) and thus presents a key intermediate supporting the proposed 
mechanism. F-I can be detected as two conformers (F-I1 and F-I2) in solution albeit the unambiguous 
nature of both conformers could not be determined (see relevant spectra for the assignments of F-I1 
and F-I2). Owing to the heavy signal overlap and the overall small intensity of both conformers they are 
treated as one species (F-I) in the reaction profiles. Figure S-4-12 shows the initial combined build-up 
of F-I1 and F-I2 (F-I, magenta), and product 3a (green). The formation of product 3a is slightly delayed, 
whereas the formation of F-I starts immediately. After around 6 minutes the signals of 3a start to increase 
as the intermediates are converted into 3a in a concurrent dark reaction. This was further confirmed by 
turning the light off in some instances, leading to a steady decrease of F-I1 and F-I2 while 3a is 
constantly generated (see Fig. S-4-2) solidifying the role of F-I1 and F-I2 as a precursor of 3a.1 
In Figure S-4-11 it can be observed that the starting material 1a decreases faster than 2b and is fully 
consumed after ~6 hours, which also halts product conversion of 3a (and OC-I as well as F-I) at ~40 %. 
This big difference compared to the batch reaction (96 % isolated yield, see Chapter 4.2.1 Table 4-1 
entry 3a) is due to heavy precipitation of a yellow solid. It could be demonstrated that this precipitate 
contains a significant amount of product 3a next to DIPEA and probably fluoride salts (see Fig. S-4-14). 
It can also be assumed that parts of this solid could still participate in the reaction as it also contains 
photocatalyst P3. Next to the main products presented in Figure S-4-11 several other fragmentation 
products originating from DIPEA could be assigned (data not shown). These are diisopropylamine,  
N-ehtylisopropylamine, acetaldehyde and acetone. These fragmentation products support the function 
of DIPEA as a hydrogen source for the formation of 4. But it is to be noted that several other, unknown 
side products, originating from DIPEA are also present in solution in low amounts. 
                                                          
1 It is to be noted that besides the signal sets of 3a, F-I1 and F-I2, all remaining signal sets stay constant 
within the observed time frame without illumination (10-20 minutes) 
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Figure S-4-11. 1H NMR reaction profile recording the photoreaction of 1a (100 mM), 2b (110 mM), 
DIPEA (300 mM) and P3 (2 mM) in CD3CN at 298 K with illumination at 405 nm. The build-up of the 
desired product 3a (green) correlates with the formation of the fragmentation product 4 (red) of 2b 
(black). Moreover, two intermediates (F-I, magenta and OC-I, cyan) could be readily assigned. F-I is the 
direct precursor of 3a stemming from the reaction of 1a with in situ generated fluorophosgene whereas 
OC-I is the result from the reaction of 1a with acetaldehyde, which in turn is a fragmentation product of 
DIPEA. 
 
Figure S-4-12. 1H NMR reaction profile showing the initial trend of 3a (green) and F-I (F-I1 + F-I2, 
magenta). The formation of 3a is preceded by an initial lag-phase whilst the intermediate F-I is generated 
immediately after the light is turned on as the direct precursor of 3a solidifying its role as a direct 
precursor to 3a. 
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Figure S-4-13. 1H and 19F NMR reaction profile. Increase and decrease in signal intensity of the starting 
material 2b (1H black; 19F blue) and the corresponding reaction product 4 (red). The profile shows a 
clean conversion of 2b into 4. The deviation of the 1H and 19F intensities for 2b comes from overlapping 
signals in the 1H NMR spectrum 
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Figure S-4-14 shows the 19F NMR reaction profile of the photoreaction of 1a (100 mM), 2b (110 mM), 
DIPEA (300 mM) and P3 (2 mol %) in CD3CN at 298 K with illumination at 405 nm. Although 2b (blue) 
decreases continuously, there is only a slight increase of other fluorine species over time (green). At the 
end of illumination all other fluorine species only amount to ~12% of the total signal intensity (compared 
to 2b in the beginning). As the proposed mechanism (Chapter 4.2.2 Fig. 4.3) suggest that fluoride (F-) 
gets liberated not only from the OCF3- fragment from 2b but also from the reaction of fluorophosgene 
with 1a and the subsequent intramolecular cyclization to yield 3a, it can be assumed that most of the 
fluorine in the reaction is F-, which then mostly precipitates as some sort of insoluble salt, that can be 
witnessed as a yellowish solid at the bottom of the NMR tube after illumination. Only small amounts of 
free F- can be observed in solution (broad singlet at ~-125 ppm). 
 
Figure S-4-14. 19F NMR reaction profile showing the decrease of the starting material 2b (blue) and the 
increase of all detectable fluorine species (green). The combined observable fluorine species only 
amount to ~12 % because the bulk of fluorine probably precipitates as various fluoride salts, as F- is the 
main fluorine species generated in the reaction. 
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Ex situ NMR reaction profiles  
Ex situ NMR reaction profiles were also recorded, besides the in situ reaction profiles. Figure S-4-15 
shows the reaction profile of diluted 100 uL aliquots (final volume 400 uL; backfilled with CD3CN) from 
the photoreaction of P3 (2 mM), 2b (110 mM), 1a (100 mM) and DIPEA (300 mM) in 2 mL CD3CN at 
298 K under continuous illumination with 400 nm. Similar to the in situ reaction profile two main products 
(3a, green and 4, red) and two significant intermediates (F-I, magenta and OC-I, cyan) can be assigned 
next to the two starting materials 2b (black) and 1a (blue). The decrease of 2b and the increase of its 
fragmentation product 4 (red) directly correlate to one another, similar to in situ approach. Furthermore, 
the increase of the main product 3a (green) also correlates with the decrease of 2b and the increase of 
4. But it is evident that the conversion rate of 1a to 3a is significantly higher compared to the in situ 
reaction owing to the higher light intensity. The two conformations of the important fluorointermediate 
(F-I1 and F-I2) can also be assigned. Analogous to the in situ reaction profile F-I1 and F-I2 are treated 
as one entity (F-I) in the reaction profile. Like in the in situ reaction, one can detect the chiral side product 
OC-I originating from a side reaction of 1a with in situ generated acetaldehyde. Furthermore, large 
amounts of precipitate can be again witnessed. The precipitate contains product 3a, photocatalyst P3 
and fluoride salts, similar to the in situ reaction. To sum up, the overall trend of the ex situ approach is 
very much comparable to the in situ approach, albeit the ex situ approach lead to significantly increased 
product conversion and shows increased reaction rates. However, there is still a noteworthy, observable 
difference between the results of the ex situ reaction kinetic and the in situ reaction kinetics. At the  
3 hour mark it is evident that substrate 1a und F-I are fully consumed. Nevertheless, product 3a is still 
generated, whereas OC-I is decreasing steadily. This is due to a water off-cycle equilibrium between 1a 
and OC-I. As a result, OC-I gets slowly converted back to 1a, which can than react further on to yield 
3a (and F-I) as long as fluorophosgene is still liberated. 
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Figure S-4-15. Ex situ 1H NMR reaction profile showing the photoreaction of 1a (100 mM), 2b (105 mM), 
DIPEA (300 mM) and P3 (2 mM) in 2 mL CD3CN at 298 K with illumination at 405 nm. The build-up of 
the desired product 3a (green) correlates with the formation of the fragmentation product 4 (red) of 2b 
(black). Furthermore, two intermediates (F-I, magenta and OC-I, cyan) can be detected. F-I is the direct 
precursor of 3a stemming from the reaction of 1a with in situ generated fluorophosgene whereas OC-I 
is the result from the reaction of 1a with acetaldehyde, which in turn is a fragmentation product of DIPEA. 
OC-I and 1a are in a water dependent off-cycle equilibrium leading to an ongoing generation of 3a even 
after 1a and F-I are consumed as long as fluorophosgene is still liberated. 
In situ NMR reaction profiles without 1a 
Next to reaction profiles of the full photoreaction, NMR reaction profiles without the starting material 1a 
were recorded as well. 
Figure S-4-16 illustrates the full 1H and 19F NMR reaction profile of the photoreaction of 2b (110 mM), 
DIPEA (300 mM) and P3 (2 mM) in CD3CN at 300 K with illumination at 405 nm. Immediately after 
turning on the light all signals of 2b (1H; black and 19F; blue) start to decrease. Simultaneously a new 
signal set belonging to 4 (red) appears in the 1H NMR spectra. The decrease of 2b and the increase of 
4 show that both are directly correlated, as 4 presents the fragmentation product of 2b. Similar to the 
full reaction mixture only low amounts of other fluorine signals can be observed in the 19F NMR spectra. 
Next to a 19F signal of fluoride, several carbonylfluoride signals could be detected. Most of the fluorine 
again reacts to F- (broad singlet at ~-125 ppm) and precipitates as an insoluble salt at the bottom of the 
NMR tube (see in situ NMR reaction profiles with 1a).  
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Figure S-4-16. 1H and 19F NMR reaction profile recording the photoreaction of 2b (110 mM), DIPEA 
(300 mM) and P3 (2 mM) in CD3CN at 300 K with illumination at 405 nm. The decrease of 2b (1H black; 
19F blue) directly correlates with the formation of the fragmentation product 4 (red). The combined 
observable fluorine species only amount to ~13 % because the bulk of fluorine probably precipitates as 
various fluorides.  
Figure S-4-17 shows an excerpt of the reaction mixture of 2b (110 mM), DIPEA (300 mM) and P3  
(2 mM) in CD3CN at 300 K after illumination with 405 nm. Overall three 19F signals can be detected  
(F1-F3; all singlets) next to the starting material 2b and fluoride2, 1H19F-HMBC spectra show clear cross 
signals in the HMBC spectrum for all three signals (Fig. S-4-18). Hence, concerning the proton chemical 
shifts (3.2 to 1.2 ppm), it can be concluded that F1 to F3 are side products from the reaction with DIPEA 
and/or its fragmentation products (diisopropylamin, N-ethylisopropylamine, etc).  
 
Figure S-4-17. Excerpt of the 19F fluorine spectrum region of the signals in the chemical shift range of 
carbonylfluorides. Up to three 19F signals (F1-F3) can be clearly identified. Reaction conditions: 2b  
(100 mM), DIPEA (300 mM) and P3 (2 mM in CD3CN at 300 K after illumination with 405 nm. 
                                                          
2 Fluoride usually appears as a broad singlet at around ~-125 ppm, but the chemical shift heavily 
depends on the reaction conditions and the progress of the reaction. 
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Figure S-4-18. a, 1H19F-HMBC. All fluorine signals (F1-F3) in the carbonylfluoride region show clear 
HMBC cross signals to protons of secondary DIPEA products. Parameters: PP = hmbcgpndqf; NS = 16; 
DS = 16; TD-F1 = 128; TD-F2 = 4096; D1 = 1; SW-F1 = 120; SW-F2 = 12; O-F1 = -10; O-F2 = 5; 
evolution long range coupling = 71.4 ms. b, Likely framework of the secondary products from the reaction 
of COF2 with fragmentation products of DIPEA. 
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Off-cycle equilibrium and role of water 
Next to the NMR reaction profiles, further NMR studies were conducted to corroborate the proposed 
mechanism (see Chapter 4.2.2 Fig. 4.3). Figure S-4-19 depicts a proposal for the water dependent off-
cycle equilibrium between 1a and OC-I. Acetaldehyde is released through fragmentation after secondary 
reactions of DIPEA (see also Chapter 4.2.2 Fig. 4.3), which hereupon can react with starting material 
1a under dehydration to yield the off-cycle intermediate OC-I. In turn, addition of water to OC-I yields 1a 
and acetaldehyde again. The proposed water dependent off-cycle equilibrium leads to two conclusions. 
First, as long as fluorophosgene is liberated from 2b, the reaction towards 3a should continue if OC-I is 
in solution, independent of 1a and/or F-I still being present in detectable amounts. Second, addition of 
water should shift the equilibrium presented in Figure S-4-19 towards 1a, eventually suppressing OC-I.  
 
Figure S-4-19. Proposed water dependent off-cycle equilibrium between 1a and OC-I. Secondary 
reactions of DIPEA lead to the liberation of acetaldehyde, which readily reacts with starting material 1a 
to yield OC-I. Afterwards OC-I and 1a are in a slow water dependent equilibrium, which can be shifted 
towards 1a by the addition of extra water. 
Figure S-4-20 shows excerpts of the 1H NMR spectra of the aliphatic region for position 3 of F-I, position 
3 and 1 of 3a and position 8 for OC-I. Spectrum a at the bottom depicts the reaction mixture under 
standard conditions after 24 hours of illumination. Both starting materials (2b and 1a) and F-I are fully 
consumed. Hence, no reaction is running anymore and only 3a and OC-I are present in solution as 
relevant reaction products. Spectrum b at the top shows the same reaction mixture from spectrum a 
after addition of 5 μL of 2b and 1 hour of continuous illumination (total illumination 25 h). It can be clearly 
witnessed that the intermediate F-I is again present in solution, while OC-I has decreased in intensity, 
despite the absence of 1a and 2b (product 3a also increased but concerning the big intensity difference 
of 3a and OC-I it is hardly presentable). This experiment demonstrates that there has to be an 
equilibrium between 1a and OC-I, as OC-I presents the only conceivable source to provide 1a. 
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Figure S-4-20. Excerpts of the 1H NMR spectra of the aliphatic region for position 3 of F-I, position 3 
and 1 of 3a and position 8 for OC-I of the reaction mixture under standard conditions. Spectrum a, 
reaction solution after 24 hours of illumination. 1a, 2b and F-I are fully consumed, hence no reaction is 
progressing. Spectrum b, reaction solution after addition of 5 μL 2b to the mixture of spectrum a and  
1 hour of further illumination (total illumination time 24 h). F-I and 3a start to be generated again, while 
OC-I is decreasing affirming the proposed off-cycle equilibrium.  
To further investigate on how to influence the off-cycle equilibrium ex situ NMR measurements were 
performed testing different reaction conditions with respect to the general conditions (general conditions: 
1a 100 mM, 2b 105 mM, P3 2 mM, DIPEA 300 mM, in CD3CN). Next to the general conditions, three 
modified reaction conditions were tested which were derived from the off-cycle proposal (Fig. S-4-19).3 
Samples were taken after two hours of continuous illumination comparing the amount of 3a, F-I 
(comprising of F-I1 and F-I2) and OC-I. The results are summarized in Table S1. First the general 
conditions yield the same result as the regular ex situ NMR reaction kinetics with a comparable amount 
of 3a and OC-I and low amounts of F-I. For the first modified condition, the concentration of 2b was 
doubled from 105 mM (1.05 eq) to 210 mM (2.10 equiv.) with the idea that more 2b should lead to a 
longer and increased supply of fluorophosgene. The result shows a heavily increased amount of 
generated F-I, while OC-I is already suppressed by around 50 % with respect to the general conditions 
whereas the amount of 3a stays rather constant. For the second modified reaction condition, the 
influence of water on the off-cycle equilibrium between 1a and 3a was investigated. Here, the solvent 
mixture was changed to CD3CN/H2O (9:1) instead of pure CD3CN. The results in Table S-4-1 indicate a 
distinct shift in the off-cycle equilibrium towards 1a as well as a much faster reaction. After two hours 
the sum of 3a and F-I already reaches above 90 % and OC-I is almost fully suppressed. This shows that 
the water amount influences the off-cycle equilibrium considerably and can be used to effectively 
accelerate the reaction. The last modification of reaction conditions is basically a combination of the two 
                                                          
3 All reactions within the ex situ NMR measurements including the general conditions also contained  
12 equiv. of 1,4-cyclohexadiene, which leads to a partial recovery of DIPEA. But it didn’t notably affect 
any kinetics or yields. 
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modifications already described. The concentration of 2b is increased from 105 mM (1.05 equiv.) to 210 
mM (2.1 equiv.) and the solvent was changed from pure CD3CN to CD3CN/H2O (9:1). Under these 
conditions, generation of OC-I can be completely suppressed, while conserving the high amount of 3a 
+ F-I.  
The results presented in Table S-4-1 allow the conclusion that the reaction can be very much optimized 
substrate specific by tuning the amount of 2b and the water content.  
Table S-4-1. Influence of 2b and water on product and intermediate formation investigated by ex situ 
NMR measurements.  
 
The amount of 3a + F-I can be viewed as ‘potential’ amount of product 3a, because F-I converts into 3a 
by a self-propagating dark reaction and serves as better comparison between the different reaction 
conditions (red bracket). 
The appearing precipitate during the reaction was also investigated, because a considerable amount 
was observed in both the ex situ and in situ reaction approaches. Figure S-4-21 shows an excerpt of 
the 1H NMR spectrum of the precipitate dissolved in DMSO. It is evident that the reaction product 3a is 
one of the main constituents within the precipitate apart from fluoride which isn’t observable in the proton 
NMR spectrum. The presence of 3a in the precipitate is one likely reason that the conversion of 1a to 
3a is never fully completed in the in situ 1H NMR reaction profiles (and sometimes also ex situ 1H NMR 
measurements). Next to 3a, DIPEA and secondary products of DIPEA were also found in small amounts 
within the precipitate. Furthermore, the photocatalyst P3 could be identified probably owing to its poor 
solubility in CD3CN even at low concentrations. Due to the precipitate being dissolved in non-deuterated 
DMSO, a double solvent suppression comprising of presaturation and excitation sculpting was employed 
to get rid of the DMSO and water signals. 
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Figure S-4-21. Excerpt of the 1H proton spectrum of the precipitated solid during the reaction dissolved 
in DMSO. The signals clearly show product 3a as one of the prominent components besides the 
photocatalyst P3, DIPEA and secondary products of DIPEA. The DMSO and water peaks were 
suppressed via a combination of excitation sculpting and presaturation.  
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4.5 Product Characterizations 
3-Benzyloxazolidin-2-one[21]  
 3a 
Yield: 96%, 0,096 mmol, 17.0 mg, yellowish oil; (70%, 4.9 mmol, 865 mg for the gram scale reaction). 
1H NMR (400 MHz, CDCl3); δ [ppm]: 7.39-7.27 (m, 5H); 4.43 (s, 2H); 4.33-4.27 (t, J = 8.0 Hz, 2H); 3.45-
3.39 (t, J = 8.0 Hz, 2H. 13C NMR (101 MHz, CDCl3); δ [ppm]: 158.7; 135.9; 129.0; 128.3; 128.1; 61.9; 
48.6; 44.1. HR-MS (ESI): (M+H)+: calc.: 178.0863, found: 178.0867. MF: C10H11NO2. MW: 177.20 g/mol. 
 
3-Methyloxazolidin-2-one[22] 
 3b 
Yield: 99%, 0,199 mmol, 20.1 mg, yellowish oil. 
1H NMR (400 MHz, CDCl3); δ [ppm]: 4.32-4.26 (t, J = 8.0 Hz 2H); 3.58-3.52 (t, J = 8.0 Hz 2H); 2.87 (s, 
3H). 13C NMR (101 MHz, CDCl3); δ [ppm]: 158.9; 61.6; 46.9; 31.2. HR-MS (ESI): (M+H)+: calc.: 
102.0550, found: 102.0550. MF: C4H7NO2. MW: 101.11 g/mol. 
 
1-Butylimidazolidin-2-one 
 3c 
Yield: 99%, 0,198 mmol, 28.2 mg, yellowish oil. 
1H NMR (400 MHz, CDCl3); δ [ppm]: 4.73 (brs, 1H); 3.42-3.68 (m, 4H); 3.19-3.13 (t, J = 7.3 Hz, 2H); 
1.51-1.43 (m, 2H); 1.36-1.29 (m, 2H); 0.94-0.89 (t, J = 7.3 Hz, 3H). 13C NMR (101 MHz, CDCl3); δ [ppm]: 
163.1; 45.1; 43.4; 38.4; 29.9; 20.1; 13.9. HR-MS (ESI): (M+H)+: calc.: 143.1179, found: 143.1182. MF: 
C7H14N2O. MW: 142.20 g/mol. 
 
1-Benzylimidazolidin-2-one[23] 
 3d 
Yield: 68%, 0,136 mmol, 25.6 mg, yellowish solid. 
1H NMR (400 MHz, CDCl3); δ [ppm]: 7.36-7.24 (m, 5H); 4.85 (brs, 1H); 4.37 (s, 2H); 3.43-3.37 (m, 2H); 
3.33-3.27 (m, 2H). 13C NMR (101 MHz, CDCl3); δ [ppm]: 162.8; 137.2; 128.7; 128.2; 127.6; 47.8; 44.7; 
38.2. HR-MS (ESI): (M+H)+: calc.: 177.1022, found: 177.1025. MF: C10H12N2O. MW: 176.22 g/mol. 
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Oxazolidin-2-one[24] 
 3e 
Yield: 84%, 0,146 mmol, 14.6 mg, yellowish solid. 
1H NMR (400 MHz, CDCl3); δ [ppm]: 5.98 (brs, 1H); 4.49-4.39 (t, J = 8.0 Hz 2H); 3.66-3.60 (t, J = 8.0 Hz 
2H). 13C NMR (101 MHz, CDCl3); δ [ppm]: 160.8; 65.1; 40.8. HR-MS (EI): (M)+∙: calc.: 87.0315, found: 
87.0330. MF: C3H5NO2. MW: 87.08 g/mol. 
 
1,3-Oxazinan-2-one[25] 
 3f 
Yield: 63%, 0,126 mmol, 12.8 mg, yellowish solid. 
1H NMR (400 MHz, DMSO-d6); δ [ppm]: 7.11 (brs, 1H); 4.17-4.11 (t, J = 5.3 Hz 2H); 3.18-3.12 (m, 2H); 
1.85-1.77 (quint., J = 5.0 Hz, 6.0 Hz, 2H). 13C NMR (101 MHz, DMSO-d6); δ [ppm]: 152.8; 66.1; 38.9; 
20. 9. HR-MS (ESI): (M+H)+: calc.: 102.0550, found: 102.0552. MF: C4H7NO2. MW: 101.11 g/mol. 
 
1,3-Dioxolan-2-one[26] 
 3g 
Yield: 70%, 0,139 mmol, 12.3 mg, yellowish oil. 
1H NMR (400 MHz, CDCl3); δ [ppm]: 4.52 (s, 1H). 13C NMR (101 MHz, CDCl3); δ [ppm]: 155.5; 64.7. 
HR-MS (EI): (M)+∙: calc.: 88.0160, found: 88.0168. MF: C3H4O3. MW: 88.06 g/mol. 
1,3-Dioxan-2-one[27] 
 3h 
Yield: 99%, 0,198 mmol, 20.2 mg, yellowish oil. 
1H NMR (400 MHz, CDCl3); δ [ppm]: 4.47-4.41 (t, J = 5.7 Hz, 4H); 2.17-2.10 (quint, J = 5.7 Hz, J = 5.7 
Hz, 2H). 13C NMR (101 MHz, CDCl3); δ [ppm]: 148.6; 68.0; 21.9. HR-MS (EI): (M)+∙: calc.: 102.0317, 
found: 102.0320. MF: C4H6O3. MW: 102.09 g/mol.   
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Imidazolin-2-one[28] 
 3i 
Yield: 65%, 0,130 mmol, 11.2 mg, yellowish solid. 
1H NMR (400 MHz, Acetone-d6); δ [ppm]: 5.61 (brs, 2H); 3.42 (s, 4H). 13C NMR (101 MHz, Acetone-
d6); δ [ppm]: 165.4; 41.4. HR-MS (ESI): (M+H)+: calc.: 87.0553, found: 87.0551. MF: C3H6N2O. MW: 
86.09 g/mol. 
 
Tetrahydropyrimidin-2-(1H)-one[29] 
 3j 
Yield: 73%, 0,146 mmol, 14.7 mg, yellowish solid. 
1H NMR (400 MHz, DMSO-d6); δ [ppm]: 6.05 (s, 2H); 3.10-3.04 (m, 4H); 1.71-1.63 (quint, J = 5.8 Hz, 
5.8 Hz, 2H). 13C NMR (101 MHz, DMSO-d6); δ [ppm]: 155.8; 39.4; 21.5. HR-MS (ESI): (M+H)+: calc.: 
101.0709, found: 101.0710. 
MF: C4H8N2O. MW: 100.12 g/mol. 
 
3-(2-Hydroxypropyl)-5-methyloxyzolidin-2-one 
 3k 
Yield: 70%, 0,140 mmol, 22.4 mg, yellowish oil. 
1H NMR (400 MHz, CDCl3); δ [ppm]: 4.71-4.56 (m, 1H); 4.07-3.97 (m, 1H); 3.83-3.74 (m, 1H); 3.30-3.12 
(m, 3H); 2.65 (brs, 1H); 1.44-1.40 (d, J = 6.3 Hz, 3H); 1.22-1.19 (d, J = 6.3 Hz, 3H). 13C NMR (101 MHz, 
CDCl3); δ [ppm]: 159.1; 70.6; 66.7; 53.2; 51.8; 21.1; 20.7. HR-MS (ESI): (M+H)+: calc.: 160.0968, found: 
160.0968. MF: C7H13NO3. MW: 159.19 g/mol. 
 
(3aR,8aS)-decahydro-2H-indeno[1,2-d]oxazol-2-one 
 3l 
Yield: 53%, 0,106 mmol, 18.3 mg, yellowish solid. 
1H NMR (400 MHz, CDCl3); δ [ppm]: 7.34-7.23 (m, 4H); 6.37 (brs, 1H); 5.44-5.38 (m, 1H); 5.20-5.15 (d, 
J = 7.3 Hz, 1H); 3.45-3.30 (m, 2H). 13C NMR (101 MHz, CDCl3); δ [ppm]: 159.5; 140.3; 140.0; 129.6; 
128.1; 125.8; 124.8; 80.7; 61.3; 39.0. HR-MS (ESI): (M+H)+: calc.: 176.0706, found: 176.0707. MF: 
C10H9NO2. MW: 175.19 g/mol. 
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(3aR,7aS)-Hexahydrobenzo[d][1,3]dioxol-2-one 
 3m 
Yield: 72%, 0,144 mmol, 20.6 mg, yellowish oil. 
1H NMR (400 MHz, CDCl3); δ [ppm]: 4.71-4.64 (m, 2H); 1.94-1.85 (m, 4H); 1.68-1.56 (m, 2H); 1.47-1.37 
(m, 2H). 13C NMR (101 MHz, CDCl3); δ [ppm]: 155.5; 75.9; 26.9; 19.3. HR-MS (EI): (M-HCO2)+∙: calc.: 
97.0653, found: 97.0655. MF: C7H10O3. MW: 142.15 g/mol.  
 
Ethyl (S)-2-oxooxazolidinine-4-carboxylate[30] 
 3n 
Yield: 99%, 0,198 mmol, 31.6 mg, yellowish oil. 
1H NMR (400 MHz, CD3CN); δ [ppm]: 6.23 (brs, 1H); 4.56-4.49 (m, 1H); 4.40-4.34 (m, 2H); 4.23-4.16 
(q, J = 7.2 Hz, 7.0 Hz, 2H); 1.28-1.23 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CD3CN); δ [ppm]: 171.8; 
159.6; 67.7; 62.7; 54.6; 14.4. HR-MS (ESI): (M+H)+: calc.: 160.0604, found: 160.0610. MF: C6H9NO4. 
MW: 159.14 g/mol. 
Reaction conditions: The compound was prepared according to general procedure A but 4 equiv. of 
DIPEA were used because the starting material was a hydrochloride salt. 
 
Benzyl (S)-2-oxooxazolidinine-4-carboxylate 
 3o 
Yield: 79%, 0,158 mmol, 35.1 mg, yellowish oil. 
1H NMR (400 MHz, CD3CN); δ [ppm]: 7.38-7.32 (m, 5H); 6.28 (brs, 1H); 4.62-4.55 (m, 1H); 4.52-4.46 
(m, 1H); 4.45-4.39 (m, 1H). 13C NMR (101 MHz, CD3CN); δ [ppm]: 170.0; 158.9; 134.6; 129.0; 128.9; 
128.7; 68.1; 66.7; 53.9. HR-MS (ESI): (M+H)+: calc.: 222.0761, found: 222.0764. MF: C11H11NO4. MW: 
221.21 g/mol. 
Reaction conditions: The compound was prepared according to general procedure A but 4 equiv. of 
DIPEA were used because the starting material was a hydrochloride salt. 
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Methyl (4S,5R)-5-methyl-2-oxooxazolidine-4-carboxylate[31] 
 3p 
Yield: 70%, 0,140 mmol, 22.4 mg, yellowish oil. 
1H NMR (400 MHz, CDCl3); δ [ppm]: 6.25 (brs, 1H); 4.77-4.68 (quint, J = 6.3 Hz, 5.9 Hz, 1H); 4.01-3.97 
(d, J = 5.4 Hz, 1H); 3.80 (s, 3H); 1.56-1.53 (d, J = 6.4 Hz, 3H). 13C NMR (101 MHz, CDCl3); δ [ppm]: 
170.3; 158.3; 75.7; 60.4; 53.1; 21.2. HR-MS (ESI): (M+H)+: calc.: 160.0604, found: 160.0612. MF: 
C6H9NO4. MW: 159.14 g/mol. 
Reaction conditions: The compound was prepared according to general procedure A but 4 equiv. of 
DIPEA were used because the starting material was a hydrochloride salt. 
 
Methyl (R)-2-oxothiazolidine-4-carboxylate[30] 
 3q 
Yield: 60%, 0,120 mmol, 19.4 mg, yellowish oil. 
1H NMR (400 MHz, CDCl3); δ [ppm]: 6.14 (brs, 1H); 4.47-4.39 (m, 1H); 3.82 (s, 3H); 3.71-3.67 (d, J = 
8.2 Hz, 1H) 3.66-3.62 (d, J = 5.2 Hz, 1H). 13C NMR (101 MHz, CDCl3); δ [ppm]: 174.4; 170.5; 55.9; 53.3; 
31.9. HR-MS (ESI): (M+H)+: calc.: 162.0219, found: 162.0219. MF: C5H7NO3S. MW: 161.18 g/mol. 
Reaction conditions: The compound was prepared according to general procedure A but 4 equiv. of 
DIPEA were used because the starting material was a hydrochloride salt. 
 
(S)-Tetrahydro-1H,3H-pyrrolo[1,2-c]oxazol-3-one[32] 
 3r 
Yield: 58%, 0,116 mmol, 14.8 mg, yellowish oil. 
1H NMR (400 MHz, CDCl3); δ [ppm]: 4.54-4.47 (t, J = 8.3 Hz, 1H); 4.19-4.13 (dd, J = 8.9 Hz, 3.7 Hz, 
1H); 3.90-3.84 (m, 1H); 3.69-3.60 (m, 1H); 3.22-3.13 (m, 1H); 2.11-2.01 (m, 2H); 1.97-1.87 (m, 1H); 
1.53-1.41 (m, 1H). 13C NMR (101 MHz, CDCl3); δ [ppm]: 161.8; 67.9; 59.6; 45.9; 30.9; 25.8. HR-MS 
(ESI): (M+H)+: calc.: 128.0706, found: 128.0709. MF: C6H9NO2. MW: 127.14 g/mol. 
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(S)-4-Isopropyloxazolidin-2-one[32] 
 3s 
Yield: 59%, 0,118 mmol, 15.1 mg, yellowish oil. 
1H NMR (400 MHz, CDCl3); δ [ppm]: 6.39 (brs, 1H); 4.47-4.40 (t, J = 8.6 Hz, 3.7 Hz, 1H); 4.13-4.06 (dd, 
J = 6.3 Hz, 2.4 Hz, 1H); 3.64-3.56 (q, J = 6.8 Hz, 8.4 Hz, 1H); 1.76-1.69 (m, 1H); 0.97-0.94 (d, J = 6.7 
Hz, 2H); 0.91-0.88 (d, J = 6.8 Hz, 2H). 13C NMR (101 MHz, CDCl3); δ [ppm]: 160.4; 68.7; 58.5; 32.8; 
18.1; 17.8. HR-MS (ESI): (M+H)+: calc.: 130.0863, found: 130.0866. MF: C6H11NO2. MW: 129.16 g/mol. 
 
(S)-4-(4-Hydroxybenzyl)oxazolidin-2-one[33] 
 3t 
Yield: 58%, 0,116 mmol, 22.5 mg, white solid. 
1H NMR (400 MHz, DMSO-d6); δ [ppm]: 9.24 (s, 1H); 7.72 (s, 1H); 7.04-7.00 (d, J = 8.5 Hz, 2H); 6.70-
6.66 (d, J = 8.5 Hz, 2H); 4.27-4.18 (m, 1H); 4.00-3.91 (m, 2H); 2.73-2.67 (m, 1H); 2.64-2.57 (m, 1H). 13C 
NMR (101 MHz, DMSO-d6); δ [ppm]: 158.6; 156.0; 130.3; 126.5; 115.2; 68.0; 52.7; 39.4. HR-MS (ESI): 
(M+H)+: calc.: 194.0821, found: 194.0816. MF: C10H11NO3. MW: 193.20 g/mol. 
Reaction conditions: The compound was prepared according to general procedure A but 4 equiv. of 
DIPEA were used because the starting material was a hydrochloride salt. 
 
(S)-4-((1H-Indol-3-yl)methyl)oxazolidin-2-one[30] 
 3u 
Yield: 79%, 0,158 mmol, 34.0 mg, yellowish oil. 
1H NMR (400 MHz, Acetone-d6); δ [ppm]: 10.14 (brs, 1H); 7.63-7.57 (d, J = 7.8 Hz, 1H); 7.43-7.37 (d, J 
= 8.1 Hz, 1H); 7.27 (s, 1H); 7.14-6.99 (dt, J = 33.5 Hz, 7.6 Hz, 2H); 6.69 (brs, 1H); 4.41-4.33 (t, J = 8.4 
Hz, 1H); 4.28-4.19 (quint, J  = 6.6 Hz, 1H); 4.14-4.07 (m, 1H); 3.13-2.94 (m, 2H). 13C NMR (101 MHz, 
Acetone-d6); δ [ppm]: 159.6; 137.7; 128.6; 124.3; 122.3; 119.7; 119.1; 112.3; 110.6; 70.0; 53.4; 31.7. 
HR-MS (ESI): (M+H)+: calc.: 217.0972, found: 217.0970. MF: C12H12N2O2. MW: 216.24 g/mol. 
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(S)-4-(2-(Methylthio)ethyl)oxazolidin-2-one[34] 
 3v 
 
Yield: 99%, 0,198 mmol, 32.0 mg, yellowish oil. 
1H NMR (400 MHz, CDCl3); δ [ppm]: 6.19 (brs, 1H); 4.56-4.48 (m, 1H); 4.07-3.98 (m, 2H); 2.59-2.54 (t, 
J = 7.1 Hz, 2H); 2.11 (s, 3H); 1.93-1.84 (m, 2H). 13C NMR (101 MHz, CDCl3); δ [ppm]: 159.7; 70.2; 52.1; 
34.2; 30.5; 15.7. HR-MS (EI): (M)+ : calc.: 161.0505, found: 161.0506. MF: C6H11NO2S. MW: 161.22 
g/mol. 
 
1-((3aR,4R,6R,6aR)-6-(Hydroxymethyl)-2-oxotetrahydrofuro[3,4-d][1,3]dioxol-4-yl)-pyrimidine-
2,4(1H,3H)-dione 
 3w 
Yield: 27%, 0,054 mmol, 14.5 mg, colorless solid. 
1H NMR (400 MHz, DMSO-d6); δ [ppm]: 11.48 (brs, 1H); 7.77-7.71 (d, J = 8.1 Hz, 1H); 6.00-5.95 (d, J 
= 2.2 Hz, 1H); 5.68-5.63 (dd, J = 8.0 Hz, 2.1 Hz, 1H); 5.59-5.52 (dd, J = 7.8 Hz, 2.2 Hz, 1H); 5.25-5.20 
(dd, , J = 7.7 Hz, 3.8 Hz, 1H); 5.18-5.13 (t, J = 5.5 Hz, 1H); 4.29-4.24 (q, J = 5.5 Hz, 4.1 Hz, 1H); 3.63-
3.58 (t, J = 5.5 Hz, 2H). 13C NMR (101 MHz, DMSO-d6); δ [ppm]: 163.3; 153.7; 150.3; 142.8; 101.8; 
92.0; 86.2; 82.8; 80.2; 60.7. HR-MS (ESI): (M-H)-: calc.: 269.0415, found: 269.0420. MF: C10H10N2O7. 
MW: 270.20 g/mol. 
  
__________________________________________________________________________________ 
125 
1-((3aR,4R,6R,6aR)-6-(Hydroxymethyl)-2-oxotetrahydrofuro[3,4-d][1,3]dioxol-4-yl)-5-
methylpyrimidine-2,4(1H,3H)-dione 
 3x 
Yield: 44%, 0,088 mmol, 25.0 mg, colorless solid. 
1H NMR (400 MHz, Acetone-d6); δ [ppm]: 10.21 (brs, 1H); 7.63-7.58 (m, 1H); 5.97-5.93 (m, 1H); 5.68-
5.63 (dd, J = 2.3 Hz, 5.4 Hz, 1H); 5.44-5.37 (m, 1H); 4.42-4.35 (q, J = 4.8 Hz, 4.2 Hz, 1H); 4.34-4.27 (t, 
J = 5.7 Hz, 1H); 3.89-3.80 (m, 2H); 1.84-1.81 (m, 3H). 13C NMR (101 MHz, Acetone-d6); δ [ppm]: 164.3; 
154.4; 151.4; 139.3; 111.2; 94.2; 87.7; 83.9; 81.0; 62.3; 12.3. HR-MS (ESI): (M-H)-: calc.: 283.0572, 
found: 283.0580. MF: C11H12N2O7. MW: 284.22 g/mol. 
 
1-((3aR,4R,6R,6aR)-6-(Hydroxymethyl)-2-oxotetrahydrofuro[3,4-d][1,3]dioxol-4-yl)-1H-1,2,4-
triazole-3-carboxamide 
 3y 
Yield: 45%, 0,090 mmol, 24.1 mg, colorless solid. 
1H NMR (400 MHz, DMSO-d6); δ [ppm]: 8.85 (s, 1H); 7.90 (brs, 1H); 7.70 (brs, 1H); 6.58 (s, 1H); 5.80-
5.76 (d, J = 7.2 Hz, 1H); 5.49-5.45 (m, 1H); 5.14-5.09 (t, J = 5.5 Hz, 1H); 4.48-4.42 (t, J = 6.5 Hz, 1H); 
3.53-3.38 (m, 2H). 13C NMR (101 MHz, DMSO-d6); δ [ppm]: 160.5; 158.0; 153.9; 146.3; 110.0; 91.2; 
88.0; 83.7; 81.6; 60.8. HR-MS (ESI): (M+H)+: calc.: 271.0673, found: 271.0677. MF: C9H10N4O6. MW: 
270.20 g/mol. 
Reaction conditions: The compound was prepared according to general procedure A but DMF was 
used as a solvent instead of MeCN. 
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3-Isopropyl-5-((napthalen-1-yloxy)methyl)oxazolidine-2-one 
 3z 
Yield: 66%, 0,132 mmol, 37.6 mg, yellowish oil. 
1H NMR (300 MHz, CDCl3); δ [ppm]: 8.22-8.14 (m, 1H); 7.83-7.77 (m, 1H); 7.51-7.43 (m, 3H); 7.40-7.33 
(m, 1H); 6.83-6.77 (d, J = 7.4 Hz, 1H); 5.01-4.90 (m, 1H); 4.32-4.25 (d, J = 4.6 Hz, 2H); 4.25-4.14 (quint, 
J = 6.8 Hz, 6.8 Hz, 1H); 3.76-3.69 (t, J = 8.8 Hz, 2H); 3.63-3.56 (m, 1H); 1.25-1.20 (d, J = 6.8 Hz, 6H). 
13C NMR (75 MHz, CDCl3); δ [ppm]: 156.9; 153.9; 134.6; 127.6; 126.7; 125.7; 125.6; 121.8; 121.3; 
104.9; 71.0; 68.4; 45.0; 42.0; 19.9. HR-MS (ESI): (M+H)+: calc.: 286.1438, found: 286.1452. MF: 
C17H19NO3. MW: 285.34 g/mol. 
Reaction conditions: The compound was prepared according to general procedure A but 4 equiv. of 
DIPEA were used because the starting material was a hydrochloride salt. 
 
5-(3,4-Dihydroxyphenyl)-3,4-dimethyloxazolidin-2-one 
 3aa 
Yield: 67%, 0,134 mmol, 28.0 mg yellowish solid. 
1H NMR (400 MHz, Acetone d6); δ [ppm]: 8.05 (brs, 2H); 6.92-6.88 (m, 1H); 6.86-6.81 (m, 1H); 6.78-
6.74 (m, 1H); 5.38-5.30 (t, J = 7.9 Hz, 1H); 3.94-3.88 (t, J = 8.6 Hz, 1H); 3.47-3.41 (m, 1H); 2.85 (s, 3H). 
13C NMR (101 MHz, Acetone d6); δ [ppm]: 158.7; 146.4; 146.2; 132.0; 118.8; 116.1; 114.1; 75.0; 54.8; 
31.2. HR-MS (ESI): (M+H)+: calc.: 210.0761, found: 210.0765. MF: C10H11NO4. MW: 209.20 g/mol. 
Reaction conditions: The compound was prepared according to general procedure A but 4 equiv. of 
DIPEA were used because the starting material was a hydrochloride salt. 
 
3,4-Dimethyl-5-phenyloxazolidin-2-one[30] 
 3ab 
Yield: 83%, 0,166 mmol, 31.8 mg, yellowish solid. 
1H NMR (400 MHz, CDCl3); δ [ppm]: 7.41-7.24 (m, 5H); 5.60-5.55 (d, J = 8.2 Hz, 1H); 4.05-3.97 (m, 1H); 
2.88 (s, 3H); 0.80-0.76 (d, J = 6.6 Hz, 3H). 13C NMR (101 MHz, CDCl3); δ [ppm]: 158.2; 135.3; 128.61; 
128.59; 126.3; 78.5; 57.2; 29.1; 14.4. HR-MS (ESI): (M+H)+: calc.: 192.1019, found: 192.1024. MF: 
C11H13NO2. MW: 191.23 g/mol. 
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4-(1-Methyl-1H-pyrrol-2-yl)benzonitrile[35] 
 5a 
Yield: 48%, 0,096 mmol, 17.5 mg, yellowish oil. 
1H NMR (400 MHz, CDCl3); δ [ppm]: 7.69-7.65 (m, 2H); 7.83-7.77 (m, 1H); 7.53-7.48 (m, 2H); 6.80-6.77 
(m, 1H); 6.37-6.34 (m, 1H); 6.26-6.22 (m, 1H); 3.72 (s, 3H). 13C NMR (101 MHz, CDCl3); δ [ppm]: 137.8; 
132.7; 132.4; 128.4; 126.0; 119.2; 110.9; 109.8; 108.7; 35.6. HR-MS (EI): (M) +: calc.: 182.0838, found: 
182.0839. MF: C12H10N2. MW: 182.23 g/mol. 
Reaction conditions: The compound was prepared according to general procedure A but an additional 
10 equiv. of N-methylpyrrole were added to trap the aryl radical. 
 
4-(3-Phenylpropyl)benzonitrile[36] 
 5b 
 
Yield: 45%, 0,090 mmol, 20.0 mg, colorless oil. 
1H NMR (400 MHz, CDCl3); δ [ppm]: 7.60-7.54 (d, J = 8.3 Hz, 2H); 7.32-7.26 (m, 4H); 7.25-7.18 (m, 3H); 
2.75-2.61 (m, 4H); 2.02-1.92 (m, 2H). 13C NMR (101 MHz, CDCl3); δ [ppm]: 148.1; 141.7; 132.3; 129.4; 
128.6; 128.5; 126.1; 119.3; 109.8; 35.6; 35.4; 32.6. HR-MS (EI): (M) +: calc.: 221.1199, found: 221.1194. 
MF: C16H15N. MW: 221.30 g/mol. 
Reaction conditions: The compound was prepared according to general procedure A but an 
additional10 equiv. of allylbenzene were added to trap the aryl radical. 
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5. Summary 
This thesis presents photochemical and photocatalytic oxidative halogenations of arenes and aryl 
cyclopropanes as well as the reductive generation of fluorophosgene. The common aspect of the 
different projects is the presence of halides which are an often-encountered functional group in organic 
molecules (Chapter 1). Therefore, both innovative ways for the introduction of halides into organic 
molecules (Chapter 2-3) as well as new methods for their use as leaving group (Chapter 4) were 
investigated. 
 
Chapter 1 gives a summary of visible light mediated halogenation strategies involving fluorinations, 
chlorinations, brominations and iodinations of aliphatic and aromatic molecules. 
 
Aryl bromides are a versatile class of organic reagents and although many traditional, thermal methods 
for their preparation have been developed, Chapter 2 describes a visible light mediated procedure for 
this important transformation. The regio-selective bromination of electron rich arenes and heteroarenes 
can be realized with commercially available sodium-2-anthraquinone sulfate (SAS) as a “green” 
photocatalyst. SAS was characterized by determination of its excited state oxidation potential by  
UV-VIS spectroscopy and cyclovoltammetry. Further mechanistic investigations and control reactions 
suggest the direct single electron oxidation of the arene to the corresponding aryl radical cation 
intermediate as the catalytic key-step. 
 
Chapter 3 deals with the photochemical oxochlorination of aryl cyclopropanes to from β chloro ketones. 
These versatile building blocks can act as precursors for several follow-up reactions especially the 
synthesis of heterocycles and could potentially serve as starting materials for bioconjugation e.g. to from 
antibody drug conjugates. To achieve this transformation, only common lab chemicals (HCl, HNO3 and 
O2) as well as 395 nm light are necessary. The reaction mechanism was elucidated by 18O labelling 
experiments, cyclovoltammetry, UV-VIS spectroscopy and several control reactions suggesting a 
chlorine radical based chain reaction as operative pathway. 
 
In Chapter 4 the photocatalytic generation of fluorophosgene is presented. This hazardous and highly 
toxic reagent can be liberated safely from a commercially available and bench stable aryl 
trifluoromethoxyether via single electron reduction and subsequent fragmentation. The fluorophosgene 
can react in situ with diol, diamines and 2-aminoalcohols to give the corresponding carbonates, urea 
derivatives and carbamates. A key part of the project was the investigation of the reaction mechanism 
by in-depth NMR studies as well as transient spectroscopy, cyclovoltammetry and control reactions 
leading to a complex, but well supported mechanistic proposal.  
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6. Zusammenfassung 
In dieser Arbeit werden photochemische und photokatalytische oxidative Halogenierungen von Arenen 
und Arylcyclopropanen, sowie die reduktive Erzeugung von Fluorphosgen vorgestellt. Die 
Gemeinsamkeit der Projekte ist das Strukturmotiv der Halogene, die eine wichtige funktionelle Gruppe 
in der organischen Synthese darstellen (Kapitel 1). Sowohl das Einführen von Halogenen in organische 
Moleküle (Kapitel 2-3), als auch ihre Nutzung als Abgangsgruppe (Kapitel 4) wurde intensiv erforscht. 
 
Kapitel 1 gibt einen Überblick über verschiedene durch sichtbares Licht vermittelte 
Halogenierungsstrategien und beinhaltet sowohl die neusten Forschungsergebnisse über 
photokatalytische Fluorierungen als auch Chlorierungen, Bromierungen und Iodierungen. 
 
Arylbromide sind eine vielseitige Klasse organischer Reagenzien und obwohl viele thermische 
Verfahren zu ihrer Herstellung entwickelt wurden, beschreibt Kapitel 2 ein durch sichtbares Licht 
vermitteltes neues Verfahren für diese wichtige synthetische Umwandlung. Die regioselektive 
Bromierung elektronenreicher Aromaten und Heteroaromaten kann mit handelsüblichem  
Natrium-2-Anthrachinonsulfat (SAS) als "grünem" Photokatalysator realisiert werden. SAS wurde durch 
Bestimmung seines Oxidationspotentials im angeregten Zustand, durch UV-VIS-Spektroskopie und 
Cyclovoltammetrie charakterisiert. Weitere mechanistische Untersuchungen und Kontrollreaktionen 
legen die direkte Einelektronenoxidation des Aromaten zu dem entsprechenden Arylradikalkationen-
Intermediat als katalytischen Schlüsselschritt nahe. 
 
Kapitel 3 befasst sich mit der photochemischen Oxochlorierung von Arylcyclopropanen zu  
β-Chlorketonen. Diese vielseitigen Bausteine können als Vorläufer für mehrere Folgereaktionen, 
insbesondere für die Synthese von Heterocyclen, dienen und könnten möglicherweise als 
Ausgangsmaterialien für die Konjugation von Wirkstoffen an Biomoleküle verwendet werden 
(Antikörper-Wirkstoff-Konjugate). Um diese synthetische Umwandlung zu erreichen, sind nur 
gewöhnliche Laborchemikalien (HCl, HNO3 und O2) sowie Licht mit einer Wellenlänge von 395 nm 
erforderlich. Der Reaktionsmechanismus wurde durch 18O-Markierungsexperimente, 
Cyclovoltammetrie, UV-VIS-Spektroskopie und verschiedene Kontrollreaktionen aufgeklärt und läuft 
wahrscheinlich über eine Chlorradikal-Kettenreaktion ab. 
 
In Kapitel 4 wird die photokatalytische Erzeugung von Fluorphosgen vorgestellt. Dieses gefährliche und 
hochtoxische Reagens kann aus einem stabilen, im Handel erhältlichen Trifluormethoxybenzol-Derivat 
durch Einelektronenreduktion mit anschließender Fragmentierung freigesetzt werden. Das 
Fluorphosgen kann in situ mit Diolen, Diaminen und 2-Aminoalkoholen zu den entsprechenden 
Carbonaten, Harnstoffderivaten und Carbamaten reagieren. Ein wesentlicher Teil des Projekts war die 
Untersuchung des Reaktionsmechanismus durch umfassende NMR-Studien sowie transiente 
Spektroskopie, Cyclovoltammetrie und Kontrollreaktionen, die zu einem komplexen, aber experimentell 
gut belegten, mechanistischen Vorschlag führten. 
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8. Abbreviations 
A A  ampere  
 Å  Ångström  
 AcOH acetic acid 
 Ar  aryl  
 ATRA atom transfer radical addition 
B BDE  bond dissociation energy  
 bpy  2,2’-bipyridine  
 Bu  butyl  
 Bz benzyl 
C  °C  degree Celsius  
 calc.  calculated  
 CBr4 tetrabromomethane 
 CDCl3  deuterated chloroform 
 CH2I2 diiodomethane 
 CT charge transfer 
 CV  cyclic voltammetry  
D dx  deuterated (x times)  
 DADS decay associated difference spectrum 
 DCE  1,2-dichloroethane  
 DCM  dichloromethane  
 DIPEA  N,N-diisopropylethylamine  
 DMF  N,N-dimethylformamide  
 DMF-d7  deuterated N,N-dimethylformamide  
 DMSO  dimethyl sulfoxide  
 DMSO-d6 deuterated dimethyl sulfoxide  
 dr  diastereomeric ratio  
 dtbbpy  4,4’-di-tert-butyl-2,2’-dipyridyl  
E EOx/Red oxidation or reduction potential 
 EDG electron donating group 
 EI  electron ionization  
 equiv.  equivalent  
 ESI  electrospray ionization  
 ET  electron transfer 
 Et  ethyl  
 EtOAc  ethyl acetate  
 EtOH ethanol  
 Et2Zn diethyl zinc 
 eV  electron volt  
 EWG electron withdrawing group 
 EY  Eosin Y  
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F Fc  ferrocene  
 Fc+  ferrocenium  
 FID  flame ionization detector 
 Fukuzumi Cat. 9-mesityl-10-methylacridinium tetrafluoroborate 
G  GC  gas chromatography  
H h  hour(s) 
 HBF4 tetrafluoroboric acid 
 H2SO4 sulfuric acid 
 HAT  hydrogen atom transfer  
 HPLC  high-performance/pressure liquid chromatography  
 HRMS  high resolution mass spectrometry  
I 1-ITMH 1-iodo-3,5,5-trimethylhydantoin 
 IS  internal standard  
 ISC  intersystem crossing  
J J  coupling constant  
K  K  Kelvin  
 K2S2O8 potassium persulfate 
 K3PO4 potassium phosphate 
 KBr potassium bromide 
 KHSO4 potassium bisulfate 
L LC  liquid chromatography  
 LCMS liquid chromatography coupled with mass spectrometry 
 LED  light emitting diode  
 LUMO  lowest unoccupied molecular orbital  
 λ  wavelength  
M  M  molarity = mol/L  
 Me  methyl  
 MeCN  acetonitrile (= ACN)  
 MeOD  deuterated methanol  
 MeOH  methanol  
 MF  molecular formula  
 MgSO4  magnesium sulfate  
 MHz  mega hertz  
 min  minute(s)  
 mL  milli liter  
 µL  micro liter  
 mm  milli meter  
 mol%  mol percent  
 MS  mass spectrometry  
 MW  molecular weight  
N NaBr sodium bromide 
 Na2HPO4 disodium phosphate 
 Na2SO4 sodium sulphate 
 NaHCO3 sodium bicarbonate 
 NaNO2 sodium nitrite 
 NBS N-bromosuccinimide 
 NCS N-chlorosuccinimide 
 NFSI N-fluorobenzenesulfonimide 
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 NHE  normal hydrogen electrode  
 NIS N-iodosuccinimide 
 nm  nano meter  
 NMR  nuclear magnetic resonance  
 ns  nanosecond(s)  
 Nu  nucleophile  
O OD optical density 
P p.a.  pro analysis  
 PC  photocatalyst 
 P(Cy)3 tricyclohexyl phosphine 
 Pd(II)Ac2 palladium(II) acetate 
 PE  petroleum ether (hexanes)  
 PET positron emission tomography 
 Ph phenyl  
 PhCl chlorobenzene 
 phen phenanthroline  
 PIDA phenyliodine(III) diacetate 
 ppm  parts per million  
 ppy  2-phenylpyridine  
 Py  pyridine  
R R  alkyl or aryl and functional group(s), respectively 
 rt  room temperature  
S s  second(s)  
 SCE  saturated calomel electrode  
 SET  single electron transfer  
 SF6 sulfur hexafluoride 
T t time 
 TBADT tetrabutylammonium decatungstate 
 TBATFB tetrabutylammonium tetrafluoroborate 
 TEA  triethylamine  
 Tf trifluoromethanesulfonate 
 TFA trifluoroacetic acid 
 THF  tetrahydrofuran  
 TLC  thin-layer chromatography  
U UV  ultraviolet  
V V  volt  
 VIS  visible  
 vs  versus  
W W  watt  
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